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Summary  
 
Cell polarity is a highly conserved characteristic of epithelia. Baz and LKB1 are two key 
players in the establishment of a cellular polarity and the role of their membrane localization 
and organization were the subjects of this study. 
The liver kinase B1 (LKB1) is an essential kinase that regulates various cellular processes by 
modulating the activity of several downstream kinases. Its loss or inactivation is closely 
linked to tumorigenesis. Understanding the regulation of this tumour suppressor will help to 
better understand the process of tumorigenesis itself. The C-terminus of LKB1 beard a 
polybasic motif (lysine and arginine residues), which mediates its membrane localization 
together with a farnesylation site. The polybasic motif acts as a lipid binding (LB) domain 
that directly binds to phosphoinsotides. Deletions of the LB domain and farnesylation site 
cause embryonic lethality and phenocopies a null allele. LKB1 preferentially binds to 
phosphatidic acid (PA), which in turn significantly enhances its catalytic activity. 
Furthermore, also human LKB1 (hLKB1) localizes at the plasmamembrane of epithelial cells, 
which requires its conserved LB domain. Lipid binding is important for hLKB1 to counteract 
mTORC1 in order to suppress cell proliferation in human cancer cell lines. Finally, in 
specimen of melanoma patients, an association of downregulated LKB1 with elevated levels 
of PLD2 (which produces PA that activates LKB1 and mTOR) and activated mTORC1 
targets has been found. Taken together, membrane binding of LKB1 is essential to fully 
activate it in order to counteract cell proliferation and promote development.  
The oligomerization domain (OD) of Bazooka (Baz) has been reported to be important for 
viability of the Drosophila embryo and the cortical localization of the protein. This study 
found a functional redundancy of the OD and the lipid binding (LB) motif that is essential for 
the cortical localization of Baz. Thus, it has been confirmed that the OD contributes to the 
membrane localization of Baz. Nevertheless, in contrast to previous studies oligomerization 
was dispensable for viability of embryos, but a yet undescribed function of the OD to stabilize 
Baz has been observed.  
In the end, a novel basis for the interaction between Baz and Par6 has been determined. A so 
far unrecognized PDZ binding motif (PBM) at the C-terminus of Par6 directly binds to the 
first and the third PDZ domains of Baz. The previously assumed PDZ-PDZ domain 
interaction could not be confirmed in vitro. However, in vivo a functional redundancy of the 
PDZ domain and the PBM of Par6 promotes its apical localization in the epithelium of 
Drosophila embryos.  
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Introduction 
Cell polarity 
Many cell types, such as epithelial cells and stem cells, have a characteristic apical-basal or 
planar polarization. A polarization is established by the asymmetric distribution of cellular 
components, such as proteins or lipids. Polarization might either be a transient or permanent 
feature of cells. Migrating cells are transiently polarized along their migratory direction, 
whereas the oocytes of the worm Caenorhabditis elegans and the fruit fly Drosophila 
melanogaster are polarized from their anterior to posterior pole. Epithelial cells display a 
permanent apical-basal polarization. The apical region of these cells faces towards the outer 
environment or a lumen and the basal region contacts the basement membrane (Wodarz, 
2002). The apical-basal axis is further separated into subdomains with specific functions. 
These subdomains are characterized by different protein complexes that surround the apical 
domain. In Drosophila, the most apical region is the subapical region (SAR), which includes 
the Crumbs (Crb) and Par complexes. The Crb complex consists of the transmembrane 
protein Crb, the scaffold protein Stardust (Sdt), the adaptor protein Lin7 and the scaffold 
protein Pals1 associated tight junction protein (PATJ). Beneath the Crb complex localizes the 
ternary Par complex, which is formed by the scaffold protein Bazooka (Baz), the atypical 
protein kinase C (aPKC) and the scaffold protein Par6 (Tepass, 2012). 
 
 Fig. 1.1: Simplified scheme of the apical-basal polarity of epithelial cells in Drosophila 
and mammals. The different functional domains are highlighted in different colors and 
characteristic proteins are mentioned.  
 
 
Introduction 
7 
 
The adherens junctions (AJ), which are essential to mediate adhesive cell-cell contacts, are the 
subjacent region. The AJ are mainly characterized by the transmembrane protein DE-
Cadherin (DE-Cad), which forms extracellular homophilic interactions and thereby generates 
cellular adhesion. Moreover, DE-Cad connects the cell cortex with the Actin cytoskeleton via 
p120-Catenin, Armadillo (Arm) and α-Catenin (Harris, 2012). 
In the baso-lateral domain localize the septate junctions (SJ), which act as a para cellular 
diffusion barrier. The diffusion barrier is mediated among others by Yurt (Yrt), Coracle (Cor), 
Neurexin IV (NrxIV), Neuroglian (Nrg) and Na+/K+-ATPase (Fehon et al., 1994; 
Baumgartner et al., 1996; Genova and Fehon, 2003; Laprise et al., 2009). In addition, the 
Scribble (Scrib) complex, which contains the proteins Scrib, Lethal 2 giant larvae (Lgl) and 
Disc large (Dlg) is required to establish the basolateral identity by antagonizing the formation 
of apically localized protein complexes (Bilder et al., 2000; Bilder et al., 2003). 
Although the epithelial cell polarity is highly conserved among animals and most proteins are 
conserved from fly to human, its molecular organization varies. In mammals, the most apical 
region is characterized by the tight junctions (TJ). The TJ are the functional equivalent to the 
SJ in Drosophila and act as a para cellular diffusion barrier. Within the apical TJ localize the 
Crb and Par complexes similar to invertebrates. Moreover, the TJ harbor additional proteins, 
such as Occludin and Claudins, that mediate the barrier function (Anderson and van Itallie, 
2009). The AJs are comparable within animals, but the vertebrate baso-lateral domain is 
characterized by desmosomes that connect the intermediate filaments with the plasma-
membrane and form cell-cell contacts with neighboring cells (Fig. 1.1) (Getsios et al., 2004).  
 
The Par Complex 
The Par complex is a ternary complex that is formed by the scaffolding proteins Baz/Par3, 
Par6 and the kinase aPKC (Suzuki and Ohno, 2006). The name Par originates from an initial 
studies in C. elegans, where “partitioning-defective” genes were identified that affect the 
anterior posterior polarity of the early embryo (Kemphues et al., 1988; Watts et al., 1996). Six 
Par proteins have been identified: Par1/MARK, Par2 (C. elegans specific), Par3/Baz, 
Par4/LKB1, Par5/14-3-3 and Par6. The Par complex itself and its functions in cell polarity are 
highly conserved among animals (Goldstein and Macara, 2007; Salinas-Saavedra et al., 
2015).In Drosophila, the Par complex localizes in the SAR and in mammalian cells at the TJ 
(Izumi et al., 1998; Lin et al., 1999; Suzuki et al., 2001; Suzuki and Ohno, 2006; Goldstein 
and Macara, 2007). The Par complex is a key player in the establishment of an apical-basal 
cell polarity in epithelial cells and loss of either of the Par complex proteins results in severe  
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Fig. 1.2: Scheme of the apical-basal regulatory network. (A) The formation of the Par 
complex is mainly regulated by the Par1 dependent phosphorylation of Baz (green). 
Phosphorylated Baz fails to form oligomers and cannot interact with aPKC (gray). The 
dephosphorylation of Baz by PP2A in the apical region mediates the maturation of the Par 
complex. (B) Different polarity complexes mutually inhibit each other and thereby create an 
apical-lateral boundary. Par1 (activated by LKB1) counteracts the Par complex formation, as 
well as the Scrib complex. By contrast, the Par complex promotes the formation of the Crb 
complex and the AJ, whereas it represses basolateral cues.  
 
polarity defects. The initial exclusion of Baz/Par3 from the baso-lateral region by Par1 
promotes its apical accumulation (Benton and St Johnston, 2003a). In the apical domain of the 
cell, aPKC and Par6 bind to Baz/Par3 in order to give rise to the mature Par complex, which 
in turn  promotes the formation of the Crb complex, the TJ and the AJ (Wodarz et al., 2000b; 
Petronczki and Knoblich, 2001; Hirose et al., 2002; Bilder et al., 2003; Sotillos et al., 2004; 
Harris and Peifer, 2004)  
Basolateral proteins (such as Par1 and the Scrib complex) and the Par complex mutually 
antagonize each other to create a boundary between the lateral and the apical domain (Fig. 
1.2). At the lateral membrane, the Par1 mediated phosphorylation of Baz inhibits the 
formation of the Par complex (Benton and St Johnston, 2003a). Moreover, Lgl (a component 
of the Scrib complex) outcompetes Baz/Par3 for binding Par6 and aPKC and thus, prevents 
the ectopic formation of the Par complex (Yamanaka et al., 2003; Yamanaka et al., 2006; 
Wirtz-Peitz et al., 2008). By contrast, at the apical domain, the Par complex counteracts the 
Par1 and Lgl mediated inhibitions. In human cells, aPKCζ phosphorylates Par1b, which 
decreases its kinase activity and membrane association (Hurov et al., 2004). In addition, 
aPKC phosphorylates Lgl in Drosophila, which excludes Lgl from the apical cortex and 
causes the dissociation from Par6 and aPKC (Betschinger et al., 2003; Hutterer et al., 2004; 
Betschinger et al., 2005). Thus, the reciprocal inhibition of lateral and apical cues creates 
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distinct domains along the apical-basal axis (Fig. 1.2B). Thereupon, these domains further 
specify their identity and form a functional epithelium.  
Beyond the polarization of epithelial cells the Par complex is also involved in the polarization 
of neurons. In mammalian neurons the Par complex displays a polarized distribution at the tip 
of the future axon and mediates the axon formation (Shi et al., 2003; Insolera et al., 2011), 
whereas the Par complex is not required for axon and dendrite specification in Drosophila 
(Rolls and Doe, 2004). Hence, although the Par complex and its general functions in polarized 
epithelial cells are conserved among animals, the process of axon specification might underlie 
fundamental different processes in Drosophila and mammals. However, in contrast to adult 
neurons in Drosophila neuroblasts (NBs), which are neuronal stem cells, the Par complex is 
required for their apical-basal polarization. NBs have a characteristic asymmetric cell division 
where the Par complex defines the apical cortex that maintains its stem cell identity after cell 
division. In response to aPKC phosphorylation of Miranda and Numb, both proteins become 
restricted to the basal domain of the NB and recruit the cell fate determinants Prospero and 
Brat. The basal domain will give rise to a ganglion mother cell, which gives rise to either glia 
cells or neurons (Homem and Knoblich, 2012). 
The assembly of the Par complex is mediated by multiple interactions of different functional 
protein domains among Par complex members. The scaffolding protein Baz/Par3 has three  
 
 
Fig. 1.3: Scheme of the molecular interactions among the members of the Par complex. 
The assembly of the Par complex is mediated by several protein interaction modules. Par6 
and aPKC bind each other via their N-terminal PB1 domains. Moreover, aPKC bids directly 
to the PDZ domains two and three or to the aPKC binding region of Baz. Par6 also binds 
directly to the first PDZ domain of Baz and interacts with the GTPase CDC42 via its CRIB 
domain. Finally, Baz self-associates with its N-terminal oligomerization domain. Modified 
from McCaffrey and Macara (2012).  
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PDZ (Postsynaptic density protein 95, Disc large, Zonula occludens 1) domains and a C-
terminal aPKC binding domain (Kuchinke et al., 1998b; Morais-de-Sá et al., 2010). Par6 also 
bears a single PDZ domain that binds to the first PDZ domain of Baz/Par3 (Lin et al., 2000; 
Joberty et al., 2000). Moreover, Par 6 binds with its N-terminal PB1 (Phox and Bem1) 
domain the PB1 domain of aPKC (Noda et al., 2003; Hirano et al., 2005). In addition, aPKC 
binds directly to the PDZ domains two and three as well as the aPKC binding region of 
Baz/Par3 (Wodarz et al., 2000b; Morais-de-Sá et al., 2010). Taken together, the assembly of 
the Par complex depends on the interaction of multiple protein interaction domains of the 
complex members (Fig. 1.3).  
The activity of the Par complex is regulated by itself, because Par6 inhibits the kinase activity 
of aPKC. This inhibition is reversed upon binding of the GTPase CDC42 to the CRIM 
domain of Par6, which induces a conformational change of Par6 and consequently activates 
aPKC (Yamanaka et al., 2001). In contrast, more recent studies demonstrate that Par6 
activates aPKC by replacing its intramolecular pseudosubstrate (Graybill et al., 2012), 
whereas the aPKC binding domain of Baz inhibits the kinase activity of aPKC (Soriano et al., 
2016). Thus, Baz and Par6 act as regulators of the aPKC kinase activity.  
Nevertheless, the Par complex is not a permanent complex, but rather dissociates or 
rearranges during development. In Drosophila, Baz localizes beneath Par6 and aPKC at the 
AJ (Nam and Choi, 2003; Vogelmann and Nelson, 2004; Harris and Peifer, 2005; Martin-
Belmonte et al., 2007; Morais-de-Sá et al., 2010; Doerflinger et al., 2010). Baz has been 
reported to interact with aPKC and Par6 (Wodarz et al., 2000b; Petronczki and Knoblich, 
2001; Hutterer et al., 2004), however in polarized epithelial cells it seems that the Par 
complex assembles only transiently and afterwards Baz segregates towards the AJ (Harris and 
Peifer, 2005). The aPKC dependent phosphorylation of Baz at S980 induces the dissociation 
of the Par6 and aPKC from Baz (Morais-de-Sá et al., 2010). Par6 and aPKC might either be 
retained in the SAR in complex with the Crb-Sdt complex or with CDC42, which have been 
reported to bind Par6 and aPKC and mediate their cortical localization (Lin et al., 2000; 
Joberty et al., 2000; Hurd et al., 2003b; Wang et al., 2004; Kempkens et al., 2006; Atwood et 
al., 2007; Fletcher et al., 2012; Whitney et al., 2016). Moreover, Baz forms an additional 
complex with Sdt, which binds to the aPKC binding region of Baz with its PDZ domain. 
Upon S980 phosphorylation of Baz by aPKC, Baz and Sdt dissociate to give rise to the Crb-
Sdt complex (Krahn et al., 2010a). In summary, the phosphorylation of S980 of Baz by aPKC 
initiates the segregation of Baz to the AJ, the disassembly of the Par complex and the 
formation of the Crb complex, most likely together with Par6 and aPKC. 
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The scaffold protein Bazooka/Par3 
The scaffold protein Baz/Par3 is a key player in the establishment of cell polarity. Loss of baz 
prevents the formation of polarized epithelia and causes embryonic lethality. The embryonic 
epidermis of baz mutants displays holes, from which its name originates. Likewise, mice that 
are homozygous mutant for the mammalian orthologue Par3 die during early embryogenesis 
(around E12.5) (Hirose et al., 2006). In Drosophila, Baz is already maternally provided to 
initiate the early epithelial polarization. During cellularization (the formation of the cellular 
blastoderm) Baz is transported in a Dynein-dependent manner to the apical region (Harris and 
Peifer, 2005). To ensure the lateral inhibition of Baz the serine/threonine kinase Par1 
phosphorylates Baz at two conserved residues (S151 and S1085) (Benton and St Johnston, 
2003a). Binding of 14-3-3 proteins to theses phosphorylated residues prevents Baz from 
oligomerization and binding to aPKC (Benton and St Johnston, 2003a; Hurd et al., 2003a). In 
the apical domain of the cell the protein phosphatase PP2A antagonizes the Par1 mediated 
phosphorylation to promote the maturation of the Par complex (Fig. 1.2A) (Krahn et al., 
2009). By contrast, in Drosophila follicle cells (the epithelium around the egg chamber, FCs) 
Baz is dispensable for the formation of a polarized epithelium (Shahab et al., 2015). Thus, in 
FCs redundant mechanisms contribute to the cellular polarization. 
In mice, Par3 has been reported to act as an exocyst receptor at the AJs (Ahmed and Macara, 
2017). The exocyst is an octameric protein complex that mediates directed vesicle trafficking 
to deliver proteins (e.g. E-Cadherin) to the plasmamembrane. However, in Drosophila NBs 
the exocyst complex is dispensable for cell apical-basal polarity (Halbsgut et al., 2011), thus 
Baz’s function as an exocyst receptor might be restricted to epithelial cells.  
In mouse mammary glands, Par3 antagonizes tumorigenesis by counteracting metastasis 
formation by inhibiting aPKC (McCaffrey et al., 2012; Guyer and Macara, 2015). 
Nevertheless, loss of Par3 alone does not promote the formation of tumors, however, loss of 
Par3 associates with a decreased survival rate of breast cancer patients (McCaffrey et al., 
2012). Similar, in baz mutant clones of the Drosophila wing disc the loss of Baz does not 
enhace the levels of Cycline-E (personal unpublished observation). 
In mammals, another isoform of Par3, namely Par3-like (Par3L), has been identified (Fig. 
1.4). In contrast to Par3, Par3L lacks the critical aPKC binding domain (Gao et al., 2002). A 
Par3L specific function is the inhibition of LKB1 in order to maintain mammary stem cell 
identity (Huo and Macara, 2014). Although Drosophila encodes only a single Par3 isoform, 
this isoform fails to bind LKB1 and hence, cannot compensate the function of Par3L 
(personal unpublished observation). 
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Fig. 1.4: Comparison of Drosophila and human Par3 homologs. The N-terminal 
oligomerization domain (blue) of Baz is followed by three PDZ domains (orange) that 
mediate protein-protein interactions. At the C-terminus Baz has a lipid binding domain (red). 
The two Par1 phosphorylation sites (S151 and S 1085, purple) are important for its lateral 
exclusion. The aPKC phosphorylation site (S980 in Drosophila and S827 in human) is 
essential for the interaction of Baz and aPKC. The numbers represent amino acid positions.  
 
At the structural level, Baz/Par3 has a conserved N-terminal oligomerization domain (OD) 
that mediates self-association of Baz monomers in a front-to-back manner, which are further 
assembled into a filament-like oligomer (Mizuno et al., 2003; Benton and St. Johnston, 
2003b; Feng et al., 2007; Zhang et al., 2013a). Additionally, Baz contains three PDZ 
domains, which mediate protein interaction (Fig. 1.4). By interacting with the cell adhesion 
molecule Echinoid, the tight-junction-associated protein junctional adhesion molecule (JAM) 
and Armadillo (Arm)/ß-Catenin redundant mechanisms target Baz to the apical junctions 
(Itoh et al., 2001; Ebnet et al., 2001; Takekuni et al., 2003; Wei et al., 2005). In Drosophila 
photoreceptor cells, the phosphorylation of Arm by the P21-activated kinase (Pak4) is 
required to retain Baz at the AJs (Walther et al., 2016). The conserved region 3 (CR3) around 
Ser980 binds aPKC and negatively regulates its kinase activity. However, upon 
phosphorylation of Ser980 by aPKC the two proteins dissociate and Baz becomes excluded 
from the SAR and accumulates at AJs. A C-terminal lipid binding motif (K1173-74) directly 
binds to PtdIns(4,5)P2 (PIP2) and PtdIns(3,4,5)P3 (PIP3) to target Baz to the plasmamembrane 
(Krahn et al., 2010b). Furthermore, the second PDZ domain of rat Par3 has been reported to 
bind directly to phosphatidylinositol lipids (Wu et al., 2007) and the three Drosophila Baz 
PDZ domains bind in vitro to phosphatidic acid (Yu and Harris, 2012). Hence, several 
different direct interactions between Par3 and the plasmamembrane contribute to its cortical 
localization. 
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The Liver Kinase B1 
The liver kinase B1 (LKB1 or STK11) has initially been identified in patients suffering from 
Peutz-Jeghers syndrome (PJS) (Hemminki et al., 1998). PJS is a cancer prone rare genetic 
disorder and will be described later. LKB1 is a highly conserved serine/threonine kinase that 
is involved in many different cellular processes, such as cell metabolism, cell proliferation 
and cell polarity. In mice, the LKB1 gene gives rise to three different LKB1 isoforms (LKB1 
long (LKB1L), LKB1 short (LKB1S) and ∆N-LKB1) as a result of alternative splicing or 
internal initiation of translation (Fig. 1.5). The expression of LKB1S is restricted to testis and 
∆N-LKB1 lacks catalytic activity, but promotes LKB1L (hereafter LKB1) mediated AMPK 
activation, however, inhibits the LKB1 dependent cell polarization of a lung cancer cell line 
(Towler et al., 2008; Denison et al., 2009; Dahmani et al., 2015).  
LKB1 is essential for development, because LKB1-/- mice die during embryonic development 
(E8.5 – E11) with vascular and neural tube defects (Ylikorkala et al., 2001; Jishage et al., 
2002). Similar, Drosophila lkb1 mutants do not develop further than mid-pupal stage (Lee et 
al., 2006).  
LKB1 is a tumour suppressor that regulates cell proliferation in response to the cellular 
energy level. LKB1 has been reported to regulate mTOR signaling, p53 and the Hippo 
pathway (Shaw et al., 2004a; Jones et al., 2005; Mohseni et al., 2014). The role of LKB1 in 
mTOR signaling and the Hippo pathway will be discussed later, as their regulation depends 
on downstream kinases of LKB1. Although p53 has been reported to be phosphorylated by 
AMP-activated protein kinase (AMPK) (Jones et al., 2005), which stabilizes and activates 
p53, LKB1 has also been reported to interact with p53 (Karuman et al., 2001a). Moreover, 
this interaction takes place in the nucleus where p53 and LKB1 together bind to the promoter 
of the p21/WAF1 gene, which is essential to induce its transcription and consequently G1 cell 
cycle arrest (Zeng and Berger, 2006). 
LKB1 forms a ternary complex with the pseudokinase STRADα and the scaffold protein 
Mo25 (Boudeau et al., 2003a; Baas et al., 2003). LKB1 has up to five N-terminal nuclear 
localization sequences, which mediates its nuclear transport upon binding of Importin-α 
(Smith et al., 1999b; Dogliotti and Krahn, unpublished data). STRADα promotes the 
cytoplasmic shuttling of LKB1 by binding to Exportin7 and CRM1 in complex with LKB1. In 
the cytoplasm, STRADα outcompetes Importin-α for binding LKB1 (Dorfman and Macara, 
2008). In addition, binding of STRADα to LKB1 induces a conformational change of LKB1, 
which drastically enhances its catalytic activity. Binding of Mo25 to the LKB1/STRADα 
complex stabilizes the active conformation of LKB1 (Zeqiraj et al., 2009). In the cytoplasm  
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Fig. 1.5: Scheme of the Drosophila and human LKB1 variants. The large N-terminal 
domain of the Drosophila LKB1 is not conserved in the human proteins. The two human 
LKB1 variants LKB1-long (LKB1L) and LKB1-short (LKB1S) result from alternative 
splincing and are identical with the exception of their C-terminus. An alternative translation 
initiation gives rise to the human ∆N-LKB1 variant. Conserved domains are indicated and the 
numbers correspond to amino acid positions.  
 
the active LKB1/STRADα/Mo25 complex baers the potential to localize at the cell cortex as 
well  (Collins et al., 2000; Sapkota et al., 2001; Sebbagh et al., 2009). Thus, the diversity of 
LKB1’s cellular localizations highlights its potential to regulate cellular processes on many 
different levels.  
 
The LKB1/AMPK signalling pathway 
The ternary LKB1/STRADα/Mo25 complex acts together with AMPK as a cellular energy 
sensor. Under energy deprivation LKB1 phosphorylates AMPK to inhibit mTOR activity 
(Fig. 1.6) (Shackelford and Shaw, 2009). Additionally, LKB1 phosphorylates 12 AMPK 
related kinases in their activation loop: SAD-A/B (BRSK2 and BRSK1), NUAK1/2 (ARK5 
and SNARK), SIK1/2/3, MARK1/2/3/4 and SNRK (Lizcano et al., 2004; Jaleel et al., 2005). 
Therefore, LKB1 acts as a master kinase to control cellular processes, such as cell 
metabolism, cell proliferation and cell polarity. 
Under energetic stress the amount of cellular AMP increases, which is bound by AMPKγ. 
Upon binding of a second AMP molecule the AMPK holoenzyme becomes active (Scott et 
al., 2004), but requires a critically phosphorylation in the activation loop on Thr172 of 
AMPKα by LKB1 (Hawley et al., 1996; Lizcano et al., 2004). Fully activated AMPK in turn 
phosphorylates and activates TSC2 (also known as Tuberin) (Inoki et al., 2003b). The 
GTPase activating enzyme TSC2 forms a complex with TSC1 (also known as Hamartin) and  
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Fig. 1.6: Scheme of the interplay between the PI3K/Akt/mTOR and LKB1/AMPK 
signalling pathways. The stimulation of growth factors leads to a receptor mediated 
activation of PI3K, which in turn phosphorylates PIP2 to produce PIP3. PIP3 is bound by 
PDK1 and Akt causing the phosphorylation an activation of Akt by PDK1. Activated Akt 
phosphorylates and inhibits the GTPase activating enzyme TSC2. The GTPase Rheb 
stimulates in its GTP bound active form mTORC1, which promotes protein translation by 
activating S6K and eIF4E-BP. Upon low energy conditions, AMPK detects the increasing 
amount of AMP molecules and binds to LKB1, which triggers its phosphorylation and 
activation. AMPK phosphorylates TSC2, such as Akt, however, thereby activating it. 
Stimulating the GTPase activity of Rheb inactivates it and consequently decreases the activity 
mTOR. Moreover, AMPK phosphorylates Raptor to create a binding site for 14-3-3 proteins 
to prevent Raptor from joining the mTORC1. In addition, AMPK inactivates Acety-CoA 
carboxylase (ACC) and HMG-CoA-Reductase (HMGCR) to inhibit lipid synthesis. Green 
arrows indicate activation and red arrows inhibition. 
 
stimulates the GTPase activity of Rheb, which becomes inactive after GTP hydrolysis (Inoki 
et al., 2003a). In contrast, active Rheb promotes the activity of the kinase mTOR (Tee et al., 
2003). The activation of mTOR causes an elevated protein translation, which is mediated by 
phosphorylation of eIF4E-BP and S6K by mTOR (Carrera, 2004). The mTOR complex1 
(mTORC1) requires binding of the scaffold protein Raptor, which recruits eIF4E-BP and S6K  
for phosphorylation (Kim et al., 2002; Hara et al., 2002). However, phosphorylation of 
Raptor (on Ser722 and Ser792 in humans) by AMPK causes its sequestration by 14-3-3 
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proteins and consequently an inhibition of mTORC1 (Gwinn et al., 2008). Thus, LKB1 
mediates the metabolic switch from anabolism towards catabolism under energetic stress. 
Therefore, AMPK also inhibits Acety-CoA carboxylase and HMG-CoA-Reductase to 
antagonize lipid synthesis (Fig. 1.6) (Carling et al., 1987; Winder and Hardie, 1996).  
In addition to the well-studied activation of the LKB1/AMPK pathway by AMP, recently the 
a fructose-1,6-bisphosphate (FBP) dependent mechanism to activate the LKB1/AMPK 
pathway has been described. Under energy deprivation the amount of FBP decreases and 
unoccupied Aldolase, which splits FBP into dihydroxyacetone phosphate (DHAP) and 
glyceraldehyde 3-phosphate (G3P), promotes the formation of a complex consisting of LKB1, 
AMPK, v-ATPase, Ragulator and AXIN (Zhang et al., 2017a). This complex localizes on 
endosomes and is essential to activate the LKB1-AMPK pathway. The knockout of either 
AXIN or LAMTOR1 (a component of the Ragulator complex) in mice prevents the LKB1 
dependent activation of AMPK (Zhang et al., 2013b; Zhang et al., 2014).  
Moreover, the LKB1/AMPK signaling pathway is implicated in cell polarity. In C. elegens 
and Drosophila, LKB1 is required for the anterior-posterior polarization of the embryo and 
oocyte, respectively (Watts et al., 2000; Martin and St Johnston, 2003). In Drosophila, 
AMPK has been reported to phosphorylate Myosin regulatory light chain (MRLC), which is 
essential for proper apical-basal polarization of the embryonic epithelium. Loss of either 
LKB1 or AMPK results in severe polarity defects (Lee et al., 2007). However, the 
phosphorylation of MRLC is not due to AMPK, but rather to other kinases, that act 
downstream of AMPK  (Bultot et al., 2009). In contrast to Drosophila, LKB1 is dispensable 
for the early polarization of the eight-cell stage mouse embryo (Krawchuk et al., 2015). In 
addition to AMPK, LKB1 phosphorylates and activates the AMPK-related kinase Par1 
(MARK1-4 in vertebrates), which regulates microtubule dynamics and counteracts the 
formation of the Par complex (as previously described) (Benton and St Johnston, 2003a; 
Lizcano et al., 2004; Wang et al., 2007; Granot et al., 2009; Amin et al., 2009).  
Taken together, the regulation of cell proliferation, metabolism and cell polarity are tightly 
connected to the LKB1/AMPK signaling axis. Loss of either LKB1 or AMPK causes severe 
defects that result in embryonic lethality. The significance of the LKB1 dependent regulations 
with respect to human pathologies will be described in the next section.   
 
 
 
Introduction 
17 
 
The role of LKB1 in human pathologies  
The regulation of cell proliferation, energy metabolism and cell polarity are essential 
processes that have to be precisely controlled. In response to energy deprivation or ionizing 
radiation LKB1 becomes active to induce a metabolic switch from anabolism towards 
catabolism. Germline mutations in the STK11 gene (encoding LKB1), which localizes on 
chromosome 19p13.3 cause the Peutz-Jeghers syndrome (PJS). The PJS is a rare autosomal 
dominant genetic disease with an incident varying from 1:50.000 to 1:200.000 individuals.  
The PJS is characterized by cutaneous mispigmentation, gastro intestinal polyps and a high 
risk of cancer (Jansen et al., 2009). The risk of PJS patients to develop cancer is highest in the 
gastro intestinal tract, however female patients bear also an increased risk to develop breast 
cancer (Hearle et al., 2006). In mice, loss of heterozygosity (LOH) of LKB1 has been reported 
by several groups to induce polyposis as well, suggesting that polyps develop due to a LKB1 
haploinsufficiency (Bardeesy et al., 2002; Miyoshi et al., 2002; Jishage et al., 2002). 
Mutations or loss of LKB1 have also been found in cancer patients without PJS, such as non-
small cell lung cancer (NSCLC), cervical cancer, ovarian cancer, breast cancer, pancreatic 
cancer and malignant melanoma (Rowan et al., 1999; Guldberg et al., 1999; Sanchez-
Cespedes et al., 2002; Carretero et al., 2004; Matsumoto et al., 2007; Wingo et al., 2009; 
Morton et al., 2010; Gill et al., 2011; Tanwar et al., 2014; George et al., 2016). Moreover, 
loss of LKB1 is associated with a poor survival rate of breast cancer patients (Sengupta et al., 
2017). The majority of mutations that have been reported from PJS and cancer patients affect 
the catalytic domain, but some affect the less characterized C-terminus as well (Boudeau et 
al., 2003c).  
Lung cancer is worldwide the most diagnosed cancer with 1.82 million new cases and 1.59 
million deaths in 2012 (Ferlay et al., 2015). In lung adenocarcinoma, LKB1 is the third most 
frequently mutated gene (Ding et al., 2008) and 60 – 70 % of lung adenocarcinoma are 
affected by LOH of LKB1 (Sanchez-Cespedes et al., 2002; Gill et al., 2011). Generally in 
NSCLC, which are with 85 % the most common lung cancer, 39 - 41 % of the tumours 
display genomic alterations of the LKB1 locus (Matsumoto et al., 2007; Gill et al., 2011; 
Calles et al., 2015). In lung adenocarcinoma, LKB1 counteracts enhanced cell migration 
independent of AMPK. Thereby LKB1 activates MARK1/4, which in turn phosphorylates the 
scaffold protein DIXDC1, which leads to a decreased activation of the FAK/MEK/ERK 
mediated Snail expression. DIXDC1 is frequently mutated in various tumours and thus, fails 
to convey the LKB1/MARK mediated tumour suppression (Goodwin et al., 2014). Similar, 
LKB1 has also been reported to repress Snail expression by activating Salt-inducible kinase 1 
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(SIK1) to maintain E-Cadherin levels (Eneling et al., 2012). 
Furthermore, LKB1 suppresses cell proliferation also by counteracting the activity of the co-
transcriptional activator YAP. The phosphorylation of MARK1/4 by LKB1 recruits the 
SCRIB complex to the lateral plasmamembrane of epithelial cells, which is essential for the 
core Hippo kinases MST1/2 and LATS1/2 to phosphorylate and inhibit YAP (Mohseni et al., 
2014). Taken together, beyond the canonical LKB1/AMPK tumour suppressor pathway a 
redundant LKB1/MARK axis antagonizes tumorigenesis.  
In addition to mutations and LOH, the promotor of the LKB1 gene is targeted by an aberrant 
methylation status in some types of cancer, such as colorectal cancer, melanoma and 
adenocarcinoma (Trojan et al., 2000; Sanchez-Cespedes et al., 2002; Zhang et al., 2017b). 
The methylation of CpG-islands in the promotor region of LKB1 reduces its gene expression 
and therefore reduces the tumour suppressive capacity of the affected cell. Nevertheless, CpG 
hypermethylation is not a frequent aberration and affects only a minor number of tumours.  
Until now there are no pharmaceuticals that directly target LKB1 in order to elevate its 
activity or expression. However, with respect to data from cell culture and mice the 
polyphenol Honokiol (HNK) from Magnolia grandiflora enhances the protein level and 
activity of LKB1 (Nagalingam et al., 2012; Avtanski et al., 2015; Seo et al., 2015; Sengupta 
et al., 2017). A xenograft breast cancer mouse model that is treated with HNK displays a 
reduced tumour growth depending on LKB1 (Sengupta et al., 2017). The activation of LKB1 
results from the HNK mediated activation of the deacetylase SIRT1, which deacetylates and 
thereby activates LKB1 (Nagalingam et al., 2012; Avtanski et al., 2015; Seo et al., 2015).  
Although HNK treatment might become a promising anti-cancer therapy, the challenge will 
be to target cancers that are deprived of LKB1. The former anti-diabetic drug Phenformin 
bears the potential to specifically target tumours that lack LKB1 (Shackelford et al., 2013). 
Phenformin inhibits the mitochondrial complex I, causing energetic stress. Treatment of a 
LKB1-/- NSCLC mouse model with Phenformin specifically induces apoptosis in LKB1 null 
tumours and prolongs survival (Shackelford et al., 2013). 
In summary, the loss of active LKB1 leads to the PJS and is a predisposition for cancer. 
Under energetic stress LKB1 is essential to promote a catabolic switch. Nevertheless, with 
respect to a potential treatment of cancer patients with Phenformin the loss of LKB1 might 
bear the advantage that cells cannot respond via the LKB1/AMPK axis and undergo 
apoptosis.  
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Aims of the study 
 
For development and homeostasis the polarization of epithelia is an essential process. The 
serine/threonine kinase LKB1 and the scaffold protein Bazooka (Baz) are key mediators of a 
celllar polarity. However, the regulation of both proteins is only poorly understood in the 
epithelium.  
LKB1 is an important regulator of cell proliferation, metabolism and cell polarity. Mutations 
or loss of LKB1 have frequently been reported from various tumours. Therefore, it is essential 
to better understand the regulation of this enzyme. The subcellular localization of LKB1 
varies strongly from nuclear to cytoplasmic and even cortical. Several functions of the nuclear 
and cytoplasmic LKB1 have already been described, however, the function and the 
mechanism by which LKB1 is targeted to the plasmamembrane remain elusive. Thus, this 
study aims to analyze the cortical localization of LKB1 and its function during development 
and tumour suppression. 
Moreover, in Drosophila, the scaffold protein Baz is an essential cue for the establishment of 
an apical-basal cell polarity in epithelial cells and neuroblasts (NBs). Baz is the core 
component of the heterotrimeric Par complex, which also includes scaffold protein Par6 and 
the atypical protein kinase C (aPKC). The N-terminal oligomerization domain (OD) and the 
C-terminal lipid binding motif of Baz are involved in the membrane localization of Baz. 
Nevertheless, the function of the Baz OD beyond its contribution to the cortical localization is 
not clear, yet. Given that the OD largely contributes to the viability of embryos, it is another 
objective of this study to further characterize the role of the OD during the development of 
Drosophila. 
Finally, although the formation and function of the Par complex in epithelial polarization are 
a dogma, the in vivo relevance of the Baz-Par6 interaction is unclear. Both proteins have in 
vitro been reported to interact via their PDZ domains, this is why this study clarifies the 
molecular basis of this interaction using in vitro structural approaches and Drosophila as an in 
vivo model. The goal of these experiments will be to understand the relevance of the in vitro 
obtained results.   
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The serine/threonine kinase LKB1 regulates various cellular processes such as cell 
proliferation, energy homeostasis and cell polarity and is frequently downregulated in various 
tumours. Many downstream pathways controlled by LKB1 have been described but little is 
known about the upstream regulatory mechanisms. Here we show that targeting of the kinase 
to the membrane by a direct binding of LKB1 to phosphatidic acid is essential to fully activate 
its kinase activity. Consequently, LKB1 mutants that are deficient for membrane binding fail 
to activate the downstream target AMPK to control mTOR signalling. Furthermore, the in 
vivo function of LKB1 during development of Drosophila depends on its capacity to associate 
with membranes. Strikingly, we find LKB1 to be downregulated in malignant melanoma, 
which exhibit aberrant activation of Akt and overexpress phosphatidic acid generating 
Phospholipase D. These results provide evidence for a fundamental mechanism of LKB1 
activation and its implication in vivo and during carcinogenesis. 
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Introduction 
 
The serine/threonine kinase LKB1 is ubiquitously expressed and highly conserved throughout 
evolution. It has been demonstrated to function as a ‘master kinase’ potentially activating 
several downstream kinases (Lizcano et al., 2004). Apart from its implication in 
carcinogenesis LKB1 plays a role in various cellular signalling pathways such as Wnt-, 
TGFβ-signalling or the mTOR-pathway reviewed by Vaahtomeri and Makela (Vaahtomeri 
and Mäkelä, 2011). The latter one is controlled by LKB1-mediated activation of AMP-
dependent kinase (AMPK), which is essential for cell survival and polarity in Drosophila and 
vertebrates, in particular under energetic stress (Hawley et al., 2003; Woods et al., 2003; 
Shaw et al., 2004b; Lee et al., 2007; van der Velden et al., 2011). Mechanistically, AMPK 
phosphorylates (among others) Raptor (a core component of mTOR complex 1) and TSC2 (an 
mTOR inhibitor), resulting in reduced mTOR activity (Arsham et al., 2003; Kimura et al., 
2003; Inoki et al., 2003b; Corradetti et al., 2004; Shaw et al., 2004a; Shaw et al., 2005; 
Gwinn et al., 2008; Shackelford et al., 2009). Consequently, the LKB1-AMPK-axis is 
believed to be a key modulator in carcinogenesis and cell polarity (Hardie and Alessi, 2013). 
Apart from its function in cell proliferation and tumour suppression, LKB1 is directly 
implicated in the establishment and maintenance of cell polarity in different cell types and 
organisms (Nakano and Takashima, 2012). 
Although many downstream pathways mediating the function of LKB1 have been described, 
little is known about the upstream mechanisms regulating LKB1 activity. Two pseudokinases 
tightly control the localization and kinase activity of LKB1: STRADα (Ste20-like kinase 
(Stlk) in Drosophila) and Mo25 form a stable ternary complex with LKB1 (Boudeau et al., 
2003a). Both proteins enhance the export of LKB1 from the nucleus into the cytoplasm and 
increase its kinase activity (Boudeau et al., 2003a; Dorfman and Macara, 2008). Secondly, the 
conserved C-terminus of LKB1 is farnesylated in vivo and thereby might directly interact with 
the plasma membrane to attach the protein to the cell cortex. Although the majority of the 
protein accumulates at the plasma membrane of polarized (epithelial) cells, farnesylation has 
been reported to be not essential for the (tumour suppressor) function of LKB1 in mammalian 
cells or mice but might be essential for oogenesis in Drosophila (Sapkota et al., 2001; Martin 
and St Johnston, 2003; Houde et al., 2014). Therefore the question remains, whether 
membrane association of LKB1 is essential for the kinase activity and function of the protein 
during development and tumour suppression. 
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Here we report that binding of LKB1 to membranes by direct interaction with phospholipids, 
in particular to phosphatidic acid, is essential for its function in vivo during development of 
Drosophila. Membrane association of LKB1 is required for its kinase activity and for efficient 
activation of AMPK in cultured mammalian cells, thus contributing to the tumour suppressor 
function of LKB1. Strikingly, we reveal a strong correlation between overexpression of 
Phospholipase D (PLD), which increases cellular levels of phosphatidic acid, downregulation 
of LKB1 and enhanced activity of mTOR in malignant melanoma, thus likely contributing to 
the pathogenesis of malignant melanoma. 
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Methods 
 
Fly stocks and genetics 
UASt::GFP-LKB1 and lkb1::GFP-LKB1 transgenes were generated using phiC31-mediated 
germ line transformation on attp40. For rescue experiments of different LKB1 variants, we 
used the lkb1x5 null allele. Lethality tests were performed in three independent experiments 
with n=100 in each experiment. For rescue experiments using the UAS/GAL4 system, we 
used UAS::GFP-LKB1 and actin5C::GAL4 instead of lkb1::GFP-LKB1. 
 
DNA and constructs 
Cloning of the cDNA of wild-type LKB1 into pENTR was performed using standard PCR on 
a full length EST clone (Drosophila Genomics Resources Center, DGRC) as template using 
the following primers: LKB1-F: 5′- CACCATGCAATGTTCTAGCTCTCGG-3′, LKB1-R: 
5′-CTACGAAGTTCGGCAGTGG-3′. Similar, truncated fragments of LKB1 were cloned 
with the following oligonucleotides: LKB1512-F: 5′-CACCATGCACACCTACGAACCGCC-
3′, LKB1536-F: 5′-CACCATGGCGCCCGTCAAGAAG-3′, LKB1552 -F: 5′-
CACCATGCTGACGTCCTGCATCTCCG-3′. For expression of LKB1 from its endogenous 
promoter we inserted a genomic fragment (from 2.8 kbp upstream of the translation start to 
1 kbp downstream of the stop codon) into pENTR using the following primers: LKB1gen-F: 
5′- CACC CACTAGCGTAATTTGACGG-3′, LKB1gen-R: 5′- CTC GAG 
CAGCAGTACGGTCATCTC-3′. An XbaI-cutting site was introduced replacing the start 
codon using mutagenesis PCR and the following primer: LKB1gen-XbaI-F: 5′-
GGCTCCGCGGAGGTTTTCTAGACAATGTTCTAGCTCTC-3′. Subsequently, GFP was 
inserted into the XbaI site by PCR and standard ligation. Mutagenesis PCR was used to 
generate defined point mutations with full length or genomic LKB1 cDNA in pENTR as 
template. The following oligonucleotides were used for mutagenesis (mutation underlined): 
LKB1ΔLB: Combination of 1. LKB1K546A R547A R548A K550A K551A-F:  
5′-TCGGCACTGGCGGCGGCCGCCGCGGCGCTGACGTCCTGC-3′ and 2.LKB1K539A 
K540A K541A-F: 5′-GAGGAGGCGCCCGTCGCCGCGGCGGGATCGGCACTG-3′,  
LKB1C564A-F: 5′-GTGCGCAAGCTTAGCCACGCCCGAACTTCGTAG, LKB1D317A-F: 5′- 
CAAACGCTGAAGATTTCCGCCTTCGGTGTGGCG. 
To express LKB1ΔLBC564A PH(PLD) and LKB1ΔLBC564A PH(Akt), the PH domain of PLCδ and Akt 
was amplified by PCR and ligated via an endogenous Bpu1101-I site into lkb1::LKB1 
pENTR using the following primers:  
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PH(PLCδ)-F: 5′- GCTGAGCCACGCCCGAACT TCGgatgaggatctacaggcgct-3′,  
PH(PLCδ)-R: 5′- GCTGAGCTAGATCTTGTGCAGCCCCAG-3′,  
PH(Akt)-F: 5′-GCTGAGCCACGCCCGAACTTCGGTCGTAAAGGAGGGGTGG-3′ and 
PH(Akt)-R: 5′- GCTGAGCTTATATGAGCCGGCTGGATAC-3′. 
For expression of hLKB1, the open reading frame of hLKB1 was cloned into pENTR using 
the following nucleotides: hLKB1-F: 5′- CACC ATGGAGGTGGTGGACCC-3′ and hLKB1-
R: 5′- TCACTGCTGCTTGCAGG-3′. For mutation of the farnesylation, lipid binding motif 
and construction of the kinase dead version, the following nucleotides were used in 
mutagenesis PCRs:  
hLKB1C430A-F: 5′- CGCCGGCTGTCGGCCGCTAAGCAGCAGTGAAAGGGT-3′, 
hLKB1R415AK416A-F: 5′- GCCCCCAACCCTGCCGCCGCGGCCTGCTCCGCCAGC-3′ and 
hLKB1D194A: 5′- ACCCTCAAAATCTCCGCCCTTGGCGTGGCCGAGGCA-3′. 
Constructs were recloned into GFP-tagged destination vectors containing a One-Strep-Tag 
fused to the N terminus of GFP (USGW, modified TGW, Murphy lab, DGRC, expression in 
S2R cells) or into a modified EGFP-C1 vector (CGW, expression in mammalian cells) 
containing a gateway cassette using the gateway technology (Life technology). 
 
Antibodies 
Antisera directed against full length LKB1 were raised by injection of a fusion protein of 
LKB1 and MBP into two guinea pigs (Amsbio, Abingdon, UK). 
 
Cell culture and cell viability assay 
HeLa, IMR90, IGR37 and MDCK cells were obtained from ATCC. All cells were maintained 
in Dulbecco’s modified Eagle’s medium supplemented with 10% fetal calf serum, 2 mM 
Glutamine at 37 °C in a 5% CO2 atmosphere and negatively tested for mycoplasma 
contamination by PCR. Cells were transfected using FUGENE (Promega) according to the 
manufacturer’s instructions. For evaluation of cell viability upon energetic stress, 50 × 103 
cells/well were transiently transfected in a 24well plate with GFP-hLKB1+STRADα 
constructs and treated for 12 h with 2.5 mM AICAR (Santa Cruz Inc.). GFP+STRADα were 
used as negative control. Cell viability was assessed in triplicates using MTT assay according 
to the manufacturer’s instructions (SIGMA). 
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Western blotting and coimmunoprecipitation 
Western blotting was done as previously described (Cidlinsky et al., 2016). For mammalian 
cell culture experiments, HeLa or IGR37 cells were transiently transfected with the indicated 
constructs. 48 hours after transfection, cells were incubated with 2 mM AICAR for 1 h and 
harvested in lysis buffer (1% Triton X-100, 150 mM NaCl, 1 mM CaCl2, 1 mM MgCl2, 
50 mM TRIS-HCl pH 7.5) supplemented with protease- and phosphatase inhibitors. For 
embryonic lysates, lkb1::GFP-LKB1 expressing embryos were collected from overnight 
plates. Coimmunoprecipitation using GFP-Trap (ChromoTek) of GFP-LKB1 with HA-tagged 
DmSTRADα (Stlk) and myc-tagged DmMo25 was done in embryonic lysates, which 
ubiquitously expressed the proteins using arm::GAL4. Primary antibodies used for western 
blotting were as follows: rabbit anti-Actin (1:1,000, sc-47778, Santa Cruz), mouse anti-S6K 
(1:500, sc-8418, Santa Cruz ), rabbit phosphoT389-S6K (1:500, sc-11759, Santa Cruz), rabbit 
anti-phospho-T172-AMPK (1:200, sc-33524, Santa Cruz), rabbit anti-phospho-MARK1/2/3 
(1:500, PA5-17495, Thermo Scientific), mouse anti-myc (1:100, 9E10, DSHB), rabbit anti-
AMPK (1:400, sc-25792, Santa Cruz), guinea pig anti LKB1 (1:500, this study), mouse anti-
GFP (1:500, sc-9996, Santa Cruz), mouse anti-HA (1:500, #11583816001, Roche), rabbit 
anti-GST (1:5,000, #G7781, SIGMA). For statistical analysis, three independent experiments 
were scored. Intensity of the bands was quantified by ImageJ. 
 
Immunohistochemistry 
Drosophila embryos were fixed in 4% formaldehyde, phosphate buffer pH 7.4 as described 
before (Sen et al., 2012). Primary antibodies used for indirect immunofluorescence were as 
follows: guinea pig anti LKB1 (1:250, this study), rabbit anti Baz (1:2,000, kindly provided 
by A. Wodarz), mouse anti α-spectrin (3A9, 1:50, DSHB), mouse anti Dlg (4F10, 1:50, 
DSHB), rat anti DE-Cad (DCAD2, 1:25, DSHB), rabbit anti GFP (1:400, sc-8334, Santa Cruz 
Inc), guinea-pig anti Miranda (1:1,000, kindly provided by A. Wodarz). HeLa cells were fixed 
with 4% PFA in PBS and stained with the rabbit anti-phospho-Sad antibody (1:250) and a 
mouse anti-LKB1 antibody (1:200, sc-32245, Santa Cruz) in 10% goat serum. 
Secondary antibodies conjugated with Alexa 488, Alexa 568 and Alexa 647 (Life 
Technology) were used at 1:400. Images were taken on a Zeiss LSM 710 Meta confocal 
microscope and processed using Adobe Photoshop. 
For immunohistochemical staining of healthy skin, nevi and melanoma, a tissue micro array 
(TMA) of paraffin-embedded healthy skin, nevi and melanoma primary tumours was 
analysed. Paraffin sections were deparaffinized for 30 min at 72 °C, washed two times for 
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7 min in Xylol and subsequently re-watered in a descending sequence of ethanol/water 
mixture. Prior to staining sections were subjected for 5 min to heat-induced epitope-retrieval 
(HIER) using 1 mM Tris-EDTA-buffer (pH 8.5) at 120 °C. Sections were blocked in 
peroxidase-blocking solution (Dako, #S2023) for 5 min at room-temperature and washed 
5 min with wash buffer (Dako, #S3006) prior to incubation with primary antibody diluted in 
antibody diluent (Dako, #S2022) for 30 min. Primary antibodies were as follows: rabbit anti-
LKB1 (D60C5F10, 1:200, Cell Signaling), rabbit anti-phospho-Akt (1:20, Cell Signaling 
#4060), rabbit anti-PLD2 (1:1,000, Cell Signaling #13891) and rabbit anti-S6K-phospho-
T389 S6K (1:50, Cell Signaling #9206). Subsequently, sections were washed with wash 
buffer and incubated for 30 min with HRP-coupled secondary antibody (Dako EnVision, # 
K5007). Stainings were developed after washing using DAB/chromogen solution (Dako, 
#K5007). To visualize cellular structures, stained sections were counterstained with 
hematoxylin (Merk, #10517505000) for 1 min and dehydrated in ethanol/xylol before 
embedding. The staining intensity was determined blinded for all tissue samples as followed: 
negative-0, weak-+, moderate-++ and strong-+++. LKB1 exhibited a strong expression in 
melanocytes in situ, so weak or negative intensity was scored as downregulation of the 
protein, whereas moderate staining was classified as slightly downregulated. Activated Akt 
was negative in healthy skin biopsies, so weak, moderate and strong staining was classified as 
upregulated. PLD2 expression was negative or weak in melanocytes in situ, thus moderate 
and strong staining was scored as upregulated. Phospho-S6K was strongly expressed in the 
nucleus but not in the cytoplasm of melanocytes but cytoplasmic staining occurred only in 
malignant tumours. Consequently, weak to strong cytoplasmic staining of phospho-S6K was 
classified as upregulated. 
 
Lipid binding assays 
Fusion proteins of the C terminus of LKB1 (aa 353–567) with MBP were expressed in E.coli 
and affinity purified. Lipid strips (Echelon) were incubated over night with purified MBP-
LKB1 fusion proteins at 0.5 μg ml−1 in TBST containing 3% BSA, washed and probed with 
antibodies against MBP (1:1,000, Santa Cruz sc-73416) as described above. 
For membrane floatation and in vitro kinase assays, lipids were obtained from Avanti Polar 
Lipids (Egg-PA, #840101, Egg-PC #840051, Brain PtdIns(4,5)P2 #840046) and Echelon 
(PtdIns(3,4,5)P3 #P-3916). Liposomes (10 mM total lipid concentration, either PC alone or 
PC:PA/PtdIns(3,4,5)P3/PtdIns(4,5)P2 in a 9:1 molar ratio) were prepared in LB buffer 
(30 mM Tris, 4 mM EGTA, pH 8.0) by extrusion through a 0.1 μm polycarbonate membrane 
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using a Mini-Extruder (Avanti Polar Lipids). The membrane floatation was performed as 
follows (Krahn et al., 2010b): liposomes (100 μl of 10 mM total lipid concentration) were 
incubated on ice for 30 min with 1 μg recombinant protein. LB buffer (30 mM Tris, 4 mM 
EGTA, 2 M sucrose (pH 8.0)) was added to the incubation reaction to bring the final sucrose 
concentration to 1.6 M, and this mixture was overlaid with cushions containing 1.4 M, 0.4 M, 
and 0.25 M sucrose in the same buffer in a TLA-55 tube. After centrifugation at 186,000g 
(4 °C) for 45 min in a TLA-55 rotor (Beckman), the 0.25/0.4 M interphase (top fraction, T) 
and the loading fraction (bottom fraction, B) were collected and analysed by SDS-PAGE and 
western blot. For statistical analysis, three independent experiments were scored. Intensity of 
the bands was quantified by ImageJ. 
 
In vitro kinase assay 
OneStrep-GFP-LKB1 plus OneStrep-GFP-Stlk were precipitated from transfected S2R cells 
(2 mg total protein lysates) using Streptactin beads (IBA, Goettingen, Germany). The beads 
were washed five times in harsh washing buffer (50 mM TRIS pH 7.5, 500 mM NaCl) and 
one time in LKB1 kinase buffer (50 mM TRIS pH 7.5, 10 mM MgCl2, 10 mM MnCl2, 1 mM 
DTT, 100 μM ATP, phosphatase- and protease inhibitors). Immunoprecipitated proteins were 
then incubated with 2 μg of recombinant GST-DmAMPKα108-280 (=aa 108–280, containing the 
T-loop with the LKB1-phosphorylation site) and 0.3 μCi[γ-32ATP] in kinase buffer for 1 h at 
30 °C. The reaction was terminated by addition of SDS sample buffer and samples were 
subjected to SDS-PAGE. Phosphorylation was detected by exposure to X-ray films and 
quantified with Aida 2D Densitometry software. 
For assays with human recombinant kinase complex (Supplemental Fig. 2.3b,c), 1 μg of a 
complex of recombinant hLKB1, STRADα and Mo25 (SIGMA) was used as described above 
replacing immunoprecipitated LKB1 protein. In this experiment, GFP-AMPKα1 from 
transfected HeLa cells (2 mg total protein lysate) was used as substrate as a recombinant 
fragment would have interfered with the autophosphorylation bands. After isolation of 
precipitated OneStrep-GFP-AMPK, recombinant hLKB1/STRADα/Mo25 was added and 
incubated as described above. Subsequently, OneStrep-GFP-AMPK was purified from the 
reaction mixture using Streptactin beads. 
For kinase assays with addition of lipids, Liposomes were prepared as described above and 
added at 10 mM final concentration. 
For statistical analysis, three independent experiments were scored. Intensity of the bands was 
quantified by ImageJ. 
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Transfection and analysis of neurons 
Hippocampal neurons were isolated from the brains of E18 rat embryos and cultured as 
described previously (Yang et al., 2014). Dissociated hippocampal neurons were plated at 
70,000 cells per well in a 24 well plate and transfected 3 h after plating by calcium phosphate 
co-precipitation. Neurons were fixed at 3 DIV and permeabilized with 0.1% Triton X-100, 
0.1% sodium citrate in PBS for 3 min on ice. Neurons were stained with the Tau-1 antibody 
as axonal marker (Chemicon, MAB3420; 1:300) and Alexa-Fluor-conjugated secondary 
antibodies (Molecular Probes; 1:300). The stage of neuronal differentiation and axon 
formation was determined according to published criteria (Schwamborn and Püschel, 2004). 
For each LKB1 variant, 3 different experiments with 100 analysed neurons in each were 
scored. 
 
Statistics 
All experiments were performed in triplicates. Error bars represent s.d. and statistical 
significance was determined using ANOVA: P<0.0001, ****P<0.001, ***P<0.01, **P<0.05, 
*P>0.05, not significant (NS). 
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Results 
LKB1 localizes to the cortex of epithelial cells and neuroblasts 
 
The activity of kinases can be modulated for instance by directly influencing their enzymatic 
activity (e.g., by a conformational change via phosphorylation) or by targeting the protein to 
different subcellular compartments. In cultured mammalian cells, LKB1 accumulates in the 
nucleus in many cell lines and only a minor fraction of the protein is found in the cytoplasm 
or at the cytocortex (Smith et al., 1999a; Tiainen et al., 1999; Song et al., 2008). LKB1 has 
been demonstrated to shuttle from the cytoplasm into the nucleus and back, with its two co-
factors, STRADα and Mo25 enhancing cytoplasmic localization and activating the kinase 
(Baas et al., 2003; Boudeau et al., 2003a; Dorfman and Macara, 2008). Whereas endogenous 
LKB1 accumulates predominately in the nucleus of non-transformed fibroblasts (Fig. 2.1A), 
epithelial cells (Madin Darby Canine Kidney, MDCK) exhibit a staining of endogenous 
LKB1 exclusively at the cell-cell contacts, partly overlapping with the AJ- and TJ markers E-
Cadherin and ZO-1 (Fig. 2.1B) (Sebbagh et al., 2009). Similar, endogenous LKB1 localizes 
to the (lateral) membrane in epithelial cells in vivo (colon or salivary glands) (Fig. 2.1C,D). 
Remarkably, polarized epithelial cells in culture (MDCK) and in situ (colon and salivary 
gland) do not exhibit nuclear staining of LKB1. In Drosophila cells endogenous LKB1 is also 
not found in the nucleus but localizes at the cortex of female germ line cells as well as at the 
lateral membrane in epithelial cells (Martin and St Johnston, 2003), whereas it shows a 
diffuse cytoplasmic pattern in neural stem cells of Drosophila larval neuroblasts (NBs) 
(Bonaccorsi et al., 2007). Similar, the Caenorhabditis elegans orthologue, PAR-4, regulating 
asymmetric cell division of the zygote, localizes to the entire cell cortex (Watts et al., 2000). 
To test which mechanisms target LKB1 to the cortex, we raised an antibody against LKB1 
and confirmed that in epithelial cells of the embryonic epidermis, endogenous LKB1 is 
localized laterally, co-staining with α-spectrin (Fig. 2.1E), but also overlapping with the 
zonula adherens (ZA), marked by Drosophila E-Cadherin (DE-Cad) (Fig. 2.1E). Notably, in 
embryonic NBs, we detect a clear cortical LKB1 staining in interphase as well as during 
mitosis (Fig. 2.1F–H). However, in contrast to key regulators of asymmetric cell division like 
the apical localized Bazooka (Baz) protein and the basally segregated adaptor protein Miranda 
(Mir), LKB1 does not show a polarized distribution during mitosis (Fig. 2.1F–H). Thus, 
LKB1 localizes predominately to the (lateral) plasma membrane in polarized epithelial cells 
and NBs in Drosophila and mammals. 
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Fig. 2.1: LKB1 localizes to the plasma membrane in polarized epithelial cells and 
neuroblasts. (a) In non-transformed mammalian fibroblasts (IMR90 cells), endogenous 
LKB1 accumulates mostly in the nucleus. (b) In polarized epithelial cells (MDCK), LKB1 is 
targeted to the cell-cell contacts, partly colocalizing with E-Cadherin (E-Cad) and Zonula 
occludens protein 1 (ZO-1). (c,d) Sections of paraffin-embedded colon (c) and salivary gland 
tissues (d) show a localization of LKB1 at the lateral plasma membrane in situ (arrows). (e–h) 
LKB1 localizes to the lateral plasma membrane in epithelial cells of the Drosophila 
embryonic epidermis (e) and to the cortex of neuroblasts (f–h). (i–n) Wild-type GFP-LKB1 as 
well as farnesylation deficient LKB1 (LKB1C564A) expressed from its endogenous promoter 
localize correctly to the (lateral) membrane of epithelial cells of the embryonic epidermis (i,j), 
of the follicular epithelium (m,n) and of neuroblasts (k,l). (o) Lethality tests of LKB1 variants 
as described in the methods section. Scale bars are 20 μm in a–d, 5 μm in e–n. Experiments 
were performed in triplicates. Error bars represent s.d. and statistical significance was 
determined using ANOVA: P<0.0001, ***P<0.01, *P>0.05, not significant (NS). 
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Farnesylation of LKB1 is not essential for its localization 
 
The C-terminus of LKB1 can be farnesylated (Collins et al., 2000; Houde et al., 2014), 
establishing a putative membrane targeting domain—however, this modification does not 
seem to be important for its tumour suppressor function in mammals (Sapkota et al., 2001) 
and for viability of mice (Houde et al., 2014). In the Drosophila germ line, a block of 
farnesylation leads to a weaker cortical association and disturbed oocyte polarity (Martin and 
St Johnston, 2003). To test whether this is also true for epithelial cells and NBs, we used the 
endogenous LKB1 promoter to express a GFP-tagged LKB1 wild-type protein or an LKB1 
version with a Cys564-Ala substitution in the fly (farnesylation-deficient LKB1, lkb1::GFP-
LKB1C564A). Wild-type GFP-LKB1 is expressed at similar protein level as endogenous LKB1 
(Supplemental Fig. 2.1A) and localizes to the lateral cortex of epithelial cells and the cortical 
membrane in NBs indistinguishable from the endogenous protein (Fig. 2.1I,K). Surprisingly, 
in the embryonic epidermis and embryonic NBs, GFP-LKB1C564A shows the same subcellular 
localization as its wild-type counterpart (Fig. 2.1J,L). The farnesylation-deficient protein 
shows a more cytosolic distribution only in epithelial cells surrounding the oocyte (follicular 
epithelium) although a substantial fraction of the protein is still associated with the lateral 
membrane (Fig. 2.1N compared to wild-type GFP-LKB1 in Fig. 2.1M). 
Notably, LKB1C564A expressed from its endogenous promoter is able to rescue an lkb1-null 
allele (lkb1X5) to a large extent (52% surviving flies in comparison to 69% for wild-type 
LKB1, Fig. 2.1O), indicating that farnesylation of LKB1 is not essential for the function of 
the protein in vivo. 
 
LKB1 directly binds to phospholipids 
 
In order to further elucidate the targeting of LKB1 to the plasma membrane, we used 
Schneider R+ (SR+) cells as they do not exhibit an intrinsic polarity and do not express 
transmembrane proteins like DE-Cad, Crumbs or Echinoid, qualifying them as a model for 
the analysis of direct plasma membrane targeting. As expected, GFP-LKB1 localizes to the 
plasma membrane in transfected S2R+ cells (Fig. 2.2C). In contrast, the farnesylation motif 
alone (GFP fused to the last 15 amino acids of LKB1, GFP-LKB1552-C) is not sufficient to 
target the protein to the cortex (Fig. 2.2D), which is in line with the hypothesis that stable 
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Fig. 2.2: LKB1 is recruited to the lateral plasma membrane by direct binding to 
phospholipids. (a) Schematic drawing showing Drosophila LKB1 with basic residues and the 
farnesylation motif within its C-terminal region highlighted. (b) Lipid overlay assay of 
recombinant LKB1 and LKB1ΔLB (=LKB1K546A R547A R548A K550A K551A K539A K540A K541A) using 
diverse lipids spotted on nitrocellulose membrane. (c–f) GFP-LKB1 and GFP-LKB1512-C 
localize to the cell cortex of transfected S2R cells (c,e), whereas a fusion protein of the last 
16aa of LKB1 with GFP (GFP-LKB1552-C) or GFP-LKB1ΔLB does not (d,f). (g–j) GFP-
LKB1512-C accumulates at the lateral membrane of epithelial cells in the embryonic epidermis 
(g), similar to full length GFP-LKB1 (h), whereas GFP-LKB1ΔLB exhibits a cytosolic 
localization in epithelial cells of the embryonic epidermis (i) and of the follicular epithelium 
(k) as well as in neuroblasts (j). Scale bars are 5 μm.  
 
membrane binding requires protein modifications (e.g., palmitoylation) or membrane binding 
domains (McTaggart, 2006) in addition to conjugation with farnesyl acid. In contrast, a longer 
C-terminal fragment of LKB1 (LKB1512-C and LKB1536-C) exhibits a robust cortical 
localization apart from a nuclear staining (Fig. 2.2E; Supplemental Fig. 2.2A). Furthermore, 
in embryos, a substantial fraction of GFP-LKB1512-C localizes to the lateral membrane (Fig. 
2.2G). 
Membrane association can be achieved not only by the interaction with transmembrane or 
membrane associated proteins but also by the direct binding to the lipid bilayer. Several  
protein domains are known to facilitate protein–lipid interactions. Beside larger domains, 
polybasic motifs have been described for several proteins to bind to (phospho)-lipids, in 
particular to phosphatidic acid (Stace and Ktistakis, 2006). Indeed, a C-terminal polybasic 
motif (aa 539–551, termed lipid-binding motif=LB, Fig. 2.2A) facilitates a direct binding of  
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Fig. 2.3: Membrane-association of LKB1 is essential for its kinase activity and function 
in vivo. (a–c) Immunostainings of lkb1-mutant ovaries (b) exhibit a disturbed localization of 
Staufen, which is rescued by expression of GFP-LKB1 (a) but not of GFP-LKB1ΔLB C564A (c). 
(d) Immunoblotting of LKB1 variants expressed in embryos demonstrating that the protein 
stability of GFP-LKB1ΔLB C564A is strongly reduced. (e) Overexpression of LKB1, but not of a 
kinase-dead version of LKB1 (LKB1D317A=LKB1KD) or GFP-LKB1ΔLB C564A results in an 
impaired eye morphology (‘rough eye’ phenotype). (f,g) In vitro kinase assays of GFP-
LKB1/GFP-STRAD purified from transfected S2R cells demonstrate a strong decrease in the 
kinase activity of LKB1ΔLB C564A measured by autophosphorylation (
32P GFP-LKB1) and 
phosphorylation of recombinant AMPK (32P GST-AMPK108-280) (f). The addition of PA-
enriched liposomes (as described in materials and methods) increased the kinase activity of 
wild type but not of membrane-binding deficient LKB1 (g). Activity of GFP-LKB1 was set as 
100%. Inputs were visualized by Western Blot against GFP (GFP, GFP-Stlk and GFP-LKB1) 
and by Coomassie Brilliant Blue staining (CCB, GST-AMPK108-280) Scale bars are 5 μm in c–
k and m, 100 μm in o and p, 10 μm in l and n. Experiments were performed in triplicates. 
Error bars represent s.d. and statistical significance was determined using ANOVA: P<0.001, 
***P<0.01, **P<0.05, not significant (NS). 
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DmLKB1 to PA, PtdIns(5)P, PtdIns(3,4,5)P3 and PtdIns(4,5)P2 as determined by a lipid 
overlay assay (Fig. 2.2B). A strong binding to PA (and to some extent to PtdIns(3,4,5)P3 and 
PtdIns(4,5)P2) was confirmed in liposome flotation assays (Supplemental Fig. 2.2B). 
Mutation of this motif (mutation of Arg and Lys in LKB1-LB to Ala, LKB1ΔLB) abolished 
liposome association in vitro (Supplemental Fig. 2.2B) as well as membrane association in 
cultured cells (Fig. 2.2F) and in Drosophila epithelia and neural stem cells (Fig. 2.2H–K). 
 
Membrane-bound LKB1 is crucial for Drosophila development 
 
LKB1 has been implicated in various cellular functions, among them cell proliferation 
control, suppression of tumour growth and regulation of cell polarity in various cell types 
(Vaahtomeri and Mäkelä, 2011; Nakano and Takashima, 2012). To address the question 
whether membrane targeting of LKB1 is crucial for its physiological function, we performed 
rescue experiments with GFP-LKB1 expressed from its endogenous promoter. As indicated 
above, not only wild-type LKB1 but also LKB1C564A can rescue the embryonic lethality of 
maternal and zygotic mutant flies to a substantial extent, indicating that wild-type and 
farnesylation-deficient GFP-LKB1 can substitute endogenous LKB1 in all tissues (Fig. 2.1O). 
Notably, GFP-DmLKB1ΔLB still exhibits a residual rescue capacity (8% of surviving flies in 
contrast to 69% for wild-type DmLKB1, (Fig. 2.1O), which might be due to a transient or 
weak membrane binding mediated by the farnesylation anchor. Indeed, removal of the 
farnesylation motif in GFP-LKB1ΔLB (GFP-LKB1ΔLB C564A) totally abolishes the rescue 
capacity of the mutant protein and all mutant flies die during embryonic stages like the null 
allele lkb1X5 (Fig. 2.1O). Moreover, lkb1-mutant flies expressing GFP-LKB1ΔLB C564A exhibit 
the same polarity defects as the null allele alone (e.g., disruption of the anterior–posterior 
polarity of ovaries, Fig. 2.3C, compared with wild-type LKB1 rescue in A and lkb1-mutant 
phenotype in B). 
Western blot analyses of lysates from embryos expressing LKB1 variants from the 
endogenous promoter reveal that GFP-LKB1ΔLB C564A is unstable or rapidly degraded (Fig. 
2.3D), indicating that the association of LKB1 with membranes is essential for protein 
stability. In contrast, transient membrane association of LKB1ΔLB, which is probably mediated 
by the farnesylation anchor, is sufficient for protein stabilization, as no differences in protein 
levels are detectable between wild-type LKB1 and lipid-binding-deficient LKB1 (Fig. 2.3D). 
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However, overexpression of GFP-DmLKB1ΔLB C564A in lkb1-mutant flies using the 
UAS/GAL4 system instead of the endogenous lkb1-promoter does not result in detectable 
rescue capacity (Supplemental Fig. 2.3A). Similar, the overexpression phenotype (rough eye 
formation) of LKB1 is abolished in GFP-DmLKB1ΔLB C564A similar to a kinase dead version 
(Fig. 2.3E). Thus, we assume that it is very unlikely that impaired functionality of GFP-
DmLKB1ΔLB C564A is only due to the instability of the protein. 
To further substantiate this assumption, we fused two different heterologous membrane-
binding domains to the C terminus of GFP-LKB1ΔLB C564A: The PH-domain of human 
phospholipase Cδ (Várnai and Balla, 1998) that preferentially binds to PtdIns(4,5)P2 
(resulting in GFP-LKB1ΔLB C564A-PH(PLCδ)), but is also capable of binding to PA with a high 
affinity (Pawelczyk and Matecki, 1999), and the PH-domain of human Akt1, (GFP-LKB1ΔLB 
C564A-PH(Akt1)) with a high affinity to PtdIns(3,4,5)P3 (Klippel et al., 1997). Similar to PLCδ, 
Akt1 has recently been demonstrated to bind PA in vitro (Bruntz et al., 2014). Strikingly, both 
chimeric proteins stabilize the protein expression of GFP-LKB1ΔLB C564A (Fig. 2.3D), localize 
at least partly to the lateral plasma membrane (Supplemental Fig. 2.4A,B) and are capable of 
rescuing the lkb1 null allele to a large extent (56 and 48% respectively, Fig. 2.1O). These 
results confirm our hypothesis that membrane association of LKB1 is crucial for its function 
in vivo. 
To test whether membrane association is essential for the kinase function of LKB1, we 
performed in vitro kinase assays using the GFP-DmLKB1/STRADα complex purified from 
transfected S2R cells. Indeed GFP-DmLKB1ΔLB C564A exhibits a strongly decreased kinase 
activity (46% in autophosphorylation and 30% in AMPK-phosphorylation relative to wild-
type GFP-LKB1, Fig. 2.3F). Furthermore, addition of PA-enriched liposomes to GFP-
DmLKB1/STRADα strongly increases the kinase activity of the LKB1 complex 
(autophosphorylation 1.6-fold and AMPK-phosphorylation 2.4-fold Fig. 2.3G). 
Reduced kinase activity of LKB1ΔLB C654A is neither due to impaired association with the 
canonical binding partners STRADα or Mo25, which enhance LKB1 activity, nor due to 
decreased substrate binding (Supplemental Fig. 2.3B). Therefore, these data suggest that the 
lipid binding capacity of DmLKB1 is essential for its kinase function. 
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Fig. 2.4: Membrane binding of hLKB1 is essential for its function in mammalian cells. 
(a) Alignment of DmLKB1 and hLKB1 reveals several positively charged aa in the C 
terminus of hLKB1. Mutated residues are marked with bold lines. (b,c) GFP-hLKB1 localizes 
predominately to the nucleus and plasma membrane of HeLa cells cotransfected with 
STRADα (b), whereas GFP-hLKB1ΔLB C430A is not recruited to the cortex (c). (d,e) 
Immunoblottings of lysates from transfected HeLa cells, which lack substantial LKB1 
expression, demonstrate an increase of activated AMPK (phospho-T172 AMPK), activated 
MARK (phospho-MARK) and decreased mTOR activation (measured by phosphorylation of 
S6K) upon GFP-hLKB1+STRADα transfection, which is not observed in GFP-hLKB1ΔLB 
C430A+STRADα transfected cells (d). Co-transfection of PLD2 but not of a catalytically 
reduced variant (PLDY511F) together with hLKB1 results in a further increase of AMPK 
activation (e). The intensity of pAMPK bands was quantified (normalized against total 
AMPK) (e, lower panel, control was set as 100%). (f) Cell viability of HeLa cells under 
energetic stress (induced by incubation with AICAR for 12 h) was estimated using the MTT 
assay (as described in the methods section). Scale bars are 10 μm. Experiments were 
performed in triplicates. Error bars represent s.d. and statistical significance was determined 
using ANOVA: P<0.01, **P<0.05, not significant (NS). 
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The function of human LKB1 depends on membrane binding 
 
As association with the membrane is essential for LKB1 to accomplish its function during 
development of Drosophila, we further investigated whether this mechanism is conserved  
throughout evolution and controls the activity of human LKB1 (hLKB1). Similar to its fly 
homologue, mutation of the polybasic region at the C terminus of hLKB1 together with 
mutation of the farnesylation motif (Fig. 2.4A) resulted in an impaired membrane localization 
in HeLa cells (Fig. 2.4B,C).Activation of AMPK is one of the most important functions of 
LKB1 during tumour progression, which is further enhanced under energetic stress. As 
activated AMPK directly and indirectly inhibits mTOR (Arsham et al., 2003; Kimura et al., 
2003; Inoki et al., 2003b; Corradetti et al., 2004; Shaw et al., 2004a; Shaw et al., 2005; 
Gwinn et al., 2008; Shackelford et al., 2009), the LKB1-AMPK pathway controls mTOR 
activity, e.g., upon aberrant activation of Akt, which occurs in various types of tumours with 
loss of function of PTEN or PI3-Kinase gain of function mutations (Menon and Manning, 
2008). Loss of membrane binding capacity of hLKB1 strongly decreases its ability to activate 
AMPK in HeLa cells (Fig. 2.4D), which lack substantial endogenous LKB1 expression, and 
consequently leads to apoptosis in metabolically stressed cells (Fig. 2.4F). Apart from AMPK 
activation, hLKB1ΔLB C430A fails to activate two other kinases of the AMPK-family, MARK 
(Fig. 2.4D) and SadA (Supplemental Fig. 2.5D). Furthermore, hLKB1ΔLB C430A is no longer 
able to inhibit mTOR (as estimated by phosphorylation of p70-S6-Kinase 1, pS6K, Fig. 
2.4D). Vice versa, addition of PA-enriched liposomes to a recombinant 
hLKB1/hSTRADα/hMo25 complex enhanced autophosphorylation of hLKB1 and AMPK 
phosphorylation in vitro, whereas Phosphatidylcholine (PC) alone or PtdIns(4,5)P2 and 
PtdIns(3,4,5)P3-enriched liposomes had only a small effect on the activity of hLKB1 
(Supplemental Fig. 2.3C,D). 
 
Overexpression of PLD2 enhances LKB1 activity 
 
PA is generated (among other pathways) from PC by two isoforms of PLD, PLD1 and 2 
(Gomez-Cambronero, 2014). Expression of PLD2 but not of a variant of PLD2 with a reduced 
catalytic activity (PLD2 Y511F (Henkels et al., 2009)) together with hLKB1 results in a 
further increase of AMPK and MARK activation (Fig. 2.4E), suggesting that PLD2-induced 
production of PA enhances LKB1 activity in vivo. Conversely, inhibition of PLD reduces  
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 Fig. 2.5: Induction of multiple axons in primary rat hippocampal neurons depends on 
membrane binding of hLKB1. (a–f) Hippocampal neurons from E18 rat embryos were 
transfected at 0 d.i.v. with vectors for GFP (control), GFP-LKB1 or GFP fusion proteins for 
the indicated LKB1 mutants and STRAD and analysed at 3 d.i.v by staining with the Tau-1 
antibody (axonal marker). Representative images of transfected neurons are shown. The scale 
bar is 20 μm. (f) The development of neuronal polarity was analysed by counting the number 
of neurons without an axon (0, black), with a single axon (1, gray) or with multiple axons (>1, 
white). Most primary rat hippocampal neurons transfected with GFP alone (control) develop 
only a single axon (a, quantified in f). In contrast, neurons overexpressing GFP-
hLKB1+STRADα or GFP-hLKB1C430A+STRADα (b,c,f) frequently establish two or more 
axons, whereas hLKB1 variants, which are deficient in membrane binding, fail to induce a 
multiple axon phenotype (d–f). Experiments were performed in triplicates. Error bars 
represent s.d. and statistical significance was determined using ANOVA: P<0.0001, 
****P<0.01, **P>0.05, not significant (NS). 
 
 
LKB1’s capacity to activate AMPK (Supplemental Fig. 2.5B). However, basal levels of 
activated AMPK are maintained, indicating that other enzymes (e.g., Diacylglycerol kinase) 
can compensate loss of PLD activity. This is in line with the observation that C. elegans, 
Drosophila and mouse mutants lacking PLD enzymes do not exhibit as dramatic phenotypes 
as LKB1ΔLB C564A (LaLonde et al., 2005; Raghu et al., 2009; Sato et al., 2013). 
 
Membrane-binding-deficient LKB1 fails to induce multiple axons 
 
Overexpression of LKB1 induces the extension of multiple axons (Shelly et al., 2007; Barnes 
et al., 2007; Veleva-Rotse et al., 2014). Consistently, overexpression of wild-type GFP-
hLKB1  
control hLKB1 hLKB1C430A
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together with STRADα results in the formation of multiple axons by the majority of 
transfected rat hippocampal neurons in culture (Fig. 2.5B,F). Remarkably, expression of 
farnesylation-deficient hLKB1C430A induces this phenotype as efficiently as wild-type LKB1 
(Fig. 2.5C,F). By contrast, mutation of the C-terminal basic region (hLKB1ΔLB) almost 
abolished the effect on axon formation (Fig. 2.5D,F). Inactivation of the farnesylation signal 
in lipid-binding-deficient hLKB1 (hLKB1ΔLB C430A) did result in further reduction of LKB1 
activity in this assay (Fig. 2.5D,F). These results confirm the importance of the C-terminal 
membrane binding domain for the function of LKB1 in mammalian cells. 
 
Expression of LKB1 is downregulated in malignant melanoma 
As we have demonstrated that overexpression of PLD2 in cell culture results in increased 
activity of LKB1 (reflected by enhanced AMPK activation, Fig. 2.4E), we next assessed the 
pathophysiological relevance of our findings regarding tumour formation in vivo. 
Interestingly, expression of PLD2 is upregulated in several types of cancer, including 
melanoma, and high PLD2 expression correlates with poor survival rates of patients (Saito et 
al., 2007; Henkels et al., 2013). In cultured melanoma cells lacking detectable LKB1 
expression (IGR37), membrane binding of LKB1 is essential for efficient AMPK (and 
MARK) activation, suppression of mTOR and cell survival under energetic stress 
(Supplemental Fig. 2.6). 
Our data suggest that an aberrant increase in PLD expression in cancer cells will lead to 
increased PA levels and subsequent mTOR activation (Fang et al., 2001; Foster et al., 2014; 
Yoon et al., 2015) only if in addition the expression of LKB1 is reduced, because PA-
mediated LKB1/AMPK activation normally counteracts mTOR activity. To test this 
hypothesis, we investigated whether increased expression of PLD, aberrant activation of Akt 
and decreased LKB1 expression correlate with enhanced mTOR activity in melanoma. 
Indeed, biopsies of melanoma primary tumours show a strong correlation between these four  
parameters. In 81% of all analyzed tumours PLD2 expression as well as phospho-Akt and 
mTOR activity were elevated while the expression of LKB1 was decreased (Fig. 2.6A–E). 
Only 12% of the samples showed mTOR activation in the presence of stimulating phospho-
Akt and PLD2-overexpression although LKB1 staining appeared normal, which might be 
explained by inactivating mutations of LKB1, which do not affect protein expression or 
stability. In contrast, melanocytes in biopsies of healthy skin exhibited a strong LKB1  
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Fig. 2.6: Downregulation of hLKB1 correlates with increased mTOR signalling in 
malignant melanoma overexpressing PLD2.  Immunostainings of paraffin-embedded tissue 
sections of normal skin (a–d), neavi (a′–d′) and primary malignant melanoma tumours (a′′–
d′′). (a) hLKB1 is highly expressed in melanocytes in the stratum basale of the epidermis in 
situ (a, arrows), and still detectable at substantial levels (a′) whereas it is almost undetectable 
in the majority of malignant melanoma (a′′). (b) PLD2 is not detectable in melanocytes of 
healthy skin sections (b, arrows) but becomes overexpressed in naevi (b′) and primary 
tumours (b′′). (c) Akt is activated (indicated by staining of phospho Akt, pAkt) in naevi (c′) 
and malignant melanoma (c′′), whereas it is not detectable in melanocytes of healthy skin 
samples (c). (d) Melanocytes in healthy skin biopsies (d) show only faint nuclear staining for 
phospho S6K (pS6K), which was used as to evaluate mTOR activation. Naevi (d′) exhibit 
only very few pS6K positive cells, whereas malignant melanoma show strong cytoplasmic 
and nuclear staining of pS6K (d′′). (e) Quantification of melanoma biopsies scored for the 
indicated correlations. ‘Others’ are tumours, which do not exhibit increased phospho-Akt or 
PLD2 staining. 
 
expression, as well as low level of PLD2, phospho-Akt and mTOR activation (Fig. 2.6A–D, 
arrows). Melanocytic nevi, a benign proliferation of melanocytes, which can give birth to 
malignant melanoma, show in many cases elevated PLD2 expression as well as activation of 
Akt, whereas LKB1 expression is still high in most cases, suppressing aberrant mTOR   
activation, which occurred only in 25% of the analyzed specimen (Fig. 2.6A’–D’). Thus in 
melanoma, loss of LKB1 in PLD2 overexpressing tumours may further contribute to mTOR 
activation, whereas in benign neoplasia higher LKB1 level counterbalance aberrant PLD2 
activation.  
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Discussion 
In this study, we have elucidated a conserved mechanism regulating LKB1 activity and 
function in vivo and during tumour suppression (Fig. 2.7). We have further established the 
first link between PLD-mediated production of PA and activation of LKB1. Our data suggest 
that membrane targeting of LKB1 by direct binding to PA is essential for the function of 
LKB1 during Drosophila development and for activation of AMPK and suppression of 
mTOR activity in cultured mammalian cells. Furthermore, downregulation of LKB1 in 
malignant melanoma specimen, which exhibit activated Akt and overexpression of PLD2, 
correlates with enhanced mTOR activity, indicating that the mechanism described in this 
study contributes to pathogenesis of malignant melanoma. In contrast to previous studies 
investigating the role of LKB1 farnesylation in the oocyte of Drosophila (Martin and St 
Johnston, 2003), we found farnesylation of LKB1 to be dispensable for the correct protein 
localization in the embryonic epidermis and NBs and for the function of LKB1 in Drosophila 
development. This observation is in line with previous findings from cultured mammalian 
cells and mice. In malignant melanoma cells, farnesylation-deficient LKB1 suppresses colony 
formation at similar degree as the wild-type kinase (Sapkota et al., 2001). Furthermore, 
studies from knock-in mice show that mice homozygous for farnesylation deficient LKB1 are 
viable and do not exhibit any obvious phenotypes (Houde et al., 2014). However, in these 
mice AMPK is less phosphorylated, whereas in cell culture experiments, no difference was 
found between wild-type and farnesylation deficient LKB1 (Denison et al., 2009). Notably, 
several C-terminally truncated hLKB1 variants (due to nucleotide deletions or point mutations 
in STK11) with an intact kinase domain have been reported (Boudeau et al., 2003d) and 
OMIM to be associated with Peutz-Jeghers syndrome, which might be due to the function of 
the C-terminal region in PA-mediated activation of LKB1. Apart from the association of 
LKB1 with STRADα/Mo25, membrane binding and PA-mediated activation of LKB1 is a 
newly described upstream mechanism, which controls LKB1 kinase activity and function in 
vitro and in vivo. The regulation of LKB1 function by membrane recruitment raises the 
question whether this depends primarily on membrane localization or whether lipid binding 
itself stimulates LKB1 activity. Several (phospho)-lipids have been demonstrated to activate 
or increase the activity of various serine/threonine kinases, including Phosphoinositide-
dependent kinase 1 (PDK1, activated by PtdIns(3,4,5)P3) or PKCζ, Raf1, and mTOR (all 
activated by PA (Limatola et al., 1994; Ghosh et al., 1996; Fang et al., 2001; Toschi et al., 
2009)). Fusion of GFP-LKB1ΔLB C564A to lipid-binding domains (PH(PLCδ) and PH(Akt1)) 
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Fig. 2.7: Simplified model of LKB1 activation by PLD2-produced PA and its 
downstream effects on AMPK activation and mTOR inhibition. Under physiological 
conditions in non-tumourous cells, PA is produced by PLD (and other enzymes), resulting in 
an activation of mTOR and LKB1. Due to the inhibition of mTOR by LKB1-activated 
AMPK, the final result of increased PA level is a balanced cell proliferation and -growth. In 
contrast, in malignant melanoma, increased PI3K/Akt-signalling and enhanced production of 
PA by overexpression of PLD results in aberrant mTOR activation which is not 
counterbalanced by LKB1/AMPK and thus leads to increased cell proliferation and -growth 
and impaired tumour suppression. 
 
resulted in a re-activation of GFP-LKB1ΔLB C564A (Fig. 2.1O; Supplemental Fig. 2.4). 
Furthermore, the activity of LKB1ΔLB C564A is strongly reduced in in vitro kinase assays (Fig. 
2.3F,G). These findings could substantiate a hypothesis, in which the membrane functions as 
a scaffold for bringing together LKB1 and its cofactors (STRADα and Mo25) or its 
substrates. However, membrane binding deficient LKB1 robustly associates with its cofactors 
and one of its substrates (AMPK, Supplemental Fig. 2.3B). Moreover, addition of PA (but not 
of PtdIns(4,5)P2 or PtdIns(3,4,5)P3) is capable to substantially enhance the kinase activity of 
LKB1 in vitro (Fig. 2.3G; Supplemental Fig. 2.3C,D). Thus it is more likely, that in addition 
to membrane recruitment, PA functions to induce a conformational change of LKB1 thus 
enhancing its kinase activity. However we cannot exclude that in our in vitro kinase assays 
using immunoprecipitated proteins from transfected cells wild-type LKB1 might have co-
immunoprecipitated with PA-enriched micelles, which enhanced its kinase activity in this 
experiment. Interestingly, PLD-produced PA activates both, LKB1 (this study) and mTOR 
(Fang et al., 2001; Toschi et al., 2009; Foster et al., 2014; Yoon et al., 2015). Up to now, 
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overexpression of PLD and increased levels of PA have been only assigned to pro-oncogenic 
pathways, in particular mTOR and Raf signalling (Ghosh et al., 1996; Rizzo et al., 1999; 
Zheng et al., 2006; Shi et al., 2007; Toschi et al., 2009). Our data thus demonstrate the first 
anti-oncogenic mechanism of PLD function, which might counterbalance its pro-oncogenic 
effects as long as the LKB1-AMPK signalling axis is intact (Fig. 2.7). Notably, 
Mukhopadhyay et al. showed recently, that in a mesenchymal-like breast cancer cell line 
(MDA-MB-231), which expresses robust levels of endogenous LKB1 (in contrast to the 
majority of breast cancer metastases), activated PLD induces a reduction in phospho-AMPK 
(Mukhopadhyay et al., 2015). Thus, PLD-mediated activation of LKB1 might be either cell 
type specific or depends on the basal activation of both signalling cascades, the LKB1-AMPK 
axis and the PI3K-AKT pathway. 
The LKB1-AMPK signalling pathway is well described to play a crucial role for cell polarity, 
energy homeostasis and cell proliferation and is frequently disturbed in various types of 
cancer (Nakano and Takashima, 2012; Hardie and Alessi, 2013). As mentioned above, one 
particular function of AMPK is to counterbalance the pro-proliferative activity of mTOR 
(Arsham et al., 2003; Kimura et al., 2003; Inoki et al., 2003b; Corradetti et al., 2004; Shaw et 
al., 2004a; Shaw et al., 2005; Gwinn et al., 2008; Shackelford et al., 2009). Defects in the 
LKB1-AMPK signalling pathway (resulting in impaired inhibition of mTOR) have been 
already demonstrated to contribute to BRAF- and KRAS-induced melanoma formation in 
mouse models (Zheng et al., 2009; Esteve-Puig et al., 2009; Liu et al., 2012b; Damsky et al., 
2015). Remarkably, somatic mutations in human STK11 (encoding LKB1) are rather rare in 
malignant melanoma (Rowan et al., 1999; Guldberg et al., 1999). However, our data 
demonstrate that downregulation of LKB1 protein expression can be observed in a majority of 
malignant melanoma samples and therefore most likely contributes to the pathogenesis of this 
type of skin cancer. 
Our study provides strong evidences for an important and conserved regulatory mechanism, 
which facilitates membrane recruitment of LKB1 by PA and is essential for the kinase activity 
and function of LKB1 during development and tumour suppression. The dissection of 
upstream regulatory mechanisms of LKB1 contributes to a better understanding of the 
physiological regulation of LKB1 and their misregulation in tumours, which might be useful 
for the development of therapeutic approaches in the future. 
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Supplemental figures 
 
 
Supplemental Fig. 2.1: Expression of LKB1 by its endogenous promoter. Western blot 
analysis Immunoblotting of embryonic lysates from w1118 flies and homozygous mutants for 
lkb1X5, an lkb1 loss of function allele (Lee et al., 2006), that express GFP-LKB1 from the 
endogenous lkb1 promoter shows comparable protein levels for endogenous and exogenous 
protein.  
 
 
 
Supplemental Fig. 2.2: LKB1 binds to phosphatidic acid in liposome flotation assays. (a) 
GFP-LKB1 536-C localizes to the cell cortex of transfected S2R cells. (b) Recombinant GST-
LKB1 or GST-LKB1 LB was incubated with liposomes (see Methods section for further 
details), overlaid with a sucrose cushion and subjected to ultracentrifugation. Liposomes were 
harvested and loaded as top fraction (T), whereas unbound protein remained in the bottom 
fraction (B). n = 3, significance (wild type LKB1 versus LKB1 LB): p < 0.005 for PA, n.s 
for PtdIns(4,5)P2 and p < 0.05 for PtdIns(3,4,5)P3.  
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Supplemental Fig. 2.3: Lipid-binding of LKB1 is essential for its function. (a) Western 
Blotting of wild type or membrane binding deficient GFP-LKB1 expressed from its 
endogenous promoter (lkb1::GFP-LKB1) or ubiquitously expressed at endogenous levels 
using the UAS/GAL4 system (UAS::GFP-LKB1). Rescue capacity (viable flies: +) of these 
proteins in an lkb1x5-mutant background is indicated. (b) Coimmunoprecipitation of GFP-
LKB1 or GFP-LKB1LB C564A from embryonic lysates expressing GFP-LKB1 variants 
together with HA-tagged STRADα and myc-tagged Mo25. Embryos expressing only HA-
STRADα and myc-Mo25 but no GFP-LKB1 served as a control. (c) Kinase activity of 
recombinant hLKB1/hSTRADα /hMo25 is strongly increased by addition of PC + PA, but 
only slightly by PC, PC + PtdIns(4,5)P2 or PC + PtdIns (3,4,5)P3. Lipids were prepared as 
liposomes as described in methods sections and applied in a 9:1 (PC:X) molar ratio. (d) In 
vitro kinase assays of GFP-AMPKα1 purified from transfected HeLa cells using recombinant 
LKB1/STRADα/Mo25 and indicated lipids. GFP-AMPK phosphorylation in the absence of 
LKB1 was not detectable. Phosphorylation of GFP-AMPK by LKB1in the absence of lipids  
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was set as 100%. Experiments were performed in triplicates. Error bars represent standard 
deviation and statistical significance was determined using ANOVA: p < 0.0001 ****, p 
<0.001***, p < 0.01**, p < 0.05*, p > 0.05 not significant (n.s.).  
 
 
 
 
Supplemental Fig. 2.4: Localization of fusion proteins of GFP-LKB1LB C564A with 
heterologous membrane-binding domains. (a and b) Immunostainings of embryos with 
GFP and α-spectrin reveal a substantial cortical localization of GFP-LKB1LB C564A fused 
to the PH domain of Phospholipase C (PH(PLCδ), a) or to the PH domain of Akt1 (PH(Akt), 
b). Scale bars are 5μm. 
 
 
 
 
 
Supplemental Fig. 2.5: Activation of AMPK and AMPK-related kinases by LKB1. (a) 
HeLa cells were transfected with plasmids for GFP-SadA and GFP alone (a) or the indicated 
GFP-hLKB1 variants (a’-a’’) and stained with antibodies specific for LKB1 (red) and 
activated Sad kinases (phosphorylated at S175 of SadA, pSAD, white). (b) Inhibition of PLD 
by 100nM 4-Fluoro-N-(2-(4-(5-fluoro-1H-indol-1-yl)piperidin-1-yl)ethyl)benzamide (FIPI) 
for 1h decreases the activation of AMPK by LKB1 in transfected HeLa cells. Scale bars are 
5μm.  
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Supplemental Fig. 2.6: Activation of AMPK by LKB1 in malignant melanoma cells 
depends on membrane binding. (a and b) The activation of AMPK and MARK kinases by 
LKB1 in was analyzed by Western blot in IGR37 cells, which lack detectable LKB1 
expression. Upon transfection of hLKB1, AMPK and MARK are activated, which is not seen 
in a membrane binding efficient LKB1 variant. This activation is further increased in the 
hLKB1+PLD2 double transfected cells (b). (c) Cell viability of IGR37 cells under energetic 
stress (induced by incubation with AICAR for 12h) was estimated using the MTT assay (as 
described in the methods section). Experiments were performed in triplicates. Error bars 
represent standard deviation and statistical significance was determined using ANOVA: p < 
0.0001****, p < 0.001***, p < 0.01**, p < 0.05*, p > 0.05 not significant (n.s.).  
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The tumour suppressor LKB1 is an essential serine/threonine kinase, which regulates various 
cellular processes such as cell metabolism, cell proliferation, cell polarity and cell migration. 
Germline mutations in the lkb1 gene are the cause of the Peutz-Jeghers syndrome, which is 
characterized by benign polyps in the intestine and a higher risk for the patients to develop 
intestinal and extraintestinal tumours. Moreover, mutations and misregulation of LKB1 have 
been reported to occur in most types of tumours and are among the most common aberrations 
in lung cancer. LKB1 activates several downstream kinases of the AMPK family by direct 
phosphorylation in the T-loop. In particular the activation of AMPK upon energetic stress has 
been intensively analysed in various diseases, including cancer to induce a metabolic switch 
from anabolism towards catabolism to regulate energy homeostasis and cell survival.  
In contrast, the regulation of LKB1 itself has long been only poorly understood. Only in the 
last years, several proteins and posttranslational modifications of LKB1 have been analysed to 
control its localization, activity and recognition of substrates. Here, we summarize the current 
knowledge about the upstream regulation of LKB1, which is important for the understanding 
of the pathogenesis of many types of tumours.  
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Introduction 
 
The regulation of cell proliferation, energy metabolism, cell polarity and - migration are 
essential processes that have to be strictly controlled. The Liver Kinase B1 (LKB1, encoded 
by STK11) is a highly conserved serine/threonine kinase that functions as a tumour 
suppressor. Germline mutations in STK11 cause the Peutz-Jeghers syndrome (PJS), an 
autosomal dominant disorder, which is characterized by cutaneous mispigmentations, benign 
gastrointestinal polyps and a high risk for the patients to develop tumours (Hemminki et al., 
1998; Mehenni et al., 1998; Jansen et al., 2009). The risk of PJS patients to develop cancer is 
highest in the gastrointestinal tract, however female patients bear also an increased risk to 
develop breast cancer (Hearle et al., 2006).  Somatic mutations or loss of LKB1 are also 
found in several other types of cancer, such as non-small cell lung cancer (NSCLC), cervical 
cancer, ovarian cancer, breast cancer, pancreatic cancer and malignant melanoma (Rowan et 
al., 1999; Guldberg et al., 1999; Sanchez-Cespedes et al., 2002; Carretero et al., 2004; 
Matsumoto et al., 2007; Wingo et al., 2009; Morton et al., 2010; Gill et al., 2011; Tanwar et 
al., 2014; George et al., 2016; Dogliotti et al., 2017). Only in the pathogenesis of salivary 
gland tumours, LKB1 seems to play no role (Cidlinsky et al., 2016). In NSCLC, genetic 
alterations of the STK11 gene are among the most common mutations in these tumours. 
Moreover, loss of LKB1 is associated with a poor survival rate of breast cancer patients (Shen 
et al., 2002; Sengupta et al., 2017).  
LKB1 forms a ternary complex with the pseudokinase STRADα and the scaffolding protein 
MO25, which promote nuclear export of the complex and enhance the kinase activity of 
LKB1. Together with the AMP-activated protein kinase (AMPK) LKB1 acts as a cellular 
energy sensor. Under energy deprivation LKB1 phosphorylates AMPK to inhibit mTORC1, 
Acety-CoA carboxylase and HMG-CoA-Reductase, thus inhibiting anabolic processes 
(Woods et al., 2003). Additionally, LKB1 phosphorylates 12 AMPK related kinases in their 
activation loop: SAD-A/B (BRSK2 and BRSK1), NUAK1/2 (ARK5 and SNARK), SIK1/2/3, 
MARK1/2/3/4 and SNRK (Lizcano et al., 2004; Jaleel et al., 2005). Given that LKB1 
regulates such a broad number of other kinases it could be considered as a “master kinase”. 
Beyond the role of LKB1 in metabolism and cell proliferation it is involved in the 
establishment of cell polarity by activating MARKs, which in turn regulate the formation of 
the Par complex (Benton and St Johnston, 2003a; Lizcano et al., 2004; Granot et al., 2009; 
Amin et al., 2009). In Drosophila, LKB1 has been described to regulate cell polarity by 
activation of AMPK, which in turn indirectly enhances the phosphorylation non-muscle 
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Figure 3.1: Schematic summary of upstream regulatory factors affecting LKB1 function 
in its four core functions. Red arrows represent inhibitory functions whereas green arrows 
indicate an activation of LKB1. 
 
myosin regulatory light chain (Lee et al., 2007; Bultot et al., 2009). Furthermore, by 
activating SAD-A/B and NUAK1 in neurons LKB1 regulates axon determination (Barnes et 
al., 2007; Courchet et al., 2013).  
 
Although at lot is known about the downstream functions of LKB1, the upstream 
mechanisms, which regulate the localization and function of this master kinase have long 
been less well characterized. Only over the recent years, several interaction partners and 
posttranslational modifications have been reported to regulate localization and function of 
LKB1, which will be summarised in this review. 
 
Non-covalent regulation by interaction partners 
 
The LKB1-STRADα-Mo25 complex 
LKB1 can either localize in the nucleus or in the cytoplasm. The N-terminal nuclear 
localization sequence (NLS) of LKB1 is recognized by Importin-α, which mediates the 
nuclear translocation (Smith et al., 1999a; Dorfman and Macara, 2008). Binding to the 
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pseudokinase STRADα (STe20 Related ADaptor) and the scaffolding protein MO25 (mouse 
protein 25) enhances nuclear export (Boudeau et al., 2003a; Baas et al., 2003; Dorfman and 
Macara, 2008). STRADα translocates LKB1 into the cytoplasm by binding  to the export 
factors CRM1 or Exportin7 and maintains LKB1 in the cytoplasm by outcompeting Importin-
α for binding to the NLS of LKB1 (Dorfman and Macara, 2008). Moreover, STRADα and 
MO25 drastically enhance the kinase activity of LKB1 (∼9 fold) (Boudeau et al., 2003a). In 
line with these results, the LKB1 mutant SL26 in PJS, which was lacks the amino acids 303 – 
306 cannot bind to STRADα and accumulates in the nucleus, which probably mediates its 
pathogenicity as the SL26 mutant is still catalytically active (Nezu et al., 1999; Baas et al., 
2003; Boudeau et al., 2004). The crystal structure of the LKB1/-STRADα-MO25 complex 
provides further insights into the formation of the active complex (Zeqiraj et al., 2009): 
STRADα binds LKB1 as a pseudosubstrate and mediates its conversion in an active 
conformation, whereas Mo25 is required to stabilize the active conformation of the LKB1 
activation loop (Zeqiraj et al., 2009). However, no structural data are available for the N- and 
C-terminus of LKB1, as in this study, only the kinase domain of LKB1 (aa 43 – 347) and the 
pseudokinase domain of STRADα (aa 59 – 431) have been analysed. This might be of 
particular interest, as the C-terminus contains several important phosphorylation sites as well 
as a farnesylation motif and a lipid-binding domain (Collins et al., 2000; Sapkota et al., 2001; 
Sapkota et al., 2002a; Sapkota et al., 2002b; Baas et al., 2003; Xie et al., 2006; Bai et al., 
2012; Dogliotti et al., 2017).    
 
The scaffolding protein AXIN 
One of the major targets of LKB1 in order to regulate metabolism and proliferation under 
energetic stress is AMPK. AMPK is sensitized for an increase in the AMP/ATP ratio: A 
single AMP molecule binds to the γ-subunit of the heterotrimeric AMPK, which enhances the 
affinity to a second AMP molecule. Upon AMP binding the catalytic domain in the α-subunit 
becomes exposed, which is then phosphorylated and activated at a conserved residue (T172) 
within the activation loop (T-loop) by LKB1. The activated kinase in turn phosphorylates 
Tuberin (TSC2) and Raptor to antagonize mTORC1 and thereby blocks the energy consuming 
protein synthesis.  
Recent studies demonstrated a more complex mechanisms of the LKB1 dependent regulation 
of AMPK (Zhang et al., 2013b; Zhang et al., 2014). In hepatocytes, AXIN functions as a 
scaffold by binding directly to LKB1 and AMPK and promotes the phosphorylation of 
AMPK in an AMP dependent manner. Consequently, knock down of AXIN in mice causes an 
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enhanced fatty liver as a result of insufficient AMPK activation (Zhang et al., 2013b). 
Furthermore, in mouse embryonic fibroblasts the AXIN-LKB1-AMPK complex is recruited 
to the late endosome and forms a complex with the v-ATPase-Ragulator complex (Zhang et 
al., 2014). This complex formation is essential for the activation of AMPK by LKB1, because 
the tissue specific knock out of LAMTOR1 (a component of the Ragulator complex) 
eliminates AMPK activation (Zhang et al., 2014).  
Interestingly, in addition to the well-known energy sensor AMPK, which is activated by 
AMP, a novel AMP-independent mechanism has been described: Upon energetic stress the 
concentration of fructose-1,6-bisphosphate (FBP) decreases and unoccupied Aldolase, which 
splits FBP into dihydroxyacetone phosphate (DHAP) and glyceraldehyde 3-phosphate (G3P), 
promotes the formation of the v-ATPase-Ragulator-AXIN-LKB1-AMPK complex to activate 
AMPK (Zhang et al., 2017a). 
It still remains to be investigated whether AXIN is a general activator of LKB1’s function or 
whether it regulates specifically the substrate recognition and phosphorylation of AMPK. 
Interestingly, AXIN is well known as a core component of the -catenin destruction complex, 
functioning as being an important regulator of the Wnt pathway, which is frequently targeted 
in tumour cells (Tortelote et al., 2017). Thus, AXIN might be a converging point, integrating 
LKB1/AMPK- and Wnt signalling. 
 
Membrane localization of LKB1 
In Drosophila and mammalian epithelial cells and fly neural stem cells, LKB1 is localized to 
the (lateral) plasma membrane, which is mediated by an C-terminal lipid binding domain and 
a farnesylation motif (C430) (Collins et al., 2000; Sapkota et al., 2001; Sebbagh et al., 2009; 
Dogliotti et al., 2017). Via its lipid binding motif, which is composed of several positively 
charged amino acids (lysines and arginines), human and Drosophila LKB1 bind to 
phosphatidic acid, which enhances its kinase activity and activation of downstream kinases (at 
least AMPK, MARKs and SAD kinases) (Dogliotti et al., 2017). The membrane association 
of LKB1 is essential in vivo to ensure protein stability and to promote polarization of the 
Drosophila oocyte as well as survival and development of the fly.  Furthermore, activation of  
AMPK in human cervical carcinoma (HeLa) and melanoma (IGR37) cells depends on 
membrane-binding of LKB1 (Dogliotti et al., 2017). The role of LKB1 farnesylation will be 
discussed later in this review. In polarized MDCK cells, E-Cadherin (E-Cad) contributes to 
the membrane localization of LKB1 and promotes the phosphorylation of AMPK (Sebbagh et 
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al., 2009). However, this regulation seems to be rather indirect and does more likely depend 
on the overall integrity of the apical-basal cell polarity (Sebbagh et al., 2009). 
 
Par3L 
The asymmetric cell division is a key feature of stem cells, where one daughter cell maintains 
its stem cell identity and the other one differentiates. In mouse mammary stem cells, the 
protein Par3-like (Par3L), but not Par3 itself, binds to LKB1 and inhibits its ability to activate 
AMPK (Huo and Macara, 2014). Loss of Par3L causes a decrease of mouse mammary stem 
cells, suggesting a role for LKB1 in stem cell maintenance, which has been also reported for 
human embryonic stem cells and haematopoietic stem cells (Nakada et al., 2010; Gurumurthy 
et al., 2010; Gan et al., 2010; Lai et al., 2012). In differentiated cells (Caco-2 human colon 
carcinoma cells), knockout of Par3L enhances the activation of AMPK, reduces cell 
proliferation and enhances cell death (Li et al., 2017). 
 
Honokiol 
Beside the cell intrinsic mechanisms to activate LKB1 several recently published studies 
report that the polyphenol Honokiol (HNK) from Magnolia grandiflora efficiently activates 
the LKB1-AMPK axis (Nagalingam et al., 2012; Seo et al., 2015; Avtanski et al., 2015; 
Sengupta et al., 2017). Upon HNK treatment of breast cancer cells, the expression of LKB1 is 
enhanced by an unknown mechanism (Nagalingam et al., 2012; Avtanski et al., 2015). 
Moreover, the expression of the deacetylases SIRT1 and SIRT3 increases, which deacetylate 
LKB1 to promote its cytoplasmic localization and activation (acetylation of LKB1 will be 
discussed later) (Avtanski et al., 2015). Enhanced expression and activity of LKB1 results in 
increased expression of the micro RNA miR-34a, which in turn inhibits the expression of 
epithelial-mesenchymal transition (EMT) markers, such as Zeb1 and Slug. Thus, the HNK 
dependent upregulation of LKB1 in breast cancer cells inhibits EMT and reduces their 
migratory capacity (Avtanski et al., 2015). In addition to the inhibition of EMT, HNK treated 
breast cancer cell display a reduced expression of the stemness transcription factors Nanog, 
Oct4 and Sox2 (Avtanski et al., 2015; Sengupta et al., 2017), which is most likely mediated 
by a decreased phosphorylation of Stat3 upon HNK treatment. Finally, in a xenograft mouse 
model HNK treatment inhibits breast tumour growth depending on LKB1 (Nagalingam et al., 
2012; Sengupta et al., 2017). Taken together, the HNK mediated activation of LKB1 might 
become a promising treatment for breast cancer patients in the future. However, on the 
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Figure 3.1: Schematic summary of posttranslational modifications of human LKB1 
Posttranslational protein modifications 
 
molecular basis, several important questions regarding the underlying mechanism are still 
unclear. 
 
Posttranslational protein modifications 
 
Phosphorylation 
Phosphorylation is the most common posttranslational modification and can either affect the 
conformation of the phosphorylated protein or create a novel interaction surface for other 
proteins. At least ten residues of LKB1 have been reported to be phosphorylated (Table 1), 
whereof some are autophosphorylation sites (S31, T185, T189, T336 and T402) and others 
residues are phosphorylated by other kinases (S307, S325, S334, T366, S399 and S428) 
(Alessi et al., 2006; Xie et al., 2009; Liu et al., 2012a; Zhu et al., 2013). However, not all 
phosphorylation events affect the (kinase) function of LKB1: None of the phospho-deficient 
or phospho-mimetic mutants of S31, S325, T336 and T366 displayed a significant change in 
their catalytic activity in vitro (Sapkota et al., 2002a). By contrast, the phospho-mimetic 
LKB1 T336E mutant prevented LKB1 from suppressing growth of a human malignant 
melanoma cell line, suggesting an autoinhibitory function of this autophosphorylation site 
(Sapkota et al., 2002a). Phosphorylated T336 is bound by 14-3-3ζ, which interferes with the 
LKB1-AMPKα interaction (Bai et al., 2012). With respect to the autophosphorylation of 
T189 contradictory functions have been reported. Either this residue is not phosphorylated at 
all or autophosphorylation of T189 negatively regulates LKB1 activity in a human 
fibrosarcoma cell line (Karuman et al., 2001b; Sapkota et al., 2002a).  
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In addition to its autophosphorylation, LKB1 is phosphorylated by PKCζ (Xie et al., 2006; 
Xie et al., 2008; Xie et al., 2009). Activation of PKCζ by either peroxynitrite or metformin in 
endothelial cells induces the phosphorylation of LKB1 at S428, which enhances the nuclear 
export of LKB1 to mediate its association with AMPK in order to activate it (Xie et al., 2006; 
Xie et al., 2008). In addition to the activation of AMPK in response to S428 phosphorylation, 
LKB1 phosphorylates and activates the lipid phosphatase PTEN to inhibit Akt signaling 
(Song et al., 2008). Moreover, PKCζ phosphorylates LKB1 at S307 (Xie et al., 2009). This 
phosphorylation is also important to enhance the nucleo-cytoplasmic shuttling of LKB1 in 
peroxynitrite stimulated cells to activate AMPK. Loss of the phosphorylation sites S307 and 
S428 attenuates the association of LKB1 with STRADα and the export factor CRM1 and thus 
decreases the cytoplasmic accumulation of LKB1 in an adenocarcinoma cell line (Xie et al., 
2009). Consequentially, the phosphorylation-deficient LKB1 S307A mutant has a reduced 
capacity to suppress angiogenesis and cannot efficiently protect cells from apoptosis (Xie et 
al., 2009).  
Apart from PKCζ, S428 is also a phosphorylation site for p90 ribosomal S6 kinase (p90-RSK) 
and cAMP-dependent protein kinase (PKA) (Collins et al., 2000; Sapkota et al., 2001; Martin 
and St Johnston, 2003). The p90-RSK mediated phosphorylation of S428 depends on ERK 
stimulation, whereas PKA phosphorylates S428 in response to adenylyl cyclase activation 
(Sapkota et al., 2001). In melanoma cells, phosphorylation of S428 is essential to suppress 
cell growth and does not affect the farnesylation at C433 (Sapkota et al., 2001). The 
PKC/PKA/p90-RSK mediated phosphorylation of LKB1 at S428 is crucial for axon 
differentiation: Only wild type LKB1, but not the S428A mutant, is capable of 
phosphorylating SAD-A/B in order to promote axon differentiation (Barnes et al., 2007; 
Shelly et al., 2007). Furthermore, phosphorylation of LKB1 S428 by PKA is essential for 
LKB1 localization and the myelination of Schwann cells (Shen et al., 2014). Notably, other 
studies reports that S428 phosphorylation of LKB1 is not essential to suppress cell growth of 
melanoma cells and to activate AMPK and SAD-A/B in vitro and in vivo (Bright et al., 2008; 
Fogarty and Hardie, 2009; Houde et al., 2014). 
The pleiotropy of studies with partly contradicting results indicates that LKB1 S428 
phosphorylation might be cell-type specific (maybe even compartment specific) and probably 
depends on the cellular context regarding cell proliferation, cell cycle, migration and 
metabolism. 
In mammals, two splice variants of LKB1 are expressed: LKB1L (long) and LKB1S (short), 
which are both widely expressed (Towler et al., 2008; Denison et al., 2009). The two protein 
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variants differ only in their last 63 amino acids, hence, LKB1S lacks the critical residues S428 
and C430. LKB1S is essential for spermatogenesis, since male lkb1S null mice are sterile 
(Towler et al., 2008). However, despite the lack of S428 in LKB1S it is still phosphorylated 
by PKCζ at its C-terminus at S399, which is unique in LKB1S (Zhu et al., 2013). 
Phosphorylation of S399 in LKB1S promotes its nuclear export followed by the activation of 
AMPK and is therefore thought to be the functional equivalent to S428 in LKB1L (Zhu et al., 
2013). 
  
Another phosphorylation site in LKB1 is S325 (Sapkota et al., 2002a). Subsequent studies 
managed to identify ERK and Cyclin D1-Cdk4/6 as the responsible kinases for the 
phosphorylation of LKB1 at this residue (Zheng et al., 2009; Casimiro et al., 2017). In 
melanoma cells, which express the oncogenic B-RafV600E variant, constitutively active ERK 
phosphorylates LKB1 at this residue. This phosphorylation decreases the affinity of LKB1 to 
AMPK and consequently leads to a reduction of AMPK activation. The authors confirmed 
their cell culture data in tissue samples of human melanoma, where the phosphorylation and 
activation of ERK associates with inactive AMPK (Zheng et al., 2009). In addition to ERK, 
LKB1 is also phosphorylated at S325 by Cyclin D1-Cdk4/6 (Casimiro et al., 2017). Like 
phosphorylation by ERK, Cyclin D1-Cdk4/6 mediated LKB1 S325 phosphorylation also 
suppresses AMPK activation and the stress-induced activation of AMPK is enhanced in cyclin 
D1-/- cells. Likewise, in mammary gland tissue of conditional cyclin D1-/- mice, the 
phosphorylation of AMPK and the level of autophagy are enhanced. (Casimiro et al., 2017)  
A previous study reported that mutations of S325 to alanine or glutamic acid did not affect the 
catalytic activity of LKB1 (Sapkota et al., 2002a). However, this inhibitory modification of 
LKB1 affects its substrate recognition rather than its kinase activity (Zheng et al., 2009). In 
the context of tumour progression the misregulation of B-Raf and Cyclin D1 is a common 
variation (Bartkova et al., 1994; Davies et al., 2002). Hence, affected tumours antagonize the 
tumour suppressor function of the LKB1-AMPK axis, which enhances their malignancy.   
 
The kinases Akt and LKB1 display antagonistic functions to control cell proliferation: Akt 
activates mTOR signalling, whereas LKB1 inhibits it via AMPK activation (Inoki et al., 
2003b; Shaw et al., 2004a). However, Akt act as an upstream regulator of LKB1, as it directly 
phosphorylates S334 of LKB1. Upon phosphorylation, 14-3-3 binds to LKB1 and antagonizes 
the interaction with STARDα. Consequentially, LKB1 is sequestered in the nucleus as fails to 
inhibit cell proliferation (Liu et al., 2012a). 
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Table 3.1: Summary of described posttranslational modifications. 
 
PTM Residue Enzyme Function  Reference 
Phosphorylation 
S31 unknown unknown Sakopta et al., 2002 
T32 unknown unknown Liu et al., 2012 
S69 unknown unknown Liu et al., 2012 
T71 unknown unknown Liu et al., 2012 
T185  LKB1 Activation   Baas et al., 2003 
T192 
(Xenopus) 
T189 
(mammals) 
LKB1 Inhibition  
Su et al., 1996 
Karuman et al., 2001 
S307 PKCζ 
Association with 
STRADα and 
cytoplasmic 
translocation  
Xie et al., 2009 
S325 
ERK, Cyclin 
D1-Cdk4/6  
Suppression of 
LKB1-AMPK 
interaction 
Sakopta et al., 2002  
Zheng et al., 2009 
Casimiro et al., 2017 
S334 Akt 
14-3-3 binding, 
nuclear retention 
and inhibition 
Liu et al., 2012 
T336 LKB1 
14-3-3 ζ binding, 
inhibition of 
AMPK 
phosphorylation  
Sakopta et al., 2002 
Bai et al., 2012 
T366 ATM 
Activation in 
response to ionizing 
radiation  
Sakopta et al., 2002 
S399  PKCζ 
Nuclear export and 
activation, only in 
LKB1s 
Zhu et al., 2013 
T402 LKB1 Activation  Baas et al., 2003 
S428 
(human)   
S431 
(mouse)   
S562 
(Drosophila) 
p90 RSK, 
PKA and 
PKCζ 
Activation 
Sakopta et al., 2001 
Martin and St 
Johnston, 2003 Xie et 
al., 2006                                  
Ubiquitination  
K41, K44, 
K48, K62, 
K63 
Skp2-SCF 
Activation, 
promotes the 
interaction with 
Mo25 
Lee et al., 2015 
unknown CHIP Degradation Gaude et al., 2012 
unknown HERC2 
Degradation upon 
recruitment by 
SIRT1 
Bai et al. 2016 
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PTM Residue Enzyme Function  Reference 
SUMOylation K178 unknown 
Promotes the 
interaction with 
AMPK under 
energetic stress 
Ritho et al., 2015 
Neddylation unknown unknown 
Stabilization of 
LKB1  
Barbier-Torres et al., 
2015 
Farnesylation C430 unknown 
Membrane 
localization 
Collins et al., 2000 
Sapkota et al., 2001 
Acetylation 
K44 unknown unknown Lan et al., 2008 
K48 unknown 
SIRT1 deacetylates 
LKB1 to promote 
its cytoplasmic 
localization and 
binding to 
STRADα 
Lan et al., 2008 
K64 unknown 
SIRT1 recruits 
HERC2 to 
acetylated K64 to 
promote the 
proteasomal 
degradation  of 
LKB1 in 
endothelial cells 
Bai et al., 2016 
K96 unknown unknown Lan et al., 2008 
K97 unknown unknown Lan et al., 2008 
K296 unknown unknown Lan et al., 2008 
K311 unknown unknown Lan et al., 2008 
K416 unknown unknown Lan et al., 2008 
K423 unknown unknown Lan et al., 2008 
K431 unknown unknown Lan et al., 2008 
S-Nitrosylation C430 none 
Promotes LKB1 
degradation 
Liu et al., 2015 
HNE adduktion K97 none Inhibition  
Dolinsky et al., 2009 
Calamaras et al., 
2012 
 
 
Beside the role of LKB1 at the membrane, LKB1 might have an additional function in the 
nucleus: In response to ionizing radiation LKB1 becomes phosphorylated at T366 by the 
protein kinase ataxia-telangiectasia mutated (ATM), which is known for its function in DNA 
damage response (Sapkota et al., 2002b). Another study investigating the ATM mediated 
phosphorylation of LKB1 T366 finds that ATM activates LKB1 in the cytoplasm upon 
treatment with reactive oxygen species (Alexander et al., 2010). Subsequently, mTORC1 is 
inhibited by the ATM-LKB1-AMPK axis, inducing autophagy (Alexander et al., 2010).   
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Ubiquitination 
The ubiquitination of proteins is a posttranslational modification that is involved in many 
different cellular processes in addition to its well-known function during protein degradation. 
LKB1 associates with the chaperon heat-shock protein 90 (Hsp90) and the co-chaperon 
Cdc37, which is essential to stabilize LKB1 by protecting it from ubiquitin dependent 
degradation (Nony et al., 2003; Boudeau et al., 2003b). Hsp90 binds to the kinase domain of 
LKB1 and pharmacological inhibition of Hsp90 causes an enhanced LKB1 degradation 
(Boudeau et al., 2003b; Nony et al., 2003). Moreover, the G163D mutation of LKB1, which 
has been found in a testicular tumour, has an impaired capacity to interact with Hsp90/Cdc37. 
Since LKB1 G163D still has some catalytic activity, the loss of the Hsp90/Cdc37 mediated 
stabilization might the reason of its pathogeny (Ylikorkala et al., 1999; Nony et al., 2003). 
The LKB1-Hsp90-Cdc37 complex does not include STRADα and in contrast to the LKB1-
STRADα-Mo25 complex lacks a catalytic activity (Gaude et al., 2012). The degradation of 
LKB1 upon Hsp90 inhibition depends on the binding of Hsp/Hsc70 to the C-terminus of 
LKB1. Hsp/Hsc70 then recruits the carboxyl terminus of Hsc70-interacting protein (CHIP), 
which is an E3-ubiquitin ligase that drives the degradation of LKB1. Thus, the two chaperone 
complexes Hsp90-Cdc37 and Hsp/Hsc70-CHIP regulate the stability of LKB1 (Gaude et al., 
2012).  
Beyond protein degradation, ubiquitination can have the opposite effect on proteins. LKB1 is 
also polyubiquitinated by the Skp2-SCF ubiquitin ligase, which activates the LKB1-AMPK 
axis (Lee et al., 2015a). The polyubiquitination of LKB1 takes place on five lysine residues 
(K41, K44, K48, K62 and K63) at the N-terminus of LKB1. Moreover, LKB1 is modified by 
a Lys-63-linked polyubiquitination, which has previously been described to activate other 
kinases (Yang et al., 2010; Lee et al., 2015a). Mechanistically, the polyubiquitination of 
LKB1 is crucial for the interaction with Mo25 and thus, for the integrity of the LKB1-
STRADα-Mo25 complex. Surprisingly, oncogenic H-Ras promotes the polyubiquitination 
and activation of LKB1. In specimen of hepatocellular carcinoma both, LKB1 and Skp2 are 
upregulated and associate with a poor survival rate (Lee et al., 2015a). Although LKB1 is 
classified as a tumour suppressor, its activation by Skp2 in response to oncogenic H-Ras 
suggest that it also exhibits pro-oncogenic potential. Furthermore, these data highlight again 
cell type specific functions of LKB1 and an ambivalent role in tumorigenesis, which should 
be explored in more detail in the future.   
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SUMOylation 
The SUMOylation of proteins is a posttranslational modification that involves the covalent 
attachment of a SUMO (Small Ubiquitin-like Modifier) protein to a substrate. Similar to 
ubiquitination SUMOylation requires an activating enzyme (E1), a conjugating enzyme (E2) 
and a ligating enzyme (E3) (Geiss-Friedlander and Melchior, 2007).  
Energetic stress promotes the SUMO1 modification of LKB1 on lysine 178 (Ritho et al., 
2015). Moreover, LKB1 seems to be SUMOylated at other lysine residues under normal 
conditions as well. The SUMO1 modification on K178 during energy deprivation promotes 
the interaction with AMPK and its activation, whereas LKB1 K178R fails to activate AMPK. 
AMPKα bears a SUMO-interacting motif (SIM), which promotes the association with LKB1 
and mutating the SIM decreases this interaction and the activation of AMPK. Cells that 
express the LKB1 K178R mutant do not display an increased level of mitophagy under 
energetic stress, which would be essential for their fitness (Ritho et al., 2015). Notably, only a 
marginal proportion of LKB1 protein seems to be SUMOylated, suggesting that only a small 
pool of the kinase might be capable of AMPK activation. Future studies must address the 
questions about the role of LKB1 SUMOylation in vivo and whether the phosphorylation of 
other substrates, in particular members of the AMPK-family kinases depends on LKB1 
SUMOylation, too.   
 
Farnesylation 
Farnesylation is a posttranslational modification of proteins that can mediate a transient 
membrane association. LKB1 is farnesylated at the C-terminus on the conserved cysteine 430. 
Nevertheless, the LKB1 localization is not restricted to the plasma membrane, but rather 
occurs in the nucleus and the cytoplasm as well, depending on the cell type and -status 
(Collins et al., 2000; Sapkota et al., 2001; Dogliotti et al., 2017). A farnesylation-deficient 
LKB1 has been reported to disable its membrane localization (Collins et al., 2000), however 
recent studies show that although the membrane localization is affected, a substantial amount 
of LKB1 still localizes at the plasma membrane (Houde et al., 2014; Dogliotti et al., 2017). 
The farnesylation of LKB1 has been reported to regulate the mesenchymal polarization and 
localizes LKB1 to the leading edge of motile cells (Konen et al., 2016; Wilkinson et al., 
2017). Nonetheless, transgenic flies and mice that cannot be farnesylated at C433 (or C564 in 
Drosophila) are viable without obvious defects (Houde et al., 2014; Dogliotti et al., 2017). 
Similar, LKB1 C433A retained its ability to suppress cell growth (Sapkota et al., 2001). In 
Drosophila, the farnesylation-deficient LKB1 C564A has a slightly decreased capacity to 
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rescue an lkb1 null allele and in mice loss of the LKB1 farnesylation results in a decreased 
activation of AMPK (Houde et al., 2014; Dogliotti et al., 2017). Given that the loss of LKB1 
farnesylation does not affect its catalytic activity (Sapkota et al., 2001), LKB1 farnesylation is 
likely to be a fine tuning mechanism to target the kinase to the plasma membrane during 
specific cellular processes, such as cell migration or under non-physiological energetic stress.  
 
Acetylation 
LKB1 is strongly acetylated and at least ten lysine residues have been identified as potential 
modification sites (K44, 48, 64, 96, 97, 296, 311, 416, 423 and 431) (Lan et al., 2008; Bai et 
al., 2016). The protein deacetylase SIRT1 specifically deacetylates LKB1 on K48, which 
enhances the interaction with STRADα, LKB1’s cytoplasmic localization and consequently 
the activation of AMPK (Lan et al., 2008). In line with these results, the hepatic 
overexpression of SIRT1 leads to an elevated activation of AMPK (Hou et al., 2008). Similar, 
SIRT1 is activated by the polyphenol Resveratrol, which in turn activates AMPK in mouse 
skeletal muscles through LKB1 deacetylation (Price et al., 2012). In contrast to the LKB1 
promoting function of SIRT1 in the liver, in endothelial cells, SIRT1 targets LKB1 for 
proteasomal degradation. The endothelial degradation of LKB1 promotes proliferation and 
inhibits endothelial senescence (Zu et al., 2010). The SIRT1 mediated degradation does not 
depend on its deacetylase activity, but rather requires a scaffolding function. SIRT1 binds to 
acetylated K64 and subsequently recruits the E3-ubiquitin ligase HERC2. HERC2 then 
ubiquitinates LKB1 in the nucleus to downregulate the amount of acetylated LKB1 (Bai et al., 
2016). 
 
Neddylation 
Neddylation is a posttranslational modification that relies on the attachment of NEDD8 to 
target proteins. Analogous to ubiquitination and SUMOylation, neddylation requires E1, E2 
and E3 enzymes. The level of neddylation is enhanced in hepatocellular carcinoma (HCC) 
and LKB1 is a neddylation target. The stability of LKB1 seems to depend on its neddylation, 
because upon the pharmacologic inhibition of NEDD8-activating enzymes the amount of 
LKB1 decreases in HCC. Furthermore, the decrease of LKB1 promotes the metabolic switch 
from oxidative phosphorylation towards glycolysis. Inhibition of neddylation enhanced 
apoptosis in HCC, which is reversible by LKB1 overexpression (Barbier-Torres et al., 2015). 
Taken together, the neddylation mediated stabilization of LKB1 seems to be disadvantageous 
in HCC.   
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S-Nitrosylation 
S-Nitrosylation is a posttranslational protein modification, where nitric oxide (NO) is attached 
to a cysteine residue. In response to stimulation of macrophages with lipopolysaccharides 
(LPS) the inducible NO-synthase (iNOS) generates NO as an innate immune response 
(MacMicking et al., 1995). However, a side effect of the increased NO synthesis might be the 
S-Nitrosylation of proteins. In LPS-challenged macrophages, LKB1 is S-Nitosylated on 
C430, which causes an enhanced degradation by the ubiquitin-proteasome system. Inhibition 
of iNOS after LSP challenge reduces the mortality of mice and enhances the LKB1 protein 
level (Liu et al., 2015). Thus, the S-Nitrosylation of LKB1 in challenged macrophages seems 
to further challenge the cells. 
 
HNE adduktion  
Under oxidative stress the electrophilic aldehyde 4-Hydroxynonenal (HNE) is produced as a 
result of an enhanced lipid peroxidation. HNE can bind to proteins and diminish the catalytic 
activity of enzymes and an increase of HNE is found in patients with cardiomyopathy 
(Schaur, 2003; Mali and Palaniyandi, 2014). In cardiomyocytes, LKB1 is affected by a HNE 
modification (Dolinsky et al., 2009; Calamaras et al., 2012, 2015). The HNE adduction takes 
place on K97 and HNE-modified LKB1 is inactive and fails to activate AMPK, resulting in an 
elevated mTORC1 activity and consequently an enhanced protein synthesis (Dolinsky et al., 
2009; Calamaras et al., 2012, 2015). Activation of the LKB1-AMPK axis with Resveratrol 
reduces the HNE modification of LKB1 and reverses the mTORC1 activation. Furthermore, 
in a mouse model for hypertension and left ventricular hypertrophy Resveratrol treated 
animals have a reduced cardiac hypertrophy (Dolinsky et al., 2009). Thus, an elevated 
production of HNE in cardiomyocytes promotes the progression of cardiomyopathies by 
inhibiting LKB1, which results in an enhanced mTORC1 dependent anabolism.  
 
Concluding remarks 
 
An increasing number of publications demonstrate that the master kinase LKB1 is regulated 
by various inputs – binding partners and targeting to subcellular compartments as well as 
posttranslational modifications. However, not for all of them an in vivo relevance is not yet 
clear. Besides its known deletion/mutation and downregulation of transcription, regulation of 
the protein stability by posttranslational modifications and/or interaction partners has emerged 
as an important mechanism to reduce active LKB1 levels, which certainly contributes to the 
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pathogenesis of tumours and might be a promising approach for the development of cancer 
therapies.   
Although LKB1 is capable of phosphorylating and thereby activating several kinases (mostly 
of the AMPK-family), most studies focus on AMPK as this is supposed to be a key enzyme in 
metabolism and tumour suppression. However, whether other LKB1 substrates are affected 
by the upstream regulatory mechanisms or whether it establishes a substrate specificity of 
LKB1 often remains to be investigated in the future. Furthermore, a possible interplay 
between the distinct posttranslational modifications and between these and described 
interaction partners is still poorly understood and might contribute to the complexity of 
LKB1’s regulation.     
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Apical-basal polarity is an important characteristic of epithelia and Drosophila neural stem 
cells. The conserved Par-complex, which consists of the atypical protein kinase C and the 
scaffold proteins Baz and Par6, is a key player in the establishment of apical-basal cell 
polarity. Membrane recruitment of Baz has been described to be accomplished by several 
mechanisms, which might function in redundancy, to ensure the correct localization of the 
complex. Here, we dissected the role of the oligomerization domain and the lipid-binding 
motif of Baz in vivo in the Drosophila embryo. We found that these domains function in 
redundancy to promote the apical junctional localization of Baz. However, inactivation of 
only one domain is not sufficient to disrupt the function of Baz during apical-basal 
polarization of epithelial cells and neural stem cells. Moreover, oligomerization stabilizes Baz 
by protecting it from degradation. Notably, we found that the mutation of both domains 
results in a strongly impaired protein stability and a phenotype characterized by embryonic 
lethality and an impaired apical-basal polarity in the embryonic epithelium and neural stem 
cells, resembling a baz-loss of function allele. Strikingly, the binding of Baz to the 
transmembrane proteins E-Cadherin, Echinoid and Starry Night was not affected in this 
mutant protein. Our findings reveal a redundant function of the oligomerization and the lipid-
binding domain, which is required for protein stability, correct subcellular localization and 
apical-basal cell polarization. 
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Introduction 
 
Apical-basal polarity is a hallmark of epithelial tissues and is essential during development 
and tissue homeostasis. In monolayered epithelial cells, the apical plasma membrane domain 
faces towards the outer environment or a lumen and the basal domain contacts the basement 
membrane. This polarity is achieved by the distinct position of conserved protein complexes 
along the apical-basal axis: The Crumbs complex (consisting of the transmembrane protein 
Crumbs and the adaptor proteins PATJ and Stardust) and the Par-complex determine the 
apical domain identity, whereas the Scribble-Lethal-Giant-Larvae and Discs large complexes 
counterbalance their activity at the basolateral domain (Goldstein and Macara, 2007; Pocha 
and Knust, 2013). Both apical junctional complexes, the Crumbs and the Par-complex overlap 
in the so called subapical region and at the adherens junctions (AJs) (Harris and Peifer, 2005; 
Krahn et al., 2010a; Sen et al., 2015; Koch et al., 2016). 
Bazooka (Baz), the Drosophila homolog of C. elegans and vertebrate Par3, is a scaffold 
protein and forms together with Par6 and aPKC the ternary Par complex (Wodarz et al., 
2000a; Petronczki and Knoblich, 2001; Suzuki and Ohno, 2006). Par3/Baz acts as an apical 
cue to establish the AJ by positioning Drosophila E-Cadherin (DE-Cad) and mediates the 
formation of the tight junctions in cultured mammalian cells (Hirose et al., 2002; Harris and 
Peifer, 2004; Chen and Macara, 2005; Horikoshi et al., 2009). Furthermore, Par3 acts as an 
exocyst receptor to regulate the delivery of membrane proteins (Lalli, 2009; Ahmed and 
Macara, 2017).  
In addition, Baz is required to establish apical-basal polarity and correct spindle orientation of 
Drosophila neural stem cells (neuroblasts, NBs), which is essential for their asymmetric cell 
division (Kuchinke et al., 1998a; Wodarz et al., 1999; Schober et al., 1999). NBs originate 
from the embryonic neuroectoderm and initially inherit their apical-basal polarization. During 
their asymmetric cell divisions, the Par-complex localizes to the apical cortex of the NB, 
which maintains its stem cell identity after asymmetric division, whereas proteins of the basal 
domain are segregated into the second daughter cell, the ganglion mother cell, which further 
differentiates into two neurons or glia cells (Wodarz, 2005; Zhong and Chia, 2008; Knoblich, 
2008).  
In epithelial cells, the kinase Par1 inhibits the formation of the Par complex in the baso-lateral 
region by phosphorylating Baz at two conserved residues (Ser151 and Ser1085). Binding of 
14-3-3 proteins to these phosphorylated residues prevents the oligomerization and association 
with aPKC (Hurd et al., 2003a; Benton and St Johnston, 2003a). In NBs, the protein 
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phosphatase PP2A counteracts the Par1 phosphorylation and thereby promotes the maturation 
of the Par complex (Krahn et al., 2009). Vice versa, at least in mammalian cells, Par1 is 
excluded at the apical domain by aPKC-mediated phosphorylation (Hurov et al., 2004). 
Furthermore, aPKC phosphorylates and inhibits Lgl at the apical cortex of NBs, which leads 
to a release of Par6 and aPKC from Lgl to promote the formation of the mature Par complex 
and the asymmetric localization of Numb and Miranda to the basal region (Betschinger et al., 
2003; Wirtz-Peitz et al., 2008). The mutual antagonism of basal and apical protein complexes 
maintains a border between both regions in epithelia and neural stem cells.  
 
Within the ternary Par complex, Par6 activates aPKC by replacing its pseudosubstrate domain 
(Graybill et al., 2012), whereas the aPKC binding region of Baz inhibits aPKC kinase activity 
(Soriano et al., 2016). The phosphorylation of Ser980 of Baz by aPKC leads to the 
dissociation of Baz/PAR-3 and aPKC whereupon Crumbs outcompetes phosphorylated Baz 
for binding to aPKC (Nagai-Tamai et al., 2002; Harris and Peifer, 2005; Morais-de-Sá et al., 
2010). Furthermore, Baz recruits the Crumbs adaptor Stardust during early embryogenesis, 
which is released upon aPKC-mediated phosphorylation of Baz (Krahn et al., 2010a; Sen et 
al., 2015). Thus, Baz/Par3 functions as an important polarity cue, recruiting the Par-complex 
to the apical junctions.  
Notably, how exactly Baz/Par3 itself localizes to the plasma membrane is still not fully 
clarified: Baz/PAR-3 contains an oligomerization domain (OD) at its N-terminus (Mizuno et 
al., 2003; Benton and St. Johnston, 2003b; Feng et al., 2007; Li et al., 2010a; Zhang et al., 
2013a) and three PDZ (PSD-95, Disc Large, ZO-1) domains, which interact with the cell 
adhesion molecule Echinoid (Ed) and Armadillo (Arm), the Drosophila homologue of ß-
catenin, which in turn stabilizes DE-Cad and thereby localizes Baz to the AJs (Wei et al., 
2005). In mammalian Par3, PDZ2 was suggested to directly bind to phospholipids of the 
plasma membrane (Wu et al., 2007) and we have demonstrated previously, that a C-terminal 
phosphoinositide lipid binding (LB) domain of Baz directly binds to PtdIns(4,5)P2 (PIP2) and 
PtdIns(3,4,5)P3 (PIP3) to tether Baz to the cell cortex (Krahn et al., 2010b), which was 
confirmed for mammalian Par3, too (Horikoshi et al., 2011).  However, deletion of any of 
these domains in Baz on its own disrupts the localization of the protein (Krahn et al., 2010b; 
Krahn et al., 2010a; McKinley et al., 2012). 
In this study we report that impaired oligomerization of Baz enhances degradation of the 
protein, but affects only mildly the rescue capacity of the mutant protein. We confirmed that 
the OD and LB motifs mediate the correct localization of the protein in redundancy. 
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Consequently, loss of both domains results in Baz degradation, which leads to the disruption 
of apical-basal cell polarity in epithelial cells of the embryonic epidermis and embryonic NBs 
and consequently embryonic lethality.  
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Material and Methods 
 
DNA and constructs 
Cloning of Baz pENTR was described before (Krahn et al., 2009).  For expression plasmids, 
we recloned Baz pENTR variants into UGW, UWS and PWG vectors (modified from UGW, 
UWG and PWG, which were obtained from the Drosophila Genomic Resource Center as 
described before (Sen et al., 2012) using the gateway technology (Life Technologies). The 
following primer were used to introduce the mutants in Baz pENTR: 
Baz1-968: 5’-ACAAACTCGGGCTGAGGATCCGGAGGTCACGCCTCCAAGGTG–3’ 
BazV14D-F: 5’ - GGCGACGTTCGCATTCTG GAT CCCTGTGGTTCCGGC - 3’ 
BazD68K-F: 5’ - GTCCGCGACGTGGCC AAA GATCGGGAGCAGATATTG - 3’ 
BazK1173K1174A-F: 5’ - AAGTCGTCGCGGGCCGCGGCGCCAAGCATACTGCGC - 3’ 
 
Fly stocks and genetics 
In all experiments, we used the baz815-8 allele, which is a null allele. baz germline clones were 
generated with baz815-8 FRT19A using the dominant female sterile technique (Chou and 
Perrimon, 1996). Homozygous mutant embryos were identified by loss of mCherry signal 
(from FM7-sqh::mCherry) in Western Blots. For immunofluorescence of germline clones, 
male embryos were selected by the absence of Sxl staining.  
Ubi::GFP-Baz, Ubi::Baz-OneStrep and UASp::Baz-GFP transgenes were generated using 
phiC31-mediated germline transformation and attP40 was used as landing site (Groth et al., 
2004). For overexpression of Baz during early embryogenesis, we used mat-tub::GAL4 
(#6356) (obtained from the Bloomington Drosophila Stock Center). 
 
Lethality test 
To test the lethality of embryos, 100 embryos of each genotype were tested in three biological 
replicates. Embryos derived from germline clones were selected against mCherry. The 
embryos were kept at 25°C on apple juice agarose plates and the amount of dead embryos, 
larval stage 1/2 (L1/2), larval stage 3 (L3), pupae and survivors was counted. 
 
Cuticle preparation 
Cuticle preparations were done as described previously (Wieschaus and Nusslein-Volhard, 
1986). The cuticle phenotypes were classified into the four categories wild type, shrunken 
with holes, holes and cuticle rest. 
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Real time PCR Analysis 
Embryos from overnight apple juice agar plates were used to isolate total RNA with TRIzol 
(Life Technologies) according to the manufactures instructions. To convert the RNA into 
cDNA, 1µg total RNA was used for reverse transcription with the qScript cDNA Synthesis 
Kit (Quantabio). Real time PCR was performed using the SensiFAST™ SYBR No-ROX Kit 
(Bioline) and the LightCycler 480 II (Roche). Relative expression levels of genes of interest 
were calculated as ΔCt values normalized to the rp49 control. The following primers were 
used: Baz qPCR F 5‘-GTCCGTTTGTGACGCAGGTG-3’, Baz qPCR R 5‘-
GGTCGGCGCGCCCACCCTTC-3’, rp49 F 5’-GCGGGTGCGCTTGTTCGATCC-3‘ rp49 
R 5’-CCAAGGACTTCATCCGCCACC-3‘. 
 
Cell culture 
Drosophila S2R cells were kept at 25 °C in Drosophila Schneider medium supplemented with 
10% FCS and 1% penicillin and streptomycin and passaged every three to four days. 
Cells were transfected with FuGene HD (Promega) according to the manufactures instructions 
and allowed to grow for additional three to four days after transfection.  
 
Antibody production 
To produce sera against the N-terminus of Baz, a rabbit and a guinea pig were immunized 
with the recombinant GST-Baz1-318 (Eurogentec Inc.). 
 
Immunofluorescence 
Embryos were fixed in 4% formaldehyde, phosphate buffer pH 7.4 as previously described 
(Krahn et al., 2009). The following primary antibodies were used for immunofluorescence: 
chicken anti GFP (1:2.000, Aves Labs Inc., #GFP-1020), mouse anti Dlg (1:25, DSHB, 
#4F3), rat anti DE-Cad (1:5, DSHB, #DCAD2), rabbit anti Baz (1:1.000, this study), Gp anti 
Baz (1:500, this study), rat anti Mir (1:1.000, gift from A. Wodarz), rabbit anti aPKC (1:500, 
Santa Cruz, #sc-216), mouse anti Sxl (1:25, DSHB, #M114). Secondary antibodies 
conjugated with Alexa 488, Alexa 568 and Alexa 647 (Life Technologies) were used at 1:400. 
Images were taken with a Zeiss LSM710 and processed with ImageJ. 
 
Embryonic lysates, immunoprecipitation and Western Blotting 
For embryonic lysates, embryos from overnight apple juice agar plates were collected and 
dechorionated in 50% bleach. The embryos were lysed in lysis buffer (1% Triton X-100, 150 
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mM NaCl, 1 mM CaCl2, 1 mM MgCl2, and 50 mM Tris-HCl, pH 7.5) supplemented with 
protease inhibitors. After incubation for 20 min at 4°C the lysates were centrifuged and SDS 
sample buffer was added before boiling at 95°C for 5 min. 
For immunoprecipitation, transfected S2R+ cells were lysed in lysis buffer supplemented with 
protease inhibitors. After centrifugation, cell lysates were added to StrepTactin beads for 
precipitation of OneStrep tagged Baz proteins for 45 min at 4°C. The beads were washed 
three times in lysis buffer and 2 x SDS sample buffer was added before boiling at 95°C for 5 
min. followed by Western blotting. Western blotting was performed according to standard 
protocols. The following primary antibodies were used in this study: mouse anti GFP (1:500, 
Santa Cruz #sc-9996), rabbit anti GST (1:5.000, Sigma #G7781), mouse anti c-Myc (1:100, 
DSHB, #9E10), mouse anti Actin (1:1.000, Santa Cruz #sc-47778), rabbit anti Baz (1:1.000, a 
gift from A. Wodarz).  
 
In vitro crosslinking 
The first 81 amino acids of wt or BazV14D D68K were fused to GST and purified from E.coli 
(strain BL21*) using glutathione beads (Macherey-Nagel). For in vitro crosslinking 
experiments, 5 µM recombinant protein was incubated in PBS for 1h on ice. Subsequently 
formaldehyde was added to a final concentration of 2% and incubated for 10 min at room 
temperature. The reaction was quenched by adding Tris to a final concentration of 250 mM. 
Then 5 x SDS sample buffer was added before boiling at 65°C for 5 min. The crosslinked 
proteins were analyzed by Western Blotting. 
 
Statistical analysis 
Data were analyzed using one-way ANOVA followed by Turkey’s post hoc test with 
Graphpad Prism 6. All plots are expressed as the mean ± standard deviation (s.d.).  
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Results 
Oligomerization and lipid binding promote Baz localization 
redundantly 
 
Baz functions on the top of a hierarchy regulating apical-basal polarization in the epidermis of 
the developing Drosophila embryo. However, it is still not fully understood, how Baz itself is 
recruited to the membrane. To analyze the contribution of structural domains of Baz to its 
localization in the Drosophila embryonic epithelium we generated transgenic flies that 
express GFP-tagged baz transgenes (Fig. 4.1A). The baz constructs were expressed with the 
ubiquitin promoter, which resulted in a weak overexpression of the full length protein (Fig. 
4.1B).  
GFP-Baz co-localizes with the AJ marker DE-Cad at the AJs (Fig. 4.2B), similar to 
endogenous Baz (Fig. 4.2A) and can fully rescue the embryonic lethality of the baz815-8 null 
allele (91,4 ± 2,8% hatched L1 larvae) (Fig. 4.1A).  
To analyse the function of the N-terminal oligomerization domain, we generated a 
oligomerization-deficient version of Baz, Baz V14D D68K (hereafter Baz∆OD), which has 
been reported to abolish the self-association of two N-terminal monomers in rat Par3 (Feng et 
al., 2007). Indeed, Baz∆OD had a strongly attenuated capacity to self-associate in vivo and in 
vitro (Fig. 4.1C-D). Surprisingly, in lethality tests with baz815-8 germ line clones (GLCs), 
which are deprived of maternal Baz mRNA and protein, GFP-Baz∆OD rescued the 
embryonic lethality of the baz815-8 null allele almost as efficient as wild type Baz (61,0 ± 
0,6%) (Fig. 4.1A). Furthermore, GFP-Baz∆OD localizes to the AJs in epithelial cells of the 
embryonic epithelium indistinguishable from its wild type counterpart (Fig. 4.2C compared to 
Fig. 4.2A and B).  
Baz is capable of binding to the phospholipids PIP2 and PIP3 (Krahn et al., 2010b). However, 
mutation of the lipid binding domain of Baz (GFP-BazK1173-1174A = Baz∆LB, Fig. 4.6B) 
did not attenuate the apical junctional localization of GFP-Baz∆LB or its rescue capacity 
(95,3 ± 5,3%) (Fig. 4.1A and Fig. 4.2D). In contrast, a variant of Baz which cannot 
oligomerize or bind to phospholipids (GFP-Baz∆OD∆LB) displayed a cytoplasmic 
localization and failed to rescue the baz815-8 mutant (Fig. 4.1A and Fig. 4.2E). Thus, Baz 
oligomerization and binding to phospholipids function in redundancy to target the protein to 
the apical junctions and ensure its function. This is confirmed by the finding, that a Baz 
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Fig. 4.1: Oligomerization of Baz is dispensable for viability (A) Schematic representation 
of different Baz deletion constructs. All constructs were expressed from the same genomic 
locus (attP40) with an N-terminal GFP-tag under the control of the ubiquitin promotor. The 
∆OD mutation (V14DD68K) prevents oligomerization and the ∆LB mutation (K1173-74A) 
abolishes membrane binding. The ability to rescue the embryonic lethality of baz815-8 germ 
lines clones was quantified and the localization determined, where “+” indicates the wild type 
situation, “+/-“indicates a lateral cortical localization and “-“indicates a cytoplasmic 
localization. (B) Expression of GFP-Baz in the baz815-8 mutant background results in a weak 
overexpression compared towards endogenous Baz. (C) Co-immunoprecipitation of GFP and 
Myc tagged Baz or Baz∆OD in S2R cells. Mutations of the OD domain strongly attenuate the 
capacity of Baz to self-associate. (D) In vitro crosslinking of the Baz OD domain (aa 1-83). 
Mutations of the OD domain (V14DD68K) strongly impair the formation of oligomers in 
vitro. 
 
variant encoding the first 968 amino acids (GFP-Baz1-968), which includes the 
oligomerization domain, is localized to the apical junctions with a slight baso-lateral 
mislocalization (Suppl. Fig. 4.1). Mutation of the oligomerization domain in GFP-Baz1-968  
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Fig. 4.2: Oligomerization and lipid-binding promote Baz localization redundantly. (A) In 
immunostainings of the Drosophila embryonic epithelium, endogenous Baz (green) co-
localizes with DE-Cadherin (DE-Cad, red) at the apical junctions. Disc large (Dlg, blue) was 
stained as a lateral marker. (B) The localization of GFP-Baz is indistinguishable from the 
endogenous protein. (C) The oligomerization-deficient GFP-Baz∆OD displays an 
accumulation at the AJ, overlapping with DE-Cad. (D) The localization of a lipid-binding 
deficient GFP-Baz∆LB protein is similar to wild type Baz. (E) The GFP-Baz∆OD∆LB double 
mutant is absent from the cell cortex and displays a diffuse cytoplasmic localization. All 
transgenes were expressed in a wild type background. Scale bars are 10 µm 
 
(GFP-Baz1-968∆OD) abolishes its cortical localization (Suppl. Fig. 4.1). Notably, GFP-Baz1-
968 did not rescue the embryonic lethality of baz815-8, most likely due to a lack of the C-
terminal part of the protein, which includes the aPKC-binding region.  
Taken together, the N-terminal oligomerization domain and the C-terminal LB motif of Baz 
contribute redundantly to the localization of the protein. Based on the rescue capacity of the 
Baz variants we found that neither the oligomerization nor the binding to phospholipids are 
essential for viability.  
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Binding to phospholipids is not sufficient for the function of Baz 
 
To further investigate the role of the LB motif regarding the localization and function of Baz 
we substituted the C-terminus including the intrinsic LB motif of GFP-Baz∆OD by the 
Pleckstrin homology (PH) domains of either PLCδ (Baz∆OD∆1106-1464-PHP) or Akt1 
(Baz∆OD∆1106-1464-PHA) (Fig. 4.1A). The PH domain of PLCδ specifically binds to 
PtdIns(4,5)P2 (PIP2) (Várnai and Balla, 1998), whereas the PH domain of Akt1 binds to 
PtdIns(3,4,5)P3 (PIP3) (James et al., 1996). Baz itself binds both, PIP2 and PIP3 in vitro (Krahn 
et al., 2010b).  
In the epithelium of transgenic embryos, both GFP-Baz∆OD∆1106-1464-PHP and GFP-
Baz∆OD∆1106-1464-PHA had a cortical localization and punctual enrichments at the AJ 
where they co-localized with DE-Cad (Suppl. Fig. 4.1). However, only GFP-Baz∆OD∆1106-
1464-PHA rescued occasionally the zygotic baz815-8 allele (<1%), but not embryos, which 
have been depleted for the maternal and zygotic protein expression (GLCs). Moreover, 
expression of both variants together, GFP-Baz∆OD∆1106-1464-PHP and GFP-
Baz∆OD∆1106-1464-PHA in a baz-mutant background did not produce surviving animals, 
indicating that either simultaneous binding of one Baz molecule to PIP2 and PIP3 is essential 
or that the C-terminus (aa 1106-1464) is essential for Baz’ function in our experimental set 
up, which differs from previous studies, which used proteins overexpressed by the 
UAS/GAL4 system (Krahn et al., 2010b; McKinley et al., 2012). 
 
Baz∆OD∆LB fails to polarize the epithelium of the embryonic 
epidermis 
 
To better understand why Baz∆OD∆LB failed to rescue baz815-8 mutant embryos, we analysed 
the epithelium of GLCs. To exclude the possibility that the N-terminal GFP-tag interferes 
with the function of Baz, we created transgenic flies, which express Baz transgenes fused with 
a small OneStrep-tag (OneS) at the C-terminus under the control of the ubiquitin promotor. 
As the GFP-variants, Baz-OneS displayed a strong rescue capacity of the embryonic lethality 
in baz815-8 GLCs, whereas Baz∆OD∆LB-OneS displayed a complete embryonic lethality (Fig. 
4.3). To test if the overexpression of Baz∆OD∆LB might help to overcome the embryonic 
lethality of baz815-8 GLCs, we expressed UASp::Baz-GFP and UASp::Baz∆OD∆LB-GFP with 
mat-Tub::Gal4 in baz815-8 GLCs (Fig. 4.5A). Baz-GFP rescues the embryonic lethality of  
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Fig. 4.3: Loss of oligomerization and lipid-binding causes embryonic lethality. Baz 
variants that carry an C-terminal One-Strep (OneS) tag were expressed under the ubiquitin 
promoter and tested for their capacity to rescue baz818-8 germ line clones. Baz-OneS 
efficiently rescues the lethality of the baz818-8 allele (10,5 ± 1,8% embryonic lethality). 
Baz∆OD∆LB-OneS failed to rescue the embryonic lethality. Fusion of the oligomerization 
domain of the human TEL protein (aa 45 – 115) to the N-terminus of Baz restores its function 
and rescues embryonic lethality of baz815-8 to a large extent (50,0 ± 6,1% embryonic lethality). 
Similar, wild type Baz-GFP overexpressed with mat-Tub::Gal4 using the Gal4/UAS-system 
had comparable efficiencies as the constitutively expressed variant (12,7 ± 8,5%), whereas 
overexpression of Baz∆OD∆LB-GFP failed to rescue (100% embryonic lethality). Bars 
represent the mean ± s.d. 
 
GLCs to the same extend as Baz-OneS (87,3 ± 8,5% and 89,5 ± 1,8%, respectively), whereas 
Baz∆OD∆LB-GFP expressing GLCs failed to escape embryonic lethality (Fig. 4.3). 
Next, we evaluated the phenotypes of embryonic cuticles of baz GLCs expressing the 
different rescue constructs. The Cuticle is secreted from the epidermis and allows drawing a 
conclusion of its integrity, in particular the formation of a function apical domain. We divided 
the observed phenotypes in five groups (hatched (=normal cuticle), wild type (= dead but 
cuticle without obvious defects), cuticle rest, holes and shrunken with holes). As expected the 
baz815-8 mutant displayed large cuticle hole or some cuticle rest (Suppl. Fig. 4.2). In contrast 
to the null allele, most animals of Baz-OneS hatch and the dead embryos had either a wild 
type or shrunken cuticle phenotype (4,8% or 5,7%, respectively, Suppl. Fig. 4.2). 
Baz∆OD∆LB-OneS partially rescued the baz815-8 phenotype, because some embryos 
developed further and had either a wt or shrunken with holes phenotype (2,3% or 23,3%, 
respectively, Suppl. Fig. 4.2). 
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Fig. 4.4: Epithelial polarization requires the functional redundancy of the OD and LB 
domains. (A) Immunostaining of endogenous Baz (green), aPKC (red) and Sxl (blue) in the 
embryonic epidermis. (B-E) Immunostaining of Baz variants and endogenous aPKC in the 
embryonic epidermis of baz818-8 germ line clones. Hemizygous mutant embryos were 
identified by the absence of Sxl staining. (B) Loss of Baz in the embryonic epidermis of 
disrupts epithelial polarization and aPKC accumulates in the cytoplasm. (C) Baz-OneS 
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efficiently recruits aPKC to the apical junctions, such as endogenous Baz, whereas 
Baz∆OD∆LB-OneS displays a cytoplasmic mislocalization (D). Baz∆OD∆LB-OneS rescues 
some aPKC to the apical junctions, but the majority of the protein still accumulates in the 
cytoplasm. (E) TEL-Baz∆OD∆LB-OneS localizes at the apical junctions and is capable of 
recruiting aPKC to rescue the defects of Baz∆OD∆LB-OneS. (F-J) Immunostaining of Baz 
(green), DE-Cad (red) and Sxl (blue) in the embryonic epidermis demonstrate a loss of AJ in 
baz815-8 germ line clones, which can be rescued by wild type Baz and (H) and TEL-
Baz∆OD∆LB-OneS (J) but not by Baz∆OD∆LB-OneS (I). Scale bars are 10 µm 
 
Interestingly, fusion of the heterologous oligomerization domain of the human TEL protein 
(residues 45-115 (Kim et al., 2001)) to the N-terminus of Baz∆OD∆LB-OneS (TEL-
Baz∆OD∆LB-OneS) partly restores the rescue capacity of the mutant Baz protein.  
Furthermore, TEL-Baz∆OD∆LB-OneS embryos had a milder phenotype, as most dead 
embryos had a wild type or shrunken cuticle phenotype (21,9% and 17,9%, respectively, 
Suppl. Fig. 4.2). 
Next, we scored for the localization of polarity markers in the embryonic epithelium by 
immunostainings. Hemizygous mutant embryos derived from GLC were identified by the lack 
of Sex lethal (Sxl) staining. As expected, in the epithelium of baz815-8 GLCs we did not detect 
a signal for Baz, whereas aPKC exhibited a cytoplasmic localization (Fig. 4.4B). Baz-OneS 
and TEL-Baz∆OD∆LB-OneS both had a robust apical localization and recruited aPKC to the 
apical junctions, similar to endogenous Baz (Fig. 4.4A, C and E). In contrast, Baz∆OD∆LB-
OneS showed a cytoplasmic mislocalization (Fig. 4.4D). Nevertheless, Baz∆OD∆LB-OneS 
managed to recruit some aPKC to the apical junctions, but the majority of the aPKC protein 
still accumulates in the cytoplasm (Fig. 4.4D). In general, the overall structure of the 
epithelium was disrupted in Baz∆OD∆LB-OneS embryos.  
Then, we examined the assembly of intact AJ by scoring for the localization of DE-Cad in 
baz815-8 GLCs (Fig. 4.4F-J). Baz-OneS and TEL-Baz∆OD∆LB-OneS both showed an apical 
junctional targeting of DE-Cad comparable to the wild type control (Fig. 4.4F, H, J). Unlike 
as for aPKC we did not see a localization of DE-Cad in the apical region or at the plasma 
membrane in Baz∆OD∆LB-OneS expressing baz815-8 GLCs (Fig. 4.4I). 
In summary, Baz∆OD∆LB-OneS has only a weak capability to polarize the embryonic 
epithelium and displayed strong cuticle defects, as well as an impaired function, since aPKC 
was inefficiently and DE-Cad not at all recruited to the apical junctions. Restoring the 
oligomerization capacity of Baz by fusing the oligomerization domain of TEL to 
Baz∆OD∆LB-OneS restores its functionality to a large extent.     
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Fig. 4.5: Neuroblast polarity requires Baz’s capacity to either self-associate or to bind 
lipids. (A) Immunostaining of endogenous Baz (green), Mir (red) and Sxl (blue) in embryonic 
metaphase NBs. Baz localizes at the apical cortex, whereas Mir accumulates basally. (B-E) 
Immunostaining of Baz variants (green) and endogenous Mir (red) in embryonic NBs of 
baz818-8 germ line clones during metaphase. Hemizygous mutant embryos were identified by 
the absence of Sxl staining. (B) Loss of Baz in baz818-8 germ line clones disrupts NB polarity 
and Mir localization. (C) Baz-OneS rescues NB polarity, whereas Baz∆OD∆LB-OneS does 
not localize at the cortex and fails to polarize NBs (D). (E) TEL-Baz∆OD∆LB-OneS restores 
apical-basal polarity in metaphase NBs, such as wild type Baz. (F) Immunostaining of 
endogenous Baz (green), aPKC (red) and Sxl (blue) in embryonic metaphase NBs. Baz 
recruits aPKC to the apical pole of metaphase NBs. (G) aPKC accumulates in the cytoplasm 
in metaphase NBs of baz818-8 germ line clones. (H, J) Baz-OneS and TEL-Baz∆OD∆LB-OneS 
both show a comparable localization and recruit aPKC to the apical pole. (I) In contrast, 
Baz∆OD∆LB-OneS localizes in the cytoplasm, such as endogenous aPKC. Scale bars are 5 
µm 
 
Apical-basal polarity of embryonic NBs is disrupted in 
Baz∆OD∆LB embryos 
 
Similar to polarization of the epithelium of the embryonic epidermis, Baz is also required for 
the establishment of apical-basal polarity of dividing NBs. Hence we investigated if 
Baz∆OD∆LB-OneS had similar phenotypes in embryonic NBs as in the epithelium. Baz 
accumulates at the apical cortex, recruiting aPKC and Par6, whereas the scaffold protein 
Miranda (Mir) is restricted to the basal region of metaphase NBs (Fig. 4.5A). Basal 
segregation of Mir depends on the apical formation of the Par complex (Rolls et al., 2003; 
Atwood and Prehoda, 2009). Therefore, we analysed the localization of Baz variants and Mir 
in NBs of baz815-8 GLCs. We found that Baz∆OD∆LB-OneS phenocopied the baz null allele, 
as Mir is not restricted to the basal region of NBs in both genotypes but can be found more or 
less all around the cortex (Fig. 4.5B, D). Baz∆OD∆LB-OneS also failed to localize to the 
apical membrane of NBs, but rather displayed a weak cytoplasmic localization (Fig. 4.5D). 
Like in the epithelium Baz-OneS and TEL-Baz∆OD∆LB-OneS rescued the asymmetric 
distribution of Mir and localized to the apical membrane in metaphase NBs, such as the 
control (Fig. 4.5A, C, E).  
In contrast to the epithelium where aPKC displayed at least a minimal polarization in 
Baz∆OD∆LB-OneS GLC, its localization in NBs is cytoplasmic, similar to the baz null allele 
(Fig. 4.5G, I). As expected, Baz-OneS and TEL-Baz∆OD∆LB-OneS recruit aPKC to the 
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apical cortex comparable to endogenous protein (Fig. 4.5F, H, J). 
Thus, the functional redundancy of the OD and the LB motif are essential to polarize 
embryonic NBs, since neither Mir nor aPKC exhibited a correct localization in Baz∆OD∆LB-
OneS GLC.  
 
Baz∆OD∆LB is still recruited to the cortex by transmembrane 
proteins  
 
In order to elucidate the mechanism why Baz∆OD∆LB-OneS fails to accumulate at the apical 
junctions and why it is non-functional, we tested whether the membrane recruitment by its 
described interacting transmembrane proteins is disturbed. Therefore, we used Drosophila 
S2R cells as a model system, because they do not exhibit a polarity or detectable amounts of 
polarity proteins (Krahn et al., 2010b). In S2R cells, Baz-GFP clearly localizes to the cell 
cortex (Fig. 4.6A), whereas Baz∆LB-GFP appears in cytoplasmic aggregates (Fig. 4.6B), 
indicating that in S2R cells cortical localization of Baz depends exclusively on the binding to 
phospholipids. Co-transfection of Baz∆LB-GFP with DE-Cad-RFP or Ed-RFP led to the 
formation of cell-cell contacts of transfected cells. Both proteins recruited Baz∆LB-GFP to 
the artificial cell-cell contacts (Fig. 4.6C-D). Additionally, the intracellular domain of the 
atypical cadherin Starry night (Stan) fused to the extracellular domain of DE-Cad also 
recruited Baz∆LB-GFP to ectopic cell-cell contacts (Fig. 4.6E). By contrast, the Stan isoform 
Flamingo, which lacks the C-terminal PDZ binding motif did not recruit lipid binding 
deficient Baz (data not shown). Expression of Baz∆OD∆LB-GFP alone or together with DE-
Cad, Ed or Stan showed that Baz∆OD∆LB-GFP was recruited to the cell-cell contacts, such 
as its oligomerizing counterpart (Fig. 4.6F-I). Thus, Baz∆OD∆LB is still able to interact with 
its reported recruiting transmembrane proteins. This is in line with the observation, that 
deletion of the PDZ domains, which facilitate binding to Stan, Ed and Arm/DE-Cad, does not 
disturb the localization of GFP-BazLB (Fig. 6J). 
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Fig. 4.6: Recruitment of Baz by DE-Cad, Ed and Stan does not depend on self-
association or lipid-binding of Baz. (A) Wild type Baz-GFP was expressed with the 
ubiquitin promoter in S2R cells and localizes at the plasma membrane. (B) Baz∆LB-GFP 
accumulates in cytoplasmic aggregates. (C, D) DE-Cad-RFP and Ed-RFP recruit Baz∆LB-
GFP to artificial cell-cell contacts. (E) Similar, the intracellular domain of Stan, fused to the 
extracellular and transmembrane domain of DE-Cad (DE-Cad∆intra-Stan∆extra) targets 
Baz∆LB-GFP to cell-cell contacts. DE-Cad∆intra-Stan∆extra was detected with an anti DE-
Cad antibody, which recognizes the extracellular domain of DE-Cad. (F-I) In the same 
experimental setup with Baz∆OD∆LB-GFP, the double mutant was efficiently recruited by 
DE-Cad, Ed and Stan without apparent differences. (J) Deletion of all three PDZ domains in 
BazLB does not affect the localization of the mutant protein at the apical junctions (green = 
GFP- BazPDZ1-3 LB, red = DE-Cad, blue = aPKC). Scale bars are 5 μm in A-I and 10 μm 
in J. 
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Oligomerization protects Baz from degradation 
 
Despite its capacity to interact with transmembrane proteins, Baz∆OD∆LB-OneS is non-
functional and does not localize to the apical junctions. Therefore, we tested, whether 
simultaneous loss of oligomerization and lipid binding affects the protein stability, we blotted 
baz815-8 GLC rescued with GFP-Baz and Baz-OneS variants to detect the exogenous Baz 
protein. Indeed, we observed that loss of the dimerization domain caused a reduced amount of 
Baz protein in the embryo, which is further enhanced upon the loss of the LB motif (Fig. 
4.7A, C). In contrast, mutation of the LB motif alone did not affect the amount of protein 
(Fig. 4.7C). Similar, the amount of Baz∆OD∆LB-OneS protein is strongly reduced in lysates 
of GLC (Fig. 4.7A), whereas Baz-OneS and TEL-Baz∆OD∆LB-OneS were not affected by 
enhanced protein degradation (Fig. 4.7A). The reduced amount of Baz∆OD∆LB-OneS was 
not due to impaired gene expression, because all transgenes were expressed from the same 
promoter and genomic location and exhibited comparable mRNA levels with no significant 
differences (Fig. 4.7B).  
Finally, we tested, whether the phenotypes observed in Baz∆OD∆LB rescued embryos are 
only due to protein degradation of the mutant protein. Strikingly, overexpression of wild type 
Baz-GFP, but not Baz∆OD∆LB-GFP rescued the embryonic lethality of baz815-8 (Fig. 4.3) 
although both proteins are expressed at comparable levels (Suppl. Fig. 4.3A). Moreover, 
Baz∆OD∆LB-GFP is still cytoplasmic, whereas its wild type counterpart localizes to the 
apical junctions (Suppl. Fig. 4.3C in comparison to B). These data suggest, that Baz∆OD∆LB 
fails to localize to the apical junctions, accumulates in the cytoplasm and is rapidly degraded. 
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Fig. 4.7: Oligomerization and lipid binding are crucial for Baz’ stabilization. (A) Lysates 
of baz818-8 germ line clones that express different Baz variants were blotted against Baz. Actin 
was used as loading control. Loss of Baz oligomerization and lipid binding (Baz∆OD∆LB) 
strongly decreases the amount of Baz protein. TEL-Baz∆OD∆LB-OneS rescues the 
degradation of Baz∆OD∆LB-OneS. (B) qPCR of total RNA from the baz818-8 germ line clones 
shows that all transgenes were expressed without significant differences (One-way ANOVA 
followed by Turkey’s post-hoc test, n.s. p>0.05, * p< 0.05, ** p< 0.01). Bars represent the 
mean ± s.d.. (C) Embryonic lysates of different GFP-Baz variants in a baz818-8 genetic 
background were blotted against GFP. Actin was used as loading control. Loss of 
oligomerization reduces the stability of GFP-Baz∆OD, which is drastically enhanced upon the 
mutation of the lipid binding motif in GFP-Baz∆OD∆LB. However, mutation of the lipid-
binding motif alone (GFP-Baz∆LB) does not affect the protein stability. (D) Scheme of the 
functional redundancy between the OD and LB domains. 
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Discussion 
 
Taken together, the oligomerization domain of Baz is not essential for viability of the 
Drosophila embryo, but contributes to the stability of the protein and the functional 
redundancy of the oligomerization domain and the LB motif are indispensable for the 
function of Baz during Drosophila embryogenesis (Fig. 4.7D). 
This is in contrast to previous findings, reporting an important role for the oligomerization 
domain for Baz/Par3 localization in Drosophila and mammalian cells (Mizuno et al., 2003; 
Benton and St. Johnston, 2003b). This discrepancy might be explained by the different setups: 
In contrast to previous studies (Benton and St. Johnston, 2003b; Krahn et al., 2010b; 
McKinley et al., 2012) using overexpressed proteins with the UAS/GAL4 system in rescue 
experiments, we used a constitutive expression, which resulted in a rather mild 
overexpression. Nonetheless, the slightly reduced rescue capacity (61% of BazOD in 
contrast to 91% for wild type Baz) and the redundant function of the OD underline the 
importance of Baz self-association. The fact, that the heterologous oligomerization domain of 
TEL can rescue the defects of Baz∆OD∆LB suggests, that the OD promotes indeed self-
association instead of interaction with other binding partners.    
In line with previous results (Krahn et al., 2010b; McKinley et al., 2012), we found that the 
lipid-binding domain of Baz/Par3 is dispensable for the localization and function of the 
protein – however, it can to a far extent compensate the loss of the OD. We further 
demonstrate here that protein stability of Baz depends on membrane localization, as 
Baz∆OD∆LB is rapidly degraded, whereas fusion of heterologous lipid-binding domains or 
an oligomerization domain rescues the protein stability (Suppl. Fig. 4.1E and Fig. 4.7A).  
Finally, one important question remains: How does the OD contribute to the localization of 
Baz? One likely possibility is that Baz forms oligomers, which are then recruited to the 
plasma membrane by a transmembrane- or membrane-associated protein. Previous studies 
have identified three transmembrane proteins (DE-Cad, Ed, Stan) as interaction partners of 
Baz, which might be capable of recruiting the protein to the membrane (Wei et al., 2005; 
Wasserscheid et al., 2007). Work from Harris and Peifer nicely demonstrated that Baz 
functions upstream of at least DE-cadherin in the polarization of the embryonic epidermis 
(Harris and Peifer, 2004). However, it is still unclear, how Baz is initially localized to the 
plasma membrane of epithelial cells during early embryonic development. Therefore, we tried 
to abolish the expression of DE-Cadherin, Ed and Stan in early embryos using triple GLCs, 
which unfortunately did not produce any eggs (data not shown), indicating that these three 
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genes are involved in oogenesis, too. Nonetheless, we observed that Baz∆OD∆LB is still able 
to interact with DE-Cad, Ed and Stan (Fig. 4.6). This is surprising as in vivo, none of these 
interaction partners seem to be capable of targeting the mutant protein to the apical junctions, 
although they are all expressed in the embryonic epidermis. Thus, we can exclude DE-
Cadherin, Ed and Stan to be involved in the recruitment of Baz oligomeric complexes. 
Moreover, the fact, that deletion of all three PDZ domains in BazΔLB does not disturb the 
correct apical junctional localization of the mutant protein (Fig. 6J), suggests that another 
domain is essential for the recruitment of Baz oligomers. Finally, the identification of an up to 
now undescribed protein (complex) binding oligomerized Baz / Par-complex remains a task 
for future studies. 
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Supplemental figures 
 
 
Supplemental Fig. 4.1: Localization of Baz variants in the embryonic epidermis. (A-D) 
Immunostainings of different GFP-Baz variants in the embryonic epidermis. All transgenes 
were expressed with the ubiquitin promotor in a wild type background. GFP (green), DE-Cad 
(red) and Dlg (blue) were stained. (A) GFP-Baz1-968 localizes mainly at the apical junctions 
with some baso-lateral mislocalization. (B) Mutation of the OD domain in this truncated 
protein causes a cytoplasmic accumulation of GFP-Baz1-968∆OD. (C, D) Chimeric proteins 
that carry the pleckstrin homology (PH) domains of either human PLCδ or Akt1 fused to the 
C-terminus GFP-Baz∆OD1-1105 promote a cortical localization in the embryonic epidermis. 
(E) Western blot of embryonic lysates of the Baz variants (A-D). The Baz variants were 
detected with a GFP antibody and Actin was used as a loading control. Scale bars are 10 µm 
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Supplemental Fig. 4.2: Cuticle phenotypes of Baz variants. (A) Cuticle phenotypes were 
classified into the four categories wt, shrunken with holes, holes and cuticle rests. (B) The 
cuticle phenotypes of baz818-8 germ line clones that express different Baz variants with the 
ubiquitin promoter were quantified (n=300 per genotype). Embryos that normally developed 
and hatched are also included as “hatched”. baz818-8 germ line clones display holes or cuticle 
rests. Embryos that express Baz-OneS hatch to a large extend (89,5%) or display either wt or 
shrunken with hole phenotypes. No embryos hatch upon the expression of Baz∆OD∆LB-
OneS. Most embryos have either cuticle rests or holes phenotypes (58,1 and 16,3%, 
respectively). Nevertheless, some embryos develop further and have a wt or shrunken with 
holes phenotype (2,3 and 23,3%, respectively). The chimeric TEL-Baz∆OD∆LB-OneS 
protein rescues the Baz∆OD∆LB phenotypes to a large extent as half of the embryos hatch 
(50,2 %) or have either wt or shrunken with holes phenotypes (21,9 and 17,9%, respectively). 
Scale bars are 200µm 
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Supplemental Fig. 4.3: Expression of Baz variants with the UAS/Gal4-system. (A) 
Western blot of embryonic lysates from embryos that express Baz-GFP and Baz∆OD∆LB-
GFP with the UASp promotor, driven by mat-Tub::Gal4. The Baz variants were detected with 
a GFP antibody and Actin was used as a loading control. (B, C) Immunostaining of Baz 
variants (green), DE-Cad (red) and aPKC (blue) in the embryonic epidermis. (B) Baz-GFP 
localizes at the apical junction, (C) whereas Baz∆OD∆LB-GFP displays a diffuse cytoplasmic 
localization. Scale bars are 10µm 
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Polarity is a fundamental property of most cell types. The Par protein complex is a major 
driving force in creating asymmetrically localized protein networks and consists of atypical 
protein kinase C (aPKC), Par3, and Par6. Dysfunction of this complex causes developmental 
abnormalities and diseases such as cancer. However, how Par3 interacts with Par6 has 
remained enigmatic. Here, we identified a PDZ domain-binding motif (PBM) in Par6 that was 
essential for Par3 interaction in vitro and Par3-mediated membrane localization of Par6 in 
cultured cells. In fly embryos, we observed that the PBM functions in redundancy with the 
PDZ domain to target Par6 to the cortex of epithelial cells. Our structural analyses by x-ray 
crystallography and NMR spectroscopy showed that both the Par3 PDZ1 and PDZ3 domains 
but not the PDZ2 engage in canonical PDZ:PBM interactions with the Par6 motif that we 
identified. Par3 thus has the potential to recruit two Par6 proteins simultaneously. This may 
facilitate the assembly of polarity protein networks through multivalent PDZ domain 
interactions. 
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Introduction 
 
Most cell types in multicellular organisms require an unequal distribution of proteins, lipids 
and mRNA for their function (Nelson, 2003). This phenomenon is referred to as cell polarity. 
During development, the differential segregation of cell fate determinants (anterior-posterior 
polarity) forms the basis for asymmetric cell division and ultimately the generation of body 
axes and cell diversity. In differentiated cells, partitioning of the cell membrane into 
functionally discrete domains enables cells to execute their specialized functions within an 
organism. Epithelia are a classic example of polarized cells and display an apico-basal 
polarity. While the apical side faces the exterior or lumen, the basal domain is directed 
towards the interior extracellular matrix and interstitial space in tissues and organs. The lateral 
cell surface allows neighboring epithelial cells to adhere and to communicate through cell-cell 
junctions. However, epithelial cells can also lose their polarity and acquire a migratory, 
mesenchymal character. While this process is vital for embryonic development and tissue 
repair, it is also adversely a key event in cancer metastasis. Elucidating the basic mechanisms 
underlying cell polarity thus has broad implications for our understanding of developmental 
and oncogenic processes. 
Although polarized cells vary substantially in their morphology and function, polarity 
depends in all cell types on the Par (partitioning-defective) protein complex that is conserved 
across the animal phyla (Ohno, 2001). The Par complex constitutes the major molecular 
machinery for creating the mutually exclusive signaling networks that cover large areas of the 
cell cortex in all polarized cells. In epithelia, the Par complex is a key polarity regulator at the 
apical surface and engages in intricate signaling networks with the Crumbs complex and cell 
adhesion proteins such as E-cadherin and nectins (Shotgun (Shg) and Echinoid (Ed), 
respectively, in Drosophila) to form and maintain cell junctions (Nelson, 2003; Tepass, 
2012). 
The Par complex comprises atypical protein kinase C (aPKC) and two scaffolding proteins, 
Par3 (Bazooka (Baz) in Drosophila) and Par6 (Fig. 5.1A). While a single set of genes encodes 
the Par complex in invertebrates, this gene family has expanded to two Par3 (Par3 and 
Par3L), two aPKC (PKC/ι and PKCζ) and three Par6 (Par6α, Par6β and Par6γ) genes in 
vertebrates (Noda et al., 2001; Gao et al., 2002; Suzuki et al., 2003). Par6 and aPKC hetero-
dimerize with high affinity via their N-terminal PB1 (Phox and Bem1) domains (Fig. 5.1A) 
(Suzuki et al., 2001; Hirano et al., 2005). In addition, Par6 contains a Crib (Cdc42/Rac 
interactive binding) motif directly preceding a PDZ protein-protein interaction domain. Par3 
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contains an N-terminal PB1-like homo-oligomerization domain (NTD) (Zhang et al., 2013a), 
three central PDZ domains and a C-terminal region with an aPKC phosphorylation site 
(Nagai-Tamai et al., 2002; Krahn et al., 2010b; Morais-de-Sá et al., 2010; Soriano et al., 
2016). Whether Par3 interacts directly with Par6 has remained controversial. The Par3 PDZ1 
domain has been described to hetero-dimerize with the Par6 Crib-PDZ domain (Lin et al., 
2000; Joberty et al., 2000; Li et al., 2010b) (Fig. 5.1A). However, these reports disagree on 
whether the Par6 Crib motif is essential for the Par3:Par6 interaction. Moreover, the in vivo 
relevance of this interaction has been debated (Li et al., 2010b), and lastly the Par3:Par6 
interaction has been reported to be indirect, requiring aPKC as a linker molecule (Suzuki et 
al., 2001; Nagai-Tamai et al., 2002). Given these controversial observations, we sought to 
investigate the mechanism of Par3:Par6 association on a structural and functional level. 
PDZ domain interactions are a recurring theme in polarity and cell-cell adhesion protein 
networks. PDZ domains fold into a six-stranded antiparallel -sheet capped by two -helices 
(Morais Cabral et al., 1996) and predominantly bind with low affinity (typically in the M 
range (Wiedemann et al., 2004; Stiffler et al., 2007)) to short (4-15 amino acids (aa)), 
disordered sequences at the C-termini of target proteins, so-called PDZ-binding motifs 
(PBMs). This interaction results in an augmentation of the PDZ -sheet by an antiparallel -
strand formed by the PBM. The four C-terminal residues constitute the specificity-
determining core PBM (Appleton et al., 2006) that can be categorized into three classes 
depending on the aa at the -2 position relative to the C-terminus: X-[S/T]-X--COO- (class I), 
X--X--COO- (class II) and X-[D/E]-X--COO- (class III), with X being any aa and  being 
a hydrophobic residue (Songyang et al., 1997). In addition, PDZ domains can recognize 
internal peptide sequences (Penkert et al., 2004) or homo- or hetero-dimerize in some cases  
(Lin et al., 2000; Joberty et al., 2000; Li et al., 2010b). 
Here, we uncover the molecular basis of the Par3:Par6 interaction. We have identified a 
previously unrecognized, highly conserved PBM in Par6 that is important for Par6 
localization in vivo and essential for Par3:Par6 interaction in vitro. We find that both the Par3 
PDZ1 and PDZ3 but not the PDZ2 domain can associate through canonical PDZ:PBM 
interactions with the Par6 PBM and show that one Par3 protein has the potential to recruit two 
Par6 molecules simultaneously. In vivo, we find that the Par6 PBM is critical for Par3-
mediated membrane recruitment of Par6 in cultured Drosophila Schneider cells (S2R) and 
plays a role in Par6 localization to the cell cortex in fly embryonic epidermal cells. In sum, 
our results provide important structural and functional details on the role of Par3 and Par6 in 
organizing polarity complexes. 
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Methods 
 
Reagents and Constructs 
Par3 and Par6 constructs were cloned from C. elegans cDNA, S2R cell cDNA or a synthetic 
gene fragment (LifeTechnologies) containing the Par3 PDZ domains (Drosophila 
melanogaster), and pK-myc-Par3b (Hs. Par3) and pK-myc-Par6C (Hs. Par6) vectors 
purchased from Addgene (plasmid #19388 and #15474). For NMR studies, gene fragments 
amplified by PCR were cloned into the following vectors: pETZ2.1a (His6-Z domain-TEV) 
for Ce. Par3 and Par6 constructs; pET-M30 (His6-GST-TEV) for Dm. Par3 PDZ constructs; 
pET-M41 (His6-MBP-TEV) for the Dm. Par3 PDZ1:Par6 PBM fusion, Dm. Par6 PDZ and 
Crib-PDZ and Hs. Par3 PDZ domains and the Hs. Par3:Par6 PBM fusion constructs; 
pRTDuet-GB1 (His6-GB1-TEV) for all Par6 and Shg PBM peptides. For GST pull down 
experiments, a gene fragment containing the three Dm. Par3 PDZ domains was cloned into a 
pETM30-HA (His6-GST-TEV-HA) vector, while full-length and truncated Dm. Par6 
constructs were cloned into a pET-M11-Sumo (His6-Sumo-TEV) vector.  
For S2R cell transfection, Dm. Par3 and Dm. Par6 were cloned into pENTR vectors. Site-
directed mutagenesis was carried out with the Par6 pENTR vector as DNA template using the 
following primers:  
Par6PDZ: 5’-
GTGCCGGAAACGCATGGTGGAGGTGGAGGTCCGGCCAATCAGCGC-3’ 
Par6 PBM: 5’-ACGATAATGGCCAGCGATTAAATCGATGGAGTGCTGCATTTG-3’.  
Par3 and wild-type and mutant Par6 variants were subsequently subcloned into pUGW and 
pURW vectors of the Drosophila Gateway Collection (DGRC) (Sen et al., 2012), 
respectively. For co-immunoprecipitation studies, the Myc-tag in the pK-myc-Par3b vector 
was replaced by a Flag-tag using QuikChange mutagenesis. All deletions in the Hs. Par6 
gene were generated by QuikChange mutagenesis using the pK-myc-Par6C vector as DNA 
template. For a complete list of constructs, see Supplemental Table 5.3. 
 
Expression and purification of recombinant proteins 
All recombinant proteins were expressed in E. coli BL21-CodonPlus (DE3) RIL cells 
(Stratagene) and purified by Ni-affinity and size-exclusion chromatography. To facilitate 
peptide production, the Par6 and Shg PBMs were fused at their N-termini to the 
immunoglobulin binding domain B1 of streptococcal protein G (GB1) domain followed by a 
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TEV protease cleavage site. For all NMR binding experiments, non-specific binding of GB1 
alone was tested. For NMR studies, unlabeled His6-GB1-Par6 and His6-GB1-Shg peptides or 
dmPar3 PDZ domains were expressed in LB medium, while 15N- or 13C,15N-labeled His6-
GB1-Shg, Par3 PDZ or Par6 (Crib-)PDZ domains were expressed in M9 minimal medium 
with 15NH4Cl or 
15NH4Cl and
 13C-glucose as sole sources of nitrogen and carbon. All NMR 
constructs were buffer exchanged into NMR buffer (20 mM Na phosphate pH 6.5 or 7.5, 150 
mM NaCl, 1 mM DTT, and 0.03% NaN3) for triple resonance and CSP experiments. 
Proteins for pull down experiments were expressed as His6-GST-HA-tagged Dm. Par3 and 
His6-Sumo-tagged Dm. Par6 proteins in E. coli BL21-CodonPlus (DE3) RIL cells 
(Stratagene) in LB medium and purified by Ni-affinity chromatography. Subsequently, buffer 
was exchanged by dialysis to 50 mM Na phosphate pH 7.5, 150 mM NaCl, 1 mM DTT, 10 % 
glycerol for Par6 proteins or to 20 mM Na phosphate pH 6.5, 150 mM NaCl, 1 mM DTT, and 
10 % glycerol for Par3 proteins.  
 
Pull down assays  
Dm. Par3 proteins containing an N-terminal His6-GST-HA-tag were incubated with 
glutathione beads (Macherey-Nagel) at 1 µM concentration together with 65 μM Dm. Par6 
proteins that contained an N-terminal His6-Sumo-tag for 1 h at 4 °C in PD buffer (50 mM Na 
phosphate pH 7.5, 150 mM NaCl, 10% glycerol, 2 mM DTT). The beads were washed four 
times with PD buffer and specifically bound proteins eluted with PD buffer supplemented 
with 25 mM reduced GSH. Eluted proteins were precipitated with 10% (w/v) TCA (Sigma) 
on ice followed by centrifugation. Protein pellets were resuspended in SDS loading buffer, 
resolved by SDS-PAGE and detected by Coomassie staining.  
 
S2R cell culture 
Immunostainings of transfected Schneider 2R cells was carried out as previously described 
(Krahn et al., 2010b). In brief, S2R cells were transfected using FUGENE (Promega) with 
Ubi::GFP-Par6 variants alone or together with Ubi::RFP-Baz. Cells were fixed with 
paraformaldehyde and imaged with a Zeiss LSM 710 Meta confocal microscope. For RNAi-
mediated downregulation of aPKC was performed as described (Krahn et al., 2009). In brief, 
a ~ 300bp dsRNA fragment was taken up by the cells and processed to several siRNAs. One 
dsRNA thus results in several siRNAs and thereby reduces the probability of off-targets. The 
efficiency of dsRNA-mediated gene knock down of aPKC was confirmed by a Western blot 
of S2R cell lysates using aPKC (1:1000, Santa Cruz sc-216, 1:1000) and mouse actin (1:1000, 
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Santa Cruz sc-47778) antibodies. The following oligonucleotides were used to amplify a 
fragment of aPKC mRNA for in vitro transcription into dsRNA:  
aPKC-dsRNA-F: 5'-ACTTCGCGTTCTCCGC-3',  
aPKC-dsRNA-R: 5'-TTGCTAGCTGGGTAAAATATTTTGA-3'. 
 
HEK293T cell culture and co-immunoprecipitation 
HEK293T cells were transfected with N-terminally Flag-tagged Hs. Par3 in a pKFlag and N-
terminally Myc-tagged Hs. Par6 in a pKMyc expression vector using Lipofectamin 
(Invitrogen), grown in DMEM supplemented with 10% Fetal Bovine Serum (Invitrogen), 2 
mM L-glutamine (Invitrogen), penicillin (Invitrogen) and streptomycin (Invitrogen) and 
harvested three days after transfection. Cells were lysed in NET buffer (50 mM Tris-HCl pH 
8.0, 150 mM NaCl, 0.1% (w/v) Triton X-100, 1 mM EDTA) supplemented with Proteinase 
Inhibitor Cocktail (Roche). The supernatants were incubated with Flag M2 antibody (2 
ug/mg cell lysate) and subsequently with GammaBind Plus Sepharose (GE Healthcare) for 1 
h each at 4 °C. The beads were washed three times with NET buffer and once with Triton-free 
NET buffer. Immunoprecipitated proteins were eluted with SDS loading buffer, separated by 
SDS-PAGE and immunoblotted using mouse Flag M2 (1:1000) (Sigma) as primary and HRP-
coupled mouse IgG (1:10.000) as secondary antibody (ThermoScientific) or mouse Myc-HRP 
(1:5000) (LifeTechnologies) antibody. Western blots were imaged by chemiluminescence. 
 
Fly stocks and genetics  
Fly stocks were cultured on standard cornmeal agar food and maintained at 25 °C. Transgenic 
flies of Ubi::GFP-Par6 variants were established using the Phi-C31-Integrase system with 
attP40 in a wild-type background (Groth et al., 2004). Fly embryo lysates were applied to 
SDS-PAGE and immuno-blotted using rabbit GFP (1:500, sc8334, Santa Cruz) and mouse 
actin (1:1000, Santa Cruz sc-47778) antibodies to ensure uniform expression of the Par6 
mutants. Western blots were imaged by chemiluminescence. To evaluate the function of GFP-
Par6 and GFP-Par6 PDZ, PBM and PDZPBM mutants in a Par6-null background, the 
transgenes were backcrossed into a homozygous par6226 mutant background (Petronczki and 
Knoblich, 2001). However, only the wild-type and PBM transgenes can rescue the 
embryonic lethality of par6226 mutant flies and be kept as stable stocks.  
 
Immunohistochemistry  
Drosophila stage 6-7 or stage 11 embryos were fixed in 4% formaldehyde, phosphate buffer 
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pH 7.4 as previously described (Sen et al., 2012). The primary antibodies used for indirect 
immunofluorescence were as follows: mouse aPKC (PKC, 1:500, sc17781, Santa Cruz), 
rabbit GFP (1:500, sc8334, Santa Cruz) and guinea pig Baz (1:500). Secondary antibodies 
conjugated with Alexa 488, Alexa 568 and Alexa 647 (Life Technologies) were used at 1:400. 
Images of the epidermis were taken from stage 11 embryos on a Zeiss LSM 710 Meta 
confocal microscope or at stage 6-7 on a Leica SP8 confocal microscope. For correlation 
analysis, the images displayed in Fig. 5.3 and Supplemental Fig. 5.6 were partitioned in three 
regions covering almost the entire image. Pearson’s correlation coefficients were estimated 
after automatic thresholding using the Costes’ approach as implemented in the JACoP v2.0 
plugin of ImageJ (Fiji) (Costes et al., 2004; Bolte and Cordelières, 2006; Schindelin et al., 
2012). 
 
NMR spectroscopy 
CSP studies were performed with 75-100M samples of 15N-labeled protein in NMR buffer 
(20 mM Na phosphate pH 6.5 (individual PDZ domains or Shg PBM) or 7.5, 150 mM NaCl, 
1 mM DTT, and 0.03% NaN3) by recording 
1H,15N-HSQC experiments on a 600 MHz Bruker 
Avance-III spectrometer at 20 °C for the Dm. and Ce. Par3 and Par6 PDZ domains and at 30 
°C for the human proteins. For CSP studies with the dmPar3 PDZ1-3 2-3loop module, we 
recorded 1H,15N-TROSY experiments at 600 MHz and 30 °C in 20 mM Na phosphate pH 7.5, 
150 mM NaCl and 1 mM DTT. Backbone resonance assignment for the Dm. Par3 PDZ 
domains was performed at 20 °C and at 25 °C for the Hs. Par3 PDZ2 and PDZ3 domains by 
recording 3D HNCACB, HNCOCACB, CCONH and HNH-NOESY spectra at 600 or 800 
MHz. NMR data were processed using the nmrPipe/nmrDraw software suite (Delaglio et al., 
1995) and analyzed using XEasy (Bartels et al., 1995) and Sparky (Lee et al., 2015b). Figures 
displaying NMR spectra were produced with nmrView (onemoonscientific.com). Average 
CSPs used for binding site mapping were calculated in ppm as ((1H)2 + (0.25*15N)2)0.5, 
where  is the difference in chemical shift at a nine-fold stoichiometric excess of Par6 PBM 
vs. the respective reference in the absence of ligand. For binding site mapping, a homology 
model of the dmPar3 PDZ3 domain was generated using HHPred (Alva et al., 2016), while 
PDB entries 2KOM and 2KOH were used for binding site mapping for the hsPar3 PDZ2 
(Jensen et al., 2010) and PDZ3 (Tyler et al., 2010) domains, respectively. Of note, a highly 
similar structure exists for the PDZ2 domain of rat Par3 (Wu et al., 2007). 
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Two-dimensional line shape fitting analysis 
1H,15N-CSP studies for the Dm. Par3 PDZ domains were quantified using TITAN (Waudby et 
al., 2016) according to instructions and online documentation (http://www.nmr-titan.com and 
https://bitbucket.org/cwaudby/titan/wiki/Home). Spectra were acquired with 1024 and 128 
points in the 1H and 15N dimensions, respectively, and processed with exponential window 
functions with a line broadening of 4 Hz and 8 Hz. Spectra were zero-filled to 4096 and 1024 
points in the 1H and 15N dimensions, respectively. In order to obtain comparable results for 
different ligands, the same cross peaks were used for the analysis of each PDZ domain 
(Supplemental Table 5.4). Errors were estimated with bootstrapping statistics on 100 replica. 
Figures for line shape analyses were prepared with TITAN. 
 
X-ray crystallography 
The Dm. Par3 PDZ1:Par6 fusion construct was crystallized in 0.1 M BisTris pH 6.5, 2 M 
(NH4)2SO4. Diffraction data were collected at 100 K using a wavelength of 1 Å and a 
PILATUS 6M-F detector at the beamline PXII of the Swiss Light Source (PSI, Villigen, 
Switzerland). Data were processed using XDS (Kabsch, 2010) and molecular replacement 
was performed using Phaser (McCoy et al., 2007). The structure was finalized by iterative 
manual modeling with Coot (Emsley et al., 2010) and refinement with Phenix (Adams et al., 
2010). Each asymmetric unit contains two protein chains with virtually identical 
conformations (backbone r.m.s.d. of 0.031 Å for the PDZ1 domain and the core PBM). All 
figures displaying protein structures were generated using PyMOL (http://www.pymol.org/). 
 
Sequence alignment 
Multiple sequence alignments were performed with MUSCLE (Edgar, 2004) and displayed 
with ClustalX (Larkin et al., 2007). The position weighted matrix for the Par6 PBM was 
created with WebLogo 3.4 (Crooks et al., 2004) using all Par6 PBMs displayed in 
Supplemental Fig. 4.3. The overall height of the stack indicates the sequence conservation at 
that position, while the height of a symbol within the stack indicates the relative frequency of 
each aa at that position. 
 
 
 
 
Chapter 4: Structural analysis of the Par3 - Par6 interaction 
97 
 
Results 
Par6 contains a PBM that associates with the Par3 PDZ1 domain 
 
In order to elucidate the molecular details of the Par3:Par6 interaction, we performed nuclear 
magnetic resonance (NMR) binding studies. This method is a powerful tool to study 
biomolecular interactions (Williamson, 2013; Wiesner and Sprangers, 2015), since the 
measured chemical shifts of atomic nuclei, that is the peak positions in NMR spectra, are 
highly sensitive to changes in the local chemical environment. In a standard experiment, an 
unlabeled binding partner is titrated to an isotope-labeled, NMR-visible protein. This results 
in concentration-dependent changes of the chemical shifts for the residues contacting the 
ligand (chemical shift perturbation; CSP) that can be used to obtain dissociation constants 
(Supplemental Fig. 5.1). Together with chemical shift assignments, this enables the mapping 
of the ligand binding surface on a protein structure with close to atomic resolution.  
Previous studies indicated a hetero-dimerization of the Par3 PDZ1 and the Par6 PDZ domains 
(Lin et al., 2000; Joberty et al., 2000; Li et al., 2010b). To investigate the mechanism of 
Par3:Par6 interaction, we first recorded 1H,15N-correlation NMR spectra of the 15N-labeled 
PDZ1 domain of human Par3. Surprisingly, we observed that this PDZ domain was largely 
unfolded in isolation (Supplemental Fig. 5.2A). The domain architectures of the Par complex 
proteins are highly conserved in metazoans suggesting that Par3 and Par6 interact in a similar 
manner (Ohno, 2001). We therefore investigated next whether the Drosophila melanogaster 
(Dm.) or Caenorhabditis elegans (Ce.) Par3 PDZ1 domains interact with the respective Par6 
PDZ or Crib-PDZ domains. Although both the Dm. and Ce. Par3 PDZ1 domains were folded 
in isolation, we observed only very few changes in the NMR spectra of the 15N-labeled Par3 
PDZ1 domains upon addition of the respective unlabeled Par6 PDZ (Supplemental Fig. 
5.2B,C) or upon addition of the unlabeled Par3 PDZ1 domains to the respective 15N-labeled 
Par6 Crib-PDZ domains (Supplemental Fig. 5.2D,E). Similarly, neither the Dm. Par3 
(dmPar3) PDZ2 nor the PDZ3 domain induced substantial CSPs in the 15N-labeled Dm. Par6 
(dmPar6) Crib-PDZ domain in our NMR experiments (Supplemental Fig. 5.2F,G). We thus 
conclude that the Par3 PDZ domains do not associate directly with the Par6 (Crib-)PDZ 
domain. 
In search of an alternative binding mechanism we revisited the Par6 protein sequence and 
identified a previously unrecognized class II (-X--COO-) PBM at its C-terminus (Fig. 
5.1B). This motif is highly conserved in metazoans (Fig. 5.1B) with the notable exception of  
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Fig. 5.1: The Par6 C-terminus contains a class II PBM that interacts with the Par3 
PDZ1 domain. (A) Reported interactions (shown as arrows) within the Par complex. The 
controversial PDZ-PDZ interaction is indicated with a dashed arrow. The Par6 PBM 
identified in this study is boxed in red. (B) Amino acid sequences of the eight C-terminal 
residues of vertebrate and invertebrate Par6 and known cell adhesion interaction partners (Lin 
et al., 1999; Itoh et al., 2001; Ebnet et al., 2001; Ebnet et al., 2003; Takekuni et al., 2003; 
Latorre et al., 2005; Iden et al., 2006; Nakayama et al., 2013). Conserved hydrophobic () 
residues are in dark pink for the 0 and -2 positions, and in light pink for the -3 position, while 
polar residues at the -1 position are in blue. Organism abbreviations are expanded in 
Supplemental Fig. 4.3. PBMs used in this study are underlined. (C) Overlay of a 
representative region of the 1H,15N-HSQC spectra of the Dm. Par3 (dmPar3) PDZ1 domain in 
the absence (black) and presence of increasing stoichiometric amounts of dmPar6 PBM as 
indicated. Dashed lines indicate the directions of chemical shift changes. Chemical shift 
assignments are shown for the most affected peaks. Peaks broadened beyond detection upon 
ligand binding are underlined. In CSP figures, residue numbers correspond to the respective 
NMR or X-ray construct (see Supplemental Table 5.3) for clarity. (D) Sequence conservation 
of the Par6 PBM shown as position weight matrix (Crooks et al., 2004) (PWM; bottom panel) 
based on the sequences shown in Supplemental Fig. 5.3. 
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nematodes (Supplemental Fig. 5.3), and we therefore focused our further efforts on the Dm. 
Par3 and Par6 proteins. To assess whether the identified Par6 PBM can interact with the Par3 
PDZ domains we performed NMR CSP experiments. We observed large peak shifts (more 
than one peak width) and line broadening for numerous residues in the 15N-labeled dmPar3 
PDZ1 domain upon addition of an unlabeled peptide containing the eight C-terminal residues 
of dmPar6 (Fig. 5.1C) as expected for two proteins that specifically interact with each other. 
This shows that in the Drosophila proteins the Par3 PDZ1 domain can directly interact with 
the Par6 PBM in vitro. In support of this, epithelial cell polarity also critically depends on 
interactions of the Par3 PDZ domains with cell adhesion proteins through PBMs that are 
highly similar to the Par6 PBM (Fig. 5.1B,D) (Lin et al., 1999; Itoh et al., 2001; Takekuni et 
al., 2003; Ebnet et al., 2003; Iden et al., 2006). 
 
The Par6 PBM is important for Par3 interaction in vitro and in 
cell culture  
 
To investigate the importance of the Par6 PBM for Par3 binding, we performed in vitro GST 
pull down experiments using recombinant GST-tagged dmPar3 fragment containing all three 
PDZ domains and Sumo-tagged dmPar6 variants (Fig. 5.2A). The Par3 PDZ1-3 domains 
efficiently pulled down wild-type Par6 (Fig. 5.2B; lane 10). By contrast, deletion of the PBM 
(PBM) (Fig. 5.2B; lane 12), the region C-terminal of the PDZ domain (PB1-CribPDZ) (Fig. 
5.2B; lanes 14) or the region C-terminal of the Crib motif (PB1-Crib) (Fig. 5.2B; lanes 16) 
essentially abolished Par6 binding to the Par3 PDZ1-3 domains. Of note, GST alone did not 
pull down any of the Par6 constructs in a control experiment (Fig. 5.2B; lanes 9, 11, 13, and 
15). These pull down experiments thus confirm our NMR experiments and show a direct and 
essential interaction of the Par6 PBM with the Par3 PDZ domains in vitro.  
To explore whether the Par6 PBM is important for Par3 interaction in cells, we transiently 
transfected Drosophila S2R cells with wild-type GFP-tagged Par6 or deletion constructs (Fig. 
5.2A) in the absence (Fig. 5.2C-F) or presence of RFP-tagged Par3 (Fig. 5.2G-J). All Par6 
variants were cytosolic in the absence of Par3 (Fig. 5.2C-F). In the presence of Par3 however, 
wild-type Par6 showed a strong co-localization with Par3 at the cell cortex (Fig. 5.2G). A 
Par6 mutant lacking the PDZ domain (PDZ) was still recruited to the plasma membrane in 
the presence of Par3 (Fig. 5.2H) with only a small fraction of Par6 remaining cytosolic. In 
contrast, membrane targeting of Par6 was strongly reduced when we co-transfected Par3 and  
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Fig. 5.2: The Par6 PBM is essential for Par3 interaction and Par3-mediated cortical 
targeting. (A) Schematic representation of the dmPar3 and dmPar6 constructs used for GST 
pull down experiments and Par6 recruitment assays. (B) GST pull down experiments using 
GST or GST-tagged dmPar3 PDZ1-3 module incubated with WT or truncated Sumo-tagged 
dmPar6 as indicated. Input and associated Par6 were detected along with GST and GST-
dmPar3 PDZ1-3 by Coomassie staining. Par6 proteins in the pull downs are highlighted with 
asterisks. (C-J) Representative fluorescence images of S2R cells transiently transfected with 
GFP-Par6 variants in the absence (C-F) or presence of RFP-Par3 (G-J). The scale bar 
corresponds to 5m. 
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a Par6 mutant that lacked the PBM (PBM) (Fig. 5.2I) or a mutant lacking both the PDZ 
domain and the PBM (PDZPBM) (Fig. 5.2J). To assess whether Par3-mediated membrane 
targeting of Par6 may depend on endogenous aPKC, we performed Par6 recruitment assays in 
S2R cells where we knocked down aPKC by RNAi (Supplemental Fig. 5.4A). We observed 
that wild-type Par6 was still efficiently recruited to the cell cortex in the presence of Par3 
(Supplemental Fig. 5.4B). In contrast, membrane targeting was compromised for all Par6 
mutants (Supplemental Fig. 5.4C-E). aPKC knockdown thus only affects the localization of 
the Par6 PDZ mutant (Supplemental Fig. 5.4D versus Fig. 5.2H), but not the PBM and 
PDZPBM mutants. This suggests that the PDZ domain may have an additional function in 
Par6 localization in the presence of aPKC. In line with our NMR binding studies and in vitro 
assays, these in vivo results show that the PBM of Par6 plays an important role in the 
interaction with Par3 and in Par3-mediated localization of Par6 to the cell cortex. 
 
The PBM functions in redundancy with the PDZ domain in Par6 
localization in vivo 
 
To explore the in vivo relevance of our findings, we generated transgenic flies expressing 
GFP-tagged Par6 under a constitutive promoter (Sen et al., 2012) and analyzed the embryos at 
stage 11 (Fig. 5.3). As expected, we observed that wild-type GFP-Par6 accumulated 
predominately at the cell-cell contacts of epidermal cells and co-localized with Par3 and 
aPKC (Fig. 5.3A). Deletion of the Par6 PBM or the PDZ domain alone mildly but 
consistently reduced cortical localization of Par6 (Fig. 5.3B,C). In contrast, deletion of both 
the PDZ domain and the PBM caused an almost complete mislocalization of this Par6 mutant 
to the cytosol (Fig. 5.3D). Of note, all GFP-Par6 variants were expressed similarly in fly 
embryos (Supplemental Fig. 5.5A). Thus, both the PDZ domain and the PBM contribute to 
correct Par6 localization in vivo with deletion of both domains resulting in almost complete 
mislocalization of Par6. Yet, This may reflect an indirect association between Par3 and Par6 
via aPKC as suggested previously (Suzuki et al., 2001; Nagai-Tamai et al., 2002) and / or 
Par6 recruitment by other epithelial cell polarity regulators such as Crumbs or Stardust that 
bind to the Par6 PDZ domain (Hurd et al., 2003b; Penkert et al., 2004; Lemmers et al., 2004; 
Wang et al., 2004; Kempkens et al., 2006; Whitney et al., 2016). 
Of these other polarity regulators Stardust is already expressed early on in fly embryos, 
whereas Crumbs is only expressed at later stages (Krahn et al., 2010a; Sen et al., 2015). To 
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 Fig. 5.3: Recruitment of Par6 to the cell cortex in fly epithelia depends on both the PBM 
and the PDZ domain. (A-D) Localization of aPKC, Par3 and GFP-Par6 variants in the 
epithelia of fly embryos (stage 11). The scale bar corresponds to 5m. Pearson’s correlation 
coefficients (PCC) of Par6, aPKC, and Par3 fluorescence intensities were determined using 
the Costes’ approach (Costes et al., 2004). The average PCCs estimated independently for 
three different regions of each image are plotted along with their standard deviations (right 
hand panels). 
 
 
examine whether the observed localization of the Par6 variants may differ between 
developmental stages, we analyzed Par6 localization in fly embryos during gastrulation (stage 
6-7) and found that Par6 localization at stage 6-7 was highly similar to stage 11 
(Supplemental Fig. 5.5B-E). Most notably, the PDZPBM mutant resulted in strong Par6 
mislocalization both at stage 6-7 and stage 11. This demonstrates that in vivo Par6 recruitment 
to the cell cortex critically depends on both the PDZ domain and the PBM and points to a 
functional redundancy of these domains in Par6 localization in vivo.  
In a par6-null background (par6226) (Petronczki and Knoblich, 2001), we found that wild-
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type GFP-Par6 and GFP-Par6 PBM restored viability as well as aPKC and Par3 localization 
(Supplemental Fig. 5.6), while the GFP-Par6 PDZ and GFP-Par6 PDZPBM could not 
rescue the lethality of the par6-null allele. Similarly to our observations in the wild-type 
background, lack of the PBM caused in stage 11 embryos a mild localization defect for Par6, 
but not for Par3 and aPKC (Supplemental Fig. 5.6B). This confirms that the PBM contributes 
to the correct localization of Par6 in vivo under physiological conditions and suggests that it 
functions in redundancy with the PDZ domain to fully establish epithelial polarity. 
 
Structural analysis of the Drosophila Par3 PDZ1:Par6 PBM 
complex 
 
Having established the importance of the Par6 PBM for Par3 interaction and Par3-mediated 
localization in vitro and in vivo, we sought to gain structural insight into the Par3:Par6 
complex. To this end, we crystallized a Dm. Par3:Par6 fusion construct comprising the Par3 
PDZ1 domain and the C-terminal PBM octapeptide of Par6 (VKDGVLHL; core PBM is 
underlined) and solved the X-ray structure of the PDZ1:PBM complex (Supplemental Table 
5.1). Both the Par3 PDZ1 domain and the Par6 core PBM are well defined with the PDZ1 
domain adopting the typical PDZ fold and the core PBM forming the canonical antiparallel -
strand with the PDZ1 2-strand (Fig. 5.4A, Supplemental Fig. 5.7A). The C-terminal 
carboxylate group is involved in an extensive hydrogen bond network with the backbone of 
the PDZ1 1-2 loop (Fig. 5.4A). The hydrophobic residues at the 0 and -2 positions of the 
PBM are deeply buried in a hydrophobic pocket formed by the carboxylate binding loop 
(Leu19), the 2 (Leu21, Ala23, Leu24, Pro25), 3 (Leu33) and 6 (Leu84, Val86) strands and the 
2 helix (Val71, Leu75, Leu79) of the PDZ1 domain (Fig. 5.4A, Supplemental Fig. 5.7B). 
Overall, our structure is highly similar to other PDZ:PBM complexes such as the INADL 
PDZ3 in complex with a phage display-derived class II PBM peptide (Fig. 5.4B) (Ernst et al., 
2014) and Par3 PDZ3:PBM complexes (Supplemental Fig. 5.7C,D) (Feng et al., 2008; Tyler 
et al., 2010). Outside the core PBM, we observed less well-defined electron density for the 
Par6 peptide and three residues of the GS-linker (Supplemental Fig. 5.8A,B) indicating an 
additional antiparallel -strand formed by the last aa of the GS-linker and the -7 and -6 PBM 
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Fig. 5.4: The Dm. Par3 PDZ1 and PDZ3 domains interact with Par6 through canonical 
PDZ:PBM interactions. (A) Interaction network of the Par6 core PBM (dark pink) with the 
Par3 PDZ1 domain (grey). Residues involved in hydrogen bonds (dashed lines) and side-
chain interactions are shown in stick representation with carbon, nitrogen and oxygen atoms 
colored in grey (PDZ1) / dark-pink (PBM), blue and red, respectively. (B) The Par3 PDZ1 : 
Par6 PBM complex is highly similar to the INADL PDZ3 in complex with a phage-derived 
class II PBM peptide (PDB code: 4Q2N, (39)) shown in green (backbone r.m.s.d. = 1.64 Å). 
(C) As Fig. 4.1C, but for the Par3 PDZ3 2-3loop domain. (D) Binding surface of the 
dmPar6 PBM mapped onto a PDZ3 homology model and colored with a linear gradient from 
white (CSP ≤ 0.05 ppm; cut-off) to red (CSP = 0.35 ppm). Unassigned residues are colored in 
dark grey, while residues broadened beyond detection in the PDZ3 are in dark red. The Par6 
core PBM is shown in yellow and was modeled by superposition of the dmPar3 PDZ1:PBM 
and PDZ3 structures. 
 
residues. However, the consistently high B-factors (Supplemental Table 5.1, Supplemental 
Fig. 5.8C,D) strongly suggest that the residues outside the core PBM are not stably structured. 
To validate key interactions of the Par6 PBM with the Par3 PDZ1 domain in our crystal 
structure, we substituted each of the three C-terminal positions in the dmPar6 peptide with 
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Ala (Par6 L349A (L-2A), H350A (H-1A) and L351A (L0A)) and tested the Par3 binding 
capabilities of the PBM mutants in NMR experiments (Supplemental Fig. 5.8E). Consistent 
with our crystal structure, both the L-2A and the L0A mutations led to an almost complete loss 
of Par6 binding, while the H-1A mutation lessened CSPs in the Par3 PDZ1 domain as 
compared to the wild-type PBM (Supplemental Fig. 5.8E versus Fig. 5.1C). In sum, our 
results demonstrate that Par6 associates with Par3 through a canonical PDZ:PBM interaction 
that crucially depends on the -2 and 0 positions of the Par6 PBM. 
 
The Par3 PDZ1 and PDZ3 domains both recognize the Par6 PBM 
 
We noticed that the residues in the PDZ1 domain contacting the 0 and -2 PBM positions are 
well-conserved in all three Par3 PDZ domains (Supplemental Fig. 5.9). We therefore also 
tested the binding specificities of the Par3 PDZ2 and PDZ3 domains towards the Par6 PBM. 
To this end, we performed NMR binding studies with the individual dmPar3 PDZ2 and PDZ3 
domains and the dmPar6 PBM peptide. In contrast to the PDZ1 domain, we observed virtually 
no CSPs for the Par3 PDZ2 domain upon addition of the Par6 PBM (Supplemental Fig. 
5.10A). The Par3 PDZ2 domain thus possesses binding specificities that are distinct from the 
Par3 PDZ1 domain. 
The PDZ3 domain contains a long, disordered insertion in the 2-3 loop that is unique to 
dmPar3 (Supplemental Fig. 5.9). Since this extension severely compromised spectral quality, 
we used a PDZ3 domain with a truncated 2-3 loop (PDZ32-3loop) for our NMR studies 
(Supplemental Fig. 5.9). As for the PDZ1 domain, addition of the Par6 PBM induced 
numerous, large CSPs in the 15N-labeled PDZ32-3loop (Fig. 5.4C). This demonstrates that 
the truncated PDZ3 domain is functional and interacts readily with the dmPar6 PBM. To map 
the observed CSPs onto the surface of the PDZ3 domain, we obtained chemical shift 
assignments for the PDZ3 domain and generated a homology model of the Par3 PDZ3 
domain. As the PDZ1 domain, in this model the PDZ3 domain binds the Par6 PBM in a 
canonical manner mainly involving the carboxylate binding loop, the 2 strand and the 2 
helix (Fig. 5.4D).  
To obtain quantitative insights into the Par3 PDZ interactions with the Par6 PBM, we 
determined dissociation constants (Kd values) by NMR line shape fitting for the chemical 
shift titrations of the Dm. Par3 PDZ1 and PDZ3 domains with the Par6 PBMs. Of note, since 
the PDZ2 domain did exhibited no CSPs upon addition of the Par6 PBM, we did not fit these 
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data. We found that the Par6 PBM bound to the PDZ1 domain with a moderate affinity of 216 
 4 M and to the PDZ3 domain with a tighter affinity of 54  1 M for the PDZ3 domain 
(Supplemental Table 5.2, Supplemental Fig. 5.11, 5.12). Next, we quantitatively addressed 
the importance of the three C-terminal positions in the Par6 PBM for PDZ1 binding 
(Supplemental Fig. 5.8E and 5.13). We found that mutation of the C-terminal position (L0A) 
weakened the affinity of the PDZ1 domain for the Par6 PBM to 2.5  0.4 mM, for the -1 
position (H-1A) to 964  60 M and for the -2 position (L-2A) to 4.0  1.1 mM, respectively 
(Supplemental Table 5.2, Supplemental Fig. 5.13). This confirms that these mutations in the 
core PBM indeed strongly compromise binding to the Par3 PDZ1 domain and that these 
residues are thus important determinants for the interaction with the Par3 PDZ1 domain.  
Overall, dissociation constants of up to a few hundreds of M have been observed for 
physiologically relevant PDZ interactions (Stiffler et al., 2007). Consistent with our analyses 
of cultured S2R cells (Fig. 5.2 and Supplemental Fig. 5.4) and fly embryos (Fig. 5.3 and 
Supplemental Fig. 5.5-6), this shows that the interaction of the newly identified Par6 PBM 
plays a role in Par3 PDZ binding in vitro and is physiologically relevant in vivo. 
 
Par3 can interact with two Par6 proteins simultaneously in vitro 
 
In polarized cells, Par complexes form micrometer-sized clusters that cover the apical plasma 
membrane. Yet, how Par complexes assemble into these sizeable protein networks is largely 
unknown. A prerequisite for forming higher order networks is that the proteins involved are 
multivalent, that is they contain multiple independent binding sites, and engage in a multitude 
of weak (M-affinity) interactions. To test whether the first and third PDZ domain of Par3 
fulfill this requirement, we recorded 1H,15N-correlation spectra of the 15N-labeled Par3 PDZ1-
3 module that contains all three PDZ domains (PDZ1-3 2-3loop) and examined its Par6 
binding capability. In this construct the 2-3 loop in the PDZ3 domain was removed to 
improve spectral quality (see above). The NMR spectra of the Par3 PDZ1-3 module and the 
individual PDZ domains superimpose well (Fig. 5.5A-C), and resonance assignments of the 
individual domains could be transferred to the PDZ1-3 module. This demonstrates that the 
individual PDZ domains in Par3 are structurally largely independent. Addition of unlabeled 
Par6 PBM to the PDZ1-3 construct resulted in CSPs comparable to the isolated PDZ domains 
(Fig. 5.5D-F versus 5.1C, 5.4C, Supplemental Fig. 5.10A). This shows that the Par3 PDZ  
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Fig. 5.5: Par3 can interact with two Par6 proteins simultaneously. Overlay of 1H,15N-
TROSY spectra of the Par3 PDZ1-32-3loop module with the isolated PDZ1 (A), PDZ2 
(B) and PDZ3 2-3loop domains (C). (D-F) Overlay of 1H,15N-TROSY spectra of the Par3 
PDZ1-3 2-3loop module in the absence (black) and presence of dmPar6 C-terminal 
peptide as indicated. Peaks not corresponding to the PDZ1 (D), PDZ2 (E) or PDZ3 2-
3loop (F) domain within the PDZ1-3 module are shown in opaque to highlight the changes of 
the individual domains within the entire module. Indicated resonance assignments correspond 
to the respective PDZ domain as shown in the panels on top and correspond to the respective 
NMR or X-ray construct (Supplemental Table 5.2). (G) Schematic representation of the 
Par3:Par6 interactions as mapped by NMR spectroscopy highlighting the 1:2 stoichiometry of 
the complex in vitro. 
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domains act as functionally independent entities within the PDZ1-3 module and that in vitro 
one Par3 protein can simultaneously interact with two Par6 proteins through its PDZ1 and 
PDZ3 domains (Fig. 5.5G). Par3 thus has the potential to engage in weak, multivalent 
interactions with Par6 and may thereby promote the assembly of large-scale clusters of Par 
complexes at the cell membrane in vivo. 
 
The Par6 PBM can compete with the PBM of E-cadherin for Par3 
binding 
 
Cell adhesion proteins such as cadherins and nectins are well-known interaction partners of 
Par3 and contain conserved class II PBMs that are highly similar to the Par6 PBM (Fig. 5.1B 
and Supplemental Fig. 5.7C). In fact, the VE-cadherin PBM interacts with the PDZ3 domain 
of murine Par3 with a Kd of ~ 6 M (Tyler et al., 2010) and thus ~ 9-fold (PDZ3) and ~ 36-
fold (PDZ1) tighter than its Dm. counterparts with the Par6 PBM (Supplemental Table 5.2). 
To address whether the Par6 PBM could compete with such ligands for Par3 binding, we 
performed NMR CSP studies with the 15N-labeled Dm. Par3 PDZ domains and added 
increasing amounts of unlabeled Shg PBM to the individual domains. Similarly to the Par6 
PBM, both the Par3 PDZ1 (Fig. 5.6A) and PDZ3 (Fig. 5.6B) domains show large CSPs for 
numerous peaks in the 1H,15N-correlation spectra upon addition of the Shg PBM. In contrast, 
the PDZ2 domain displayed only few changes (Supplemental Fig. 5.10B). Line shape fitting 
analyses for the Shg PBM chemical shift titrations of all three Dm. Par3 PDZ domains yielded 
Kd values of 128  4 M for the PDZ1, 954  45 M for the PDZ2 and 0.6  0.1 M for the 
PDZ3 domain (Supplemental Table 5.2, Supplemental Fig. 5.11C,D, Supplemental Fig. 5.14 
and Supplemental Fig. 5.12C,D). The Dm. Par3 PDZ domains thus bind tighter to the PBM of 
Shg than to the Par6 PBM albeit only by a factor of ~ 2 for the PDZ1 domain.  
To evaluate whether the PBM of Par6 and Shg compete for binding to the Par3 PDZ1 or 
PDZ3 domains, we performed a set of NMR experiments on the 15N-labeled Shg PBM. First, 
we recorded 1H,15N-correlation spectra of the peptide in the presence or absence of unlabeled 
Dm. Par3 PDZ1 or PDZ3 domain. In both cases, this resulted in PDZ:Shg complex formation 
as indicated by the observed CSPs (Fig. 5.6C,D). Subsequently, we added Par6 PBM to the 
PDZ:Shg complex in a step-wise manner and observed for both the PDZ domains a release of  
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Fig. 5.6: The Par6 PBM can compete with Shg for Par3 binding. (A) Overlay of 1H,15N-
HSQC spectra of the Dm. Par3 PDZ1 domain in the absence and presence of the Shg PBM 
peptide as indicated. (B) as (A), but for the Dm. Par3 PDZ32-3loop domain. (C) Overlay 
of 1H,15N-HSQC spectra of the Shg PBM fused to GB1 in the absence (black) or presence of 
dmPar3 PDZ1 domain (purple) and upon step-wise addition of the Par6 PBM (red and 
orange). Arrows indicate the successive reversal of the chemical shifts from the Shg:PDZ 
complex towards the unbound Shg PBM. (D) as (C), but for the PDZ3 PDZ32-3loop 
domain. 
 
the Shg peptide as indicated by chemical shift changes that reverted towards the unbound Shg 
peptide (Fig. 5.6C,D). This demonstrates that the Par6 PBM can indeed compete with Shg for 
Par3 PDZ binding. The relatively high stoichiometric amounts of Par6 PBM required to 
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outcompete the Shg peptide from the PDZ3 domain reflect the large difference in binding 
affinities (Supplemental Table 5.2). Ultimately, the question of direct competition between 
the Par6 PBM and other PBM-containing ligands for Par3 binding in vivo would require 
determining the specific subcellular concentrations of Par3, Par6 and other binding partners, 
the binding affinities within the fully assembled Par complex and the exact chronological 
order of binding events in cells. These are certainly highly interesting, though challenging 
topics for future studies. 
 
The PDZ:PBM interaction is conserved in the human Par3 and 
Par6 proteins 
 
To explore whether the PDZ:PBM interactions that mediate Par3:Par6 association in 
Drosophila are conserved in the human proteins, we co-transfected human embryonic kidney 
(HEK) 293T cells with Flag-tagged human Par3 (hsPar3) and Myc-tagged wild-type or 
truncated hsPar6. Co-immunoprecipitation (co-IP) experiments with the cell lysates showed 
that full-length Par6 readily co-precipitated with Par3, while deletion of the Par6 PBM 
(PBM) abrogated Par3 binding (Fig. 5.7A). In contrast, the amounts of Par6 PDZ that co-
immunoprecipitated with Par3 were comparable with wild-type Par6, while deletion of both 
the Par6 PDZ domain and the PBM (PDZPBM) again abrogated Par3 binding. Consistent 
with our in vitro and in vivo data for the Drosophila Par3:Par6 interaction, this demonstrates 
that the Par6 PBM is important also for the interaction of the human proteins. 
To examine whether the mode of interaction and the specificities of the individual PDZ 
domains towards the Par6 PBM are conserved among human and Drosophila Par3, we 
performed NMR binding studies. Since the human Par3 PDZ1 domain is unfolded in isolation 
(Supplemental Fig. 5.2A), we fused the eight C-terminal residues of hsPar6 to the C-
terminus of the hsPar3 PDZ1 domain separated by a 15-aa GS-linker. This led to a well-
dispersed 1H,15N-correlation spectrum of the 15N-labeled PDZ1:PBM fusion demonstrating 
that the Par6 PBM induces the folding of the PDZ1 domain and hence interacts with the 
Par3 PDZ1 domain (Fig. 5.7B). Addition of unlabeled Par6 PBM peptide to the 15N-labeled 
hsPar3 PDZ2 domain resulted in a few, though partially substantial CSPs (Fig. 5.7C, 
Supplemental Fig. 5.10C) indicating that the human Par3 PDZ2 domain binds to the Par6 
PBM. In contrast, the PDZ3 domain displayed numerous, large CSPs in the presence of Par6  
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Fig. 5.7: The PDZ:PBM interaction is conserved in the human Par3:Par6 complex. (A) 
Schematic representation of the hsPar3 and hsPar6 constructs used for co-
immunoprecipitation (IP) experiments (left). Right panel: Cell lysates of HEK293T cells co-
transfected with human Flag-tagged Par3 and Myc-tagged Par6 variants were subjected to 
Flag-antibody IP followed by immunoblotting (IB) with Flag and Myc antibodies. Equal 
amounts of protein were confirmed by IB as shown (Input). (B) Overlay of 1H,15N-correlation 
spectra of the hsPar3 PDZ1 domain in isolation and fused to the hsPar6 PBM. (C,D) 
Overlay of 1H,15N-correlation spectra of the PDZ2 (C) and the PDZ3 (D) domains in the 
absence and presence of hsPar6 PBM peptide as indicated.  
 
 
(Fig. 5.7D). Mapping of the observed CSPs on the structures of the human Par3 PDZ2 and 
PDZ3 domains shows that both domains can engage the Par6 PBM through canonical 
PDZ:PBM interactions (Supplemental Fig. 5.10C,D). Altogether, these results demonstrate 
that the Par3 PDZ:Par6 PBM interactions as well as the functions of the Par3 PDZ domains 
are largely conserved in the human and Drosophila proteins.  
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Discussion 
 
In this study, we have identified a previously unrecognized PDZ-binding motif in Par6 that 
mediates canonical PDZ:PBM interactions with the PDZ1 and PDZ3 domains of Par3. This 
interaction mode is conserved amongst the human and Drosophila Par3 and Par6 proteins. We 
demonstrate that the PBM, but not the PDZ domain, of Par6 is essential for interaction with 
Par3 in vitro. Yet, the PBM seems to function in redundancy with the PDZ domain in Par6 
localization in fly epithelia, as the individual deletions only mildly reduce cortical localization 
in vivo, and deletion of both the PBM and the PDZ domain are required for almost complete 
mislocalization of Par6.  
Overall, we found no indication of a heterodimerization of the human, Dm. or Ce. Par3 PDZ 
domains with the respective Par6 (Crib-)PDZ domain by NMR (Supplemental Fig. 5.2), in 
GST-pull down (Fig. 5.2B) or co-IP experiments (Fig. 5.7A) nor in recruitment assays in S2R 
cells (Fig. 5.2D). Our results thus provide important, novel insights into Par complex 
assembly and contrast previous findings that Par3 and Par6 associate through PDZ:PDZ 
interaction (Lin et al., 1999; Joberty et al., 2000; Li et al., 2010b). In support of our findings, 
Par3 associates in epithelial cells with various cell adhesion proteins possessing class II PBMs 
that are highly similar to the Par6 PBM (Fig. 5.1B) and we show here that the Dm. Par3 PDZ1 
and PDZ3 domains also interact with the major cell adhesion protein E-cadherin (Shg) (Fig. 
5.6A,B). These interactions have been shown to be crucial for the establishment and 
maintenance of cell junctions and epithelial cell polarity (Lin et al., 1999; Itoh et al., 2001; 
Takekuni et al., 2003; Ebnet et al., 2003; Iden et al., 2006; Tepass, 2012). Of note, as in the 
case of Par6, these adhesion protein interactions are conserved among human and Drosophila 
Par3. In sum, this supports the notion that class II PBMs constitute a general binding motif for 
the Par3 PDZ1 and PDZ3 domains to recruit polarity and cell adhesion proteins for the 
establishment and maintenance of cell polarity. Nematodes may constitute a notable 
exception, as not only their Par6 but also their cadherin (HRM-1) proteins lack a detectable, 
C-terminal PBM (Supplemental Fig. 5.3). Future studies will thus be required to elucidate the 
exact mechanism of Par3 PDZ interactions and their role in cell polarity in nematodes. 
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The individual PDZ binding preferences allow for multivalent 
Par3 interactions 
Tandem arrangement of PDZ domains is a well-known mechanism for scaffolding proteins to 
assemble different components of a signaling cascade through multivalent interactions 
(Tsunoda et al., 1997). This is based on the fact that interaction domains embedded in 
proteins can in general fold and function independently (Pawson and Nash, 2003). We find 
that the isolated Par3 PDZ1 and PDZ3 domains can both independently interact with the Par6 
PBM (Fig. 5.5D,F and 5.7B,D) and thus may function in redundancy. Indeed, these functional 
redundancies allow each Par3 molecule to simultaneously recruit two Par6 proteins in vitro 
(Fig. 5.5G). Together with Par6:aPKC hetero-dimerization and Par3 homo-oligomerization, 
this provides a basis for the role of Par3 in enforcing the spatial segregation and the assembly 
of large-scale, self-organizing Par complex networks at the cell cortex in vivo. 
 
Concluding remarks 
 
The mode of Par3:Par6 interaction has remained controversial. In a sense, this reflects the 
challenges of delineating the specific functions of proteins and even more importantly their 
individual domains and motifs in cell polarity. Functional coupling, redundant interactions, 
differences in organism strains, cell types and protein constructs and finally the existence of 
paralogs severely hamper in vivo analyses of polarity proteins (Nagai-Tamai et al., 2002; 
Fievet et al., 2013). Moreover, the composition of polarity complexes is dynamic and may 
depend on the cell type or developmental context (Henrique and Schweisguth, 2003). Lastly, 
different populations of polarity proteins may even co-exist within a single cell (Goehring et 
al., 2011). Altogether, this poses enormous obstacles for functional analyses as phenotypes 
may be obscured in mutation studies. Detailed structural analyses are thus essential to 
unambiguously determine the molecular basis of polarity complex formation. Moreover, the 
fact that PBMs require a free C-terminus for their function posits that C-terminal tagging for 
fluorescence microscopy or immunoblotting likely abrogates not only Par3:Par6 association, 
but possibly also other, yet unidentified Par6 PBM interactions. Altogether, this may explain 
some of the controversy about the Par3:Par6 interaction. 
The fact that almost all polarity and cell adhesion proteins contain either at least one PDZ 
domain or a PBM emphasizes the importance of PDZ:PBM interactions in the assembly of 
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cell polarity and adhesion signaling networks. Our work illustrates the difficulties in 
predicting PDZ specificities, as the marked differences in Par6 and Shg recognition of the 
Par3 PDZ2 (Fig. 5.5D-F, 5.6A,B and Supplemental Fig. 5.10B, Supplemental Table 5.2) were 
unexpected on the sequence level (Supplemental Fig. 5.9). A detailed characterization of the 
functional specificities and redundancies of PDZ domains, as presented here, is therefore 
indispensable to decipher their contribution to polarity protein localization and function. 
Ultimately, this will help to predict PDZ domain function and provide a better understanding 
of the interaction networks underlying the establishment, maintenance and loss of cell polarity 
and hence critical developmental and carcinogenic processes. 
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Supplemental figures 
  
 
Supplemental Fig. 5.1: Chemical shift perturbation experiments. (A) Exemplary overlay 
of 1H,15N-correlation spectra of a 15N-labeled protein in the absence and presence of an 
unlabeled binding partner at varying stoichiometric ratios. A region of the spectrum 
containing the NMR signals of two consecutive amino acids in the protein sequence is shown. 
(B) Chemical structure of the protein backbone highlighting the 1H and 15N atoms (green 
spheres) observed in the H,N-correlation spectra. The position of a peak in the spectrum 
strongly depends on the local chemical environment of the respective amino acid (indicated 
by light-blue spheres). Therefore, in contrast to an unfolded protein, peaks are distributed over 
a wide range of 1H and 15N chemical shifts in a folded protein. (C) Ligand binding (shown in 
orange) induces a change in the chemical environment, and hence in the chemical shifts, of 
those amino acids that participate in ligand binding (aa #1), but not of those that are located 
outside the binding pocket (aa #2).  
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Supplemental Fig. 5.2: The Par3 PDZ1 domain does not interact directly with the Par6 
(Crib-)PDZ domain. (A) 1H,15N-correlation spectrum of the 15N-labeled Hs. Par3 PDZ1 
domain showing that the domain is largely unstructured in isolation. The boxed region is 
magnified in Fig. 4.7B. (B,C) Overlay of 1H,15N-correlation spectra of the D. melanogaster 
(B) and C. elegans (C) Par3 PDZ1 domains in the absence and presence of a stoichiometric 
excess of the respective Par6 PDZ domain as indicated. (D,E) As (B,C) but for the D. 
melanogaster (D) and C. elegans (E) Par6 semiCRIB-PDZ constructs in the absence and 
presence of a stoichiometric excess of the Par3 PDZ1 domains as indicated. (F,G) As (B,C) 
but for the D. melanogaster Par6 Crib-PDZ construct in the absence and presence of a 
stoichiometric excess of the Par3 PDZ2 (F) and PDZ3 (G) domains as indicated. 
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Supplemental Fig. 5.3: The Par6 C-terminus contains a conserved class II PDZ binding 
motif. Sequences of the C-terminal 16 aa of various vertebrate (top), invertebrate (center) and 
nematode (bottom) Par6 proteins. The class II PBM is highlighted with a red box and 
conserved in all metazoans with the exception of nematodes. Conserved residues were color-
coded with ClustalX (Crooks et al., 2004). 
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Supplemental Fig. 5.4: Par6 localization in S2R cells upon aPKC knockdown. (A) 
Western blot analysis of aPKC expression in S2R cell lysates in the absence or presence of 
dsRNA for aPKC knockdown. (B-E) As Fig. 5.2G-J, but for S2R cells where aPKC is 
knocked down by RNAi. 
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Supplemental Fig. 5.5: Expression of Par6 variants in fly embryos and localization of 
Par6 variants in transgenic flies during gastrulation. (A) Western blot analysis of GFP-
Par6 expression in fly embryo lysates showing that all Par6 variants are stable and expressed 
similarly in a WT background. (B-E) Localization of aPKC, Par3 and GFP-Par6 variants in 
the epithelia of fly embryos during gastrulation (stage 6-7). The scale bar corresponds to 
5m. Arrows in (E) highlight small fractions of Par6 that still localize to the cell cortex. 
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Supplemental Fig. 5.6: Par6 localization in Par6-null fly embryos. (A,B) As Fig. 5.3, but 
for GFP-Par6 WT (A) and GFP-Par6 PBM (B) in a par6226 (par6-null) background.  
 
 
 
Supplemental Fig. 5.7: Crystal structure of the Par3 PDZ1 : Par6 PBM complex. (A) 
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Ribbon representation of the crystal structure of the Par3 PDZ1 : Par6 PBM complex with  
helices and  strands in the PDZ1 domain colored in green and blue, respectively, and the -
strand formed by the Par6 core PBM (VLHL) shown in dark-pink. Secondary structure 
elements are labeled. (B) Surface representation of the Par3 PDZ1 domain highlighting the 
hydrophobic pocket (light-pink) surrounding the Par6 core PBM. (C,D) Structure 
superposition of the Dm. Par3 PDZ1:Par6 PBM complex (grey for the PDZ1 domain and 
raspberry for the PBM) with the Mm. Par3 PDZ3 domain (yellow) in complex with the PBM 
of VE-Cadherin (orange) (PDB-ID: 2KOH (Ernst et al., 2014)) (C) and with the Rn. Par3 
PDZ3 domain (cyan) in complex with the PBM of the PTEN phosphatase (dark cyan) (PDB-
ID: 2K20 (Petronczki and Knoblich, 2001) (D). Otherwise as in Fig. 5.4B. 
 
 
Supplemental Fig. 5.8: Ligand electron density and importance of the 0 and -2 position 
of the Par6 PBM for PDZ interaction. (A-D) Ribbon representation of the two Par3 PDZ1 
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domains in the asymmetric unit of the crystal (blue and green). The electron difference 
density of the Par6 PBM, the three C-terminal residues of the GS-linker and the three N-
terminal residues of the neighboring PDZ1 domain is shown as 2FO-FC map contoured at a  
level of 1.0 (A,C) and 2.0 (B,D). (C,D) As (A,B), but displaying the B-factor distribution of 
the PBM highlighting the increased flexibility of the residues outside the core PBM. The 
color scale for B-factors ranges from blue ( 25 Å2) to red ( 85 Å2). (E) NMR titration 
experiments with 15N-labeled Par3 dmPar3 PDZ1 domain and Par6 core PBM mutants as 
indicated. Otherwise as Fig. 5.1C. 
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Supplemental Fig. 5.9: Structure-based sequence alignment of Par3 PDZ domains. 
Protein sequences of the individual Par3 PDZ domains were aligned with MUSCLE (Larkin 
et al., 2007), manually edited where necessary to match known Par3 PDZ structures (PDB-
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ID: 2KOM (Waudby et al., 2016) for PDZ2 and 2KOH (Ernst et al., 2014) for PDZ3) and 
color-coded with ClustalX (Crooks et al., 2004). Secondary structure elements based on the 
dmPar3 PDZ1 : dmPar6 PBM complex are shown with blue boxes and denoted on the top. 
Residues within 5 Å proton-proton distance of the PBM are highlighted with circles and 
dashed lines (red: -2 position; yellow: 0 position) for the Par3 PDZ1:Par6 and the highly 
similar Par3 PDZ3:VE-cadherin complex (Ernst et al., 2014). This shows that all residues 
contacting the specificity-determining 0 and -2 positions of the PBM are highly conserved 
and thus do not allow a specificity prediction based on sequence alignments. The region 
deleted in the dmPar3 PDZ3 2-3loop construct is indicated with a black box. 
 
 
Supplemental Fig. 5.10: Interaction of the dmPar6 and Shg PBMs with the dmPar3 
PDZ2 domain and Par6:Par3 interactions in the human proteins. (A,B) NMR titration of 
the 15N-labeled dmPar3 PDZ2 domain with Par6 (A) or Shg (B) PBM as indicated. (C,D) 
CSPs induced by the hsPar6 PBM mapped onto the structures of the human Par3 PDZ2 
(PDB-ID: 2KOM (Waudby et al., 2016); left panel) and rat Par3 PDZ3 domain (PDB-ID: 
2K20 (Petronczki and Knoblich, 2001); right panel) and colored with a linear gradient from 
white (CSP ≤ 0.05 ppm) to green (C) or blue (D) (CSP = 0.35 ppm). Residues broadened 
beyond detection in the PDZ3 are shown in dark-blue. Secondary structure elements are 
labeled (for PDZ2 1: aa 5-12, 2: aa 20-24, 3: aa 35-40, 1: aa 45-49, 4: aa 56-61, 5: aa 
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64-65, 2: aa 71-80, 6: aa 86-93; for PDZ3 1: aa 6-14, 2: aa 25-31, 3: aa 38-46, 1: aa 
51-54, 4: aa 62-67, 5: aa 70-71, 2: aa 77-89, 6: aa 97-105). Otherwise as Fig. 5.4D. 
 
 
 
 
Supplemental Fig. 5.11: Line shape fitting analyses of the dmPar3 PDZ1 interactions 
with the PBMs of dmPar6 or Shg. (A) 2D line shape fit of the Asn59 cross peak in the 
individual 1H,15N-HSQC spectra of the dmPar3 PDZ1 domain in the absence or presence of 
Par6 PBM. Observed data are presented as black lines, while fits are shown in magenta. Each 
panel represents the fit of one titration point at the indicated stoichiometric ratio of 
PDZ:PBM. (B,C) Representative region of the NMR titration of 15N-labeled dmPar3 PDZ1 
with Par6 (B) or Shg (C). Contour plots of observed CSPs are shown in the left panel, while 
the fit of the cross peaks is presented in the right panel with black lines indicating the course 
of the fit CSPs between the reference point and the estimated saturation point. Titration steps 
are color coded as indicated. The Asn59 cross peak shown in (A) and (D) is boxed. (D) as (A) 
but for the Shg PBM. 
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Supplemental Fig. 5.12: Line shape fitting analyses of the dmPar3 PDZ3 2-3loop 
interactions with the PBMs of dmPar6 and Shg. (A-D) as in Supplemental Fig. 5.11, but 
for the dmPar3 PDZ3 2-3loop and the Glu81 cross peak (A,D).  
 
 
Supplemental Fig. 5.13: Line shape fitting analyses of the dmPar3 PDZ1 interactions 
with mutant dmPar6 PBMs. (A,B) As in Supplemental Fig. 5.11A, but for the Par6 L0A 
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mutant. (C-F) as in (A,B), but for the Par6 H-1A (C,D) and L-2A (E,F) mutants.  
 
 
Supplemental Fig. 5.14: Line shape fitting analyses of the dmPar3 PDZ2 interactions 
with the Shg PBM. (A, B) as in Supplemental Fig. 5.11, but for the dmPar3 PDZ2 and the 
Ile92 cross peak.  
 
 
 
Supplemental Table 5.1. Statistics of X-ray data collection and model refinement for the 
dmPar3 PDZ1:dmPar6 PBM complex1 
Data collection  
Resolution (Å) 40.96 – 1.50 (1.59 – 1.50) 2 
Completeness (%) 99.8 (98.7) 
No. of unique reflections 86,611 (13,880) 
Redundancy 5.13 (4.88) 
CC1/2* (%) 99.9 (70.2) 
I / I 18.78 (2.12) 
Wilson B-Factor (Å2) 31.13 
FreeR (% of reflections) 5 
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1Number of crystals equals one. 
2Values in parentheses are for highest-resolution shell. 
 
 
 
 
 
Crystal properties  
Space group P31 
Unit cell dimensions  
    a, b, c (Å) 60.88, 60.88, 65.05 
     , ,  ()  90.00, 90.00, 120.00 
Solvent content (%) 57.4 
Refinement  
Resolution (Å) 40.96 – 1.50 (1.53 – 1.50) 
Rwork (%) / Rfree (%) 14.03 / 16.91 
R.m.s.d. bond lengths (Å) 0.02 
R.m.s.d. bond angles (°) 1.64 
B-Factor (Å2) (Overall) 32.18 
     PDZ domain 29.04 
     Peptide (core PBM / outside core PBM) 35.83 / 68.32 
     Solvent 45.19 
No. of atoms (Total)  1796 
      PDZ domain / peptide / solvent 1508 / 138 / 150 
Ramachandran (%) (Favored / allowed / outliers) 98 / 2 / 0 
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Supplemental Table 5.2. Dissociation constants (Kd values) in M for the Dm. Par3 PDZ 
domains and their interactions with the PBMs of Par6 and Shg.1 
Ligand PDZ1 PDZ2 PDZ3 
Par6 216  4  n.d. 54  1 
Par6 L-2A 2486  357 n.d. n.d. 
Par6 H-1A 964  60 n.d. n.d. 
Par6 L0A 4049  1113 n.d. n.d. 
Shg 128  4 954  45 0.6  0.1 
1Kd values are given in M and were determined by line shape fitting of NMR CSP 
experiments. Errors were estimated with bootstrapping statistics on 100 replica. 
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Discussion 
 
Establishing a cellular polarity is a fundamental process and is a prerequisite for development 
and the control of cellular processes. This study aimed to provide a better understanding of 
the function and the regulation of key proteins that are essential for epithelial development 
and the regulation of cellular homeostasis.  
The scaffold protein Baz/Par3 and the serine/threonine kinase LKB1 cooperate to establish 
the initial polarization of epithelial cells. In addition, LKB1 controls the metabolism and 
proliferation of differentiated cells. Baz and LKB1 were the subjects of this study and further 
characterized.  
Within this study a so far uncharacterized lipid binding (LB) domain of LKB1 has been 
identified. In vitro experiments managed to show that LKB1 prefers binding to PA, but also to 
some extend to PtdIns(5)P, PtdIns(4,5)P2 and PtdIns(3,4,5)P3. Notably, binding to PA 
activated LKB1, which was essential for Drosophila development, mouse axon formation and 
to counteract mTOR activity in human cancer cell lines. Understanding the mechanism by 
which potent tumour suppressors, such as LKB1 are activated is important in biomedical 
science to develop and improve new strategies to treat human diseases. Here, using 
Drosophila as a model organism an unknown mechanism to activate LKB1 has been 
described which is also conserved in humans. Thus, although it can be challenging to study 
human diseases like cancer in Drosophila the principle mechanisms of cell proliferation 
control are conserved. 
Moreover, it could have been shown that oligomerization and lipid binding of Baz function 
redundantly to promote the apical localization of Baz in the embryonic epithelium and NBs. 
Strikingly, neither oligomerization nor lipid binding were essential for viability, whereas loss 
of both led to embryonic lethality. Moreover, a novel function of the oligomerization domain 
has been identified, as an oligomerization-deficient protein is destabilized. Additionally, the 
organization of the Par complex has been further analyzed. Although the general functions of 
the Par complex (Baz/Par6/aPKC) in the establishment of a cell polarity became more 
obvious in recent years, the formation of the complex itself remained controversial. However, 
using a combined approach of structural biology and in vivo analysis a detailed study about 
the Par3-Par6 interaction revealed novel insights in the complex assembly. A C-terminal PDZ 
binding motif (PBM) of Par6 binds to the PDZ1 and PDZ3 domains of Par3, whereas the 
previously reported PDZ-PDZ domain interaction of Par3 and Par6 was dispensable. 
Considering the Par complex as a ternary complex is misleading, because of Par3’s capacity 
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to bind two Par6 proteins simultaneously in vitro and form homo-oligomers. Thus, it is more 
likely that the Par complex forms large clusters, which surround the apical domain. In 
addition, a C-terminal PBM of DE-Cad is capable of binding the PDZ1 and PDZ3 domains of 
Par3 independent of Armadillo. Therefore, an alternative mechanism to target Par3 to the 
plasmamembrane has been described.  
 
The membrane association of LKB1 
 
This study identified a novel lipid binding (LB) domain of LKB1 and highlighted that the 
membrane association of LKB1 provides an important cue to activate its catalytic activity. 
Membrane-binding of LKB1 could be shown to be important for the development of 
Drosophila and its function as a tumour suppressor in mammalian cells. LKB1 has previously 
been reported to localize at the plasmamembrane of Drosophila and mammalian cells (Collins 
et al., 2000; Sapkota et al., 2001; Martin and St Johnston, 2003; Sebbagh et al., 2009). It has 
been assumed that this cortical localization is mediated by the addition of a farnesyl moiety, 
which serves as a membrane anchor (Collins et al., 2000; Martin and St Johnston, 2003). 
However, in vivo the farnesylation of LKB1 seems to be dispensable. Farnesylation-deficient 
melanoma cells were still capable to suppress cell growth (Sapkota et al., 2001) and  a 
transgenic farnesylation-deficient knock-in mouse had only a decreased capacity to activate 
AMPK, but had otherwise no obvious defects (Houde et al., 2014). Likewise, the 
farnesylation-deficient flies in this study had a slightly decreased capacity to rescue an lkb1 
null allele, but were viable. By contrast, loss of the identified LB domain strongly reduced 
LKB1’s ability to rescue the mutant. Moreover, the double mutant (LKB1∆LB C564A) 
completely failed to give rise to viable offspring. Thus, although the farnesylation of LKB1 
seems to have an effect on its activity, the major mechanism that recruits LKB1 to the 
plasmamembrane and fully activates it was its LB domain rather than farnesylation.  
LKB1 preferentially bound to PA, but binding to other lipids (PtdIns(5)P, PtdIns(4,5)P2 and 
PtdIns(3,4,5)P3) has also been observed. In response to PA binding the kinase activity of 
LKB1 was strongly enhanced in vitro. PA is mainly produced by PLD and activates also other 
kinases, such as mTOR (Fang et al., 2001). Since LKB1 and its major target to counteract cell 
proliferation are activated by the same mechanism, a novel autoregulation of the activation 
and repression of mTOR signaling has been identified. The association of elevated PLD2 
expression and mTOR activity (as measured by the phosphorylation of S6K) with 
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simultaneous loss of LKB1 in histological samples of human melanoma supports the 
hypothesis of an auto-regulatory effect.  
Binding of LKB1 to PtdIns(5)P was not further investigated in this study, because PtdIns(5)P 
is a low-abundant phospholipid and enriched in endomembranes (Sarkes and Rameh, 2010; 
Ramel et al., 2011), whereas this study focused on epithelial cells in which LKB1 localizes at 
the plasmamembrane. However, with respect to data from non-epithelial cells (mouse 
hepatocytes and embryonic fibroblasts) LKB1 localizes on late endosomes in a complex 
containing AMPK, v-ATPase, Ragulator and AXIN, which is essential to activate LKB1 
(Zhang et al., 2013b; Zhang et al., 2014). Although PtdIns(5)P is more prominent in the 
membrane of the early endosome, it is also incorporated into the late endosome (Ramel et al., 
2011). The mechanism by which LKB1 is activated on late endosomes is not understood, yet. 
Thus, PtdIns(5)P might contribute to the activation of LKB1 on endosomes. In a human 
fibroblast cell line (IMR90) no cortical localization could be observed, which raises the 
question if LKB1 simply localizes in the cytoplasm or in association with endosomes. By 
using a fluorescent reporter that is fused to a PtdIns(5)P binding domain a possible 
coincidence of the lipid and LKB1 on endosomes could be analyzed.  
The elevated degradation of membrane-binding deficient LKB1 (LKB1∆LB C564A) in 
Drosophila supports the idea of an endomembrane localization of LKB1. LKB1∆LB C564A 
was absent from the plasmamembrane and accumulated in the cytoplasm, such as hLKB1 in a 
fibroblast cell line (IMR90), but without the capacity to associate with lipids. In Drosophila, 
LKB1∆LB C564A was in contrast to LKB1 affected by enhanced degradation. Therefore, 
binding to either the plasmamembrane or to endomembranes might be a mechanism to protect 
LKB1 from degradation. Accordingly, in flies that express membrane-binding deficient LKB1 
fused to the PH domains of either PLCδ or Akt1 (to mediate membrane binding), the 
transgenes were not affected by enhanced protein degradation. Nevertheless, a cell type 
specific membrane association of LKB1 could be another explanation. Moreover, the C-
terminus of LKB1, which harbors the LB domain is affected by several posttranslational 
modification, including phosphorylation and acetylation (Sapkota et al., 2001; Lan et al., 
2008). Strikingly, in non-polarized HEK293 cells, LKB1 has been reported to be acetylated 
on lysine 416 (Lan et al., 2008), which is essential for binding lipids. This acetylation might 
interfere with the membrane association of LKB1, but a role of this modification in vivo has 
not been analyzed, yet.  
Regarding the degradation of LKB1 two E3 ubiquitin ligases (CHIP and HERC2) have 
already been described to promote the proteasomal degradation of LKB1 (Gaude et al., 2012; 
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Bai et al., 2016). Given that a decreased amount of LKB1 is frequently found in various 
tumours, identifying other E3 ubiquitin ligases that target LKB1 for degradation would help 
to develop new strategies to treat cancer or to discover new biomarker. Some molecules that 
inhibit specific E3 ubiquitin ligases are currently undergoing clinical trials (Bielskienė et al., 
2015). 
 
The PA mediated activation of LKB1 
 
Given that LKB1 was activated upon binding to PA it remains to be investigated how this 
activation occurs on the molecular level. The structure of the LKB1/STRADα/Mo25 complex 
has previously been resolved (Zeqiraj et al., 2009). Based on the reported crystal structure of 
the complex, binding of STRADα to LKB1 causes an allosteric activation of LKB1, which is 
stabilized by Mo25. However, in this study only truncated variants of STRADα (residues 59 – 
431) and LKB1 (residues 43 – 347) have been analyzed (Zeqiraj et al., 2009). Therefore, a 
putative role in the activation of LKB1 of the either the N- or C-terminus remains enigmatic. 
Loss of the membrane binding capacity of LKB1 did not affect its association with STRADα 
(Stlk in Drosophila), Mo25 and AMPK in the Drosophila embryo. Nevertheless, this complex 
had a significantly decreased catalytic activity and failed to rescue an lkb1 null allele. The 
chimeric proteins that were fused to the PH domains of either PLCδ or Akt1 were able to 
restore the membrane localization of LKB1 and to rescue the null allele to a large extend. In 
vitro, the addition of PA to the recombinant human LKB1/STRADα/Mo25 complex strongly 
enhances its kinase activity, whereas adding either PtdIns(4,5)P2 or PtdIns(3,4,5)P3 led only 
to a moderate activation. This indicates the specific association of LKB1 with PA is required 
to fully activate its catalytic activity.  
In order to better understand the PA-dependent activation of LKB1 at the molecular level the 
structure of LKB1 in complex with liposomes containing PA could be determined by NMR. 
The conformational change of LKB1 upon binding to PA should induce a chemical shift 
perturbation (CSP), if the conformation of LKB1 changes upon binding PA. Therefore PA-
containing liposomes could be titrated to LKB1, which also allows determining the 
dissociation constant (KD-value) that will provide information about the strength of the 
interaction. Knowing the structure of the PA-activated LKB1 will help to gain insight to the 
(mis)regulation of this important tumour suppressor. To this end, sequence optimized variants 
of the human LKB1 and the membrane-binding deficient form have been generated, because 
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of an inefficient translation of the human codon sequences in E. coli (data not shown). 
Moreover, an attempt to gain insight into the PA-dependent regulation of LKB1 using atomic 
force microscopy (AFM, in cooperation with AG Gießibl, University of Regensburg) has 
been made. AFM bears the potential to provide structural information of molecules at atomic 
resolution. Nevertheless, although we were able to visualize lipid head groups of a lipid 
bilayer, which was adsorbed on mica, we could not acquire structural information about 
membrane-bound recombinant LKB1 (data not shown). 
 
The functional redundancy of the OD and LB motif 
 
The N-terminal oligomerization domain (OD) of Baz/Par3 is highly conserved among animals 
and has been described to be essential in Drosophila and mammalian cells (MDCK) to target 
Baz/Par3 to the plasmamembrane (Benton and St. Johnston, 2003b; Mizuno et al., 2003). In 
addition, loss of the OD results in a severely compromised capacity to rescue a baz null allele 
(Benton and St. Johnston, 2003b). However, this study found that the OD is neither essential 
to tether Baz to the plasmamembrane nor for viability of Drosophila embryos. Baz∆OD 
localizes entirely at the apical junctions, overlapping with DE-Cad. Likewise, mutating the 
lipid binding (LB) domain did not affect the localization or rescue ability as well, which is in 
line with previous data (Krahn et al., 2010b). Surprisingly, loss of both domains 
(Baz∆OD∆LB) completely abolished the cortical localization, ability to rescue a null allele 
and protein stability of Baz. This indicates a functional redundancy between the OD and LB 
motif, which cannot be compensated by any other domain (e.g. the PDZ domains) of Baz. 
Given that a chimeric protein, which carries the oligomerization domain of the human TEL 
protein efficiently restores the function of Baz∆OD∆LB, oligomerization per se rather than a 
specific feature of the OD is enough for the function of Baz in the absence of the lipid binding 
motif.  
Although Baz has been reported to localize to the plasmamembrane by binding to Ed, Arm 
and Stan via its PDZ domains (Wei et al., 2005; Wasserscheid et al., 2007), none of these 
proteins seems to be capable to initially recruit Baz to the plasmamembrane. Strikingly, the 
interaction of Baz∆OD∆LB with any of these proteins was impaired, as all of them managed 
to recruit Baz∆OD∆LB to artificial cell-cell contacts in S2R cells. This suggests a role for 
oligomerization and lipid binding as important initial cues to tether Baz to the 
plasmamembrane. The observation that the simultaneous loss of the PDZ (interacts with Ed, 
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Arm and Stan) domains and the LB motif did not affect the apical localization of Baz further 
highlights the role of the OD and LB motif for the localization of Baz, rather than the PDZ 
domains. Nevertheless, loss of all PDZ domains causes embryonic lethality (Krahn et al., 
2010b), whereas mutating either the OD or LB motif can be compensated and produces viable 
offspring. The PDZ domains of Baz/Par3 have been reported to bind directly to phospholipids 
in vitro (Wu et al., 2007; Yu and Harris, 2012), however in cell culture experiments the PDZ 
domains were not able to mediate a cortical localization of Baz∆LB. This suggests, that the 
association of the PDZ domains with phospholipids is either not relevant in vivo (at least not 
in S2R cells) or is restricted to a certain function of Baz. Although the PDZ domains seem to 
be dispensable for the initial recruitment of Baz to the plasmamembrane they become 
indispensable during further development. The initial recruitment of Baz to the 
plasmamembrane neither requires the OD nor the LB motif, but rather a specific function, 
which is mediated in redundancy by them. 
 
Oligomerization promotes the stability of Baz  
 
In addition to the role of the OD in localizing Baz, this study described a novel function of the 
OD to maintain the stability of Baz. Mutations that affect the critical residues, which are 
required to mediate the self-association of Baz, markedly reduce the amount of Baz protein. 
The enhanced degradation of oligomerization-deficient Baz was rescued by fusing the 
heterologous OD of the human TEL protein to the Baz N-terminus. Therefore, although 
oligomerization is not essential for viability it contributes to the stability of Baz. However, it 
remains to be investigated by which mechanism the amount of Baz∆OD protein decreases. 
Oligomerization-deficient Baz could either be prone to aberrant targeting of proteases or E3-
ubiquitin ligases that promote its proteasomal degradation. Baz has previously been reported 
to have multiple truncated variants (based on observations from western blots), which arise 
either from proteolytic cleavage or proteasomal degradation (Krahn et al., 2009). Thus, the 
self-assembly of Baz might shield the protein from degradation.   
In future studies it could become an objective to identify potential Baz proteases or E3-
ubiquitin ligases that degrade Baz. The immunoprecipitation of wildtype and oligomerization-
deficient Baz followed by mass spectrometry could be a promising approach to analyze 
potential differences in the interactome of both proteins. Another approach for the analysis of 
dimer-specific interaction partner would be bimolecular complementation affinity purification 
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(BiCAP) (Croucher et al., 2016), which is also followed by mass spectrometry. The loss of 
Baz’s oligomerization could favor the interaction with its degrading enzymes, which might 
facilitate their identification.  
 
Novel insights into the structural organization of the Par complex 
 
This study provided a novel understanding of the molecular organization of the Par complex. 
The current model of the Par complex supposes that Par6 binds to the first PDZ domain of 
Baz/Par3 via its own PDZ domain, which might also require its CRIB motif (Lin et al., 2000; 
Joberty et al., 2000). However, the data shown here reject this model. PDZ domains are 
frequently bound by proteins that harbor a PDZ binding motif (PBM). Here, a so far 
undescribed PBM at the C-terminus of Par6 has been identified. Loss of the Par6 PBM 
abolishes the interaction with the PDZ domains of Baz in vitro and a recombinant Par6 CRIB-
PDZ protein fails to bind the Baz PDZ domains. In addition, Par6∆PDZ is efficiently 
recruited to the cell cortex by Baz in S2R cells. Finally, the NMR spectra of neither Par6 PDZ 
nor Par3 PDZ changed upon incubation with each other, which indicates that the two domains 
do not interact with each other. Furthermore, in contrast to previous studies we found that 
Par6 binds in addition to the first PDZ domain of Baz also to the third PDZ domains, which 
enables Baz to bind two Par6 proteins simultaneously. The interaction between the Par6 PBM 
and the Baz PDZ3 domain were even four times stronger than between Par6 PBM and Baz 
PDZ1. Taken together, the interaction between Par6 and Baz does not depend on a PDZ-PDZ 
interaction, but rather on the PBM of Par6. Nevertheless, in the epidermis of Drosophila 
embryos the PDZ domain and the PBM of Par6 function redundantly to recruit Par6 to the 
apical junctions. Moreover, embryos that express Par6∆PBM overcome the embryonic 
lethality of a par6 null allele, whereas Par6∆PDZ expressing embryos die. The importance of 
the Par6 PDZ domain for embryonic viability is most likely due to its function of binding to 
the ECR1 domain of Sdt to join the Crb complex or to directly bind the PBM of Crb upon the 
apical exclusion of Baz (Lemmers et al., 2004; Wang et al., 2004; Morais-de-Sá et al., 2010; 
Whitney et al., 2016; Koch et al., 2016). Given that Baz also forms a complex with Sdt prior 
to the expression of Crb (Krahn et al., 2010a), Par6∆PBM could associate with the Baz-Sdt 
complex by binding Sdt during gastrulation and afterwards join to the Crb complex. Binding 
either directly to Baz (via PBM) or indirectly in complex with Sdt (via PDZ domain) could 
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explain the functional redundancy and would be in line with the cytoplasmic localization of 
the double mutant (Par6∆PDZ∆PBM). 
In addition to the novel PBM-PDZ interaction of Par6 and Baz, this study further showed a 
direct interaction of DE-Cad and Baz for the first time. In Drosophila, the interaction of Baz 
and DE-Cad has been described to be indirect and requires Arm (Wei et al., 2005). By 
contrast, mammalian VE-Cad binds directly with its C-terminal PBM to the first and third 
PDZ domains of Par3, which is essential for the polarization of endothelial cells (Iden et al., 
2006). Similar to the mammalian system, DE-Cad contains a class II PBM that mediates the 
interaction with the first and third PDZ domain of Baz as well. Notably, the interaction of the 
DE-Cad PBM with the third PDZ domain of Baz is more than 50 times stronger compared 
towards the PBM of Par6. However, both PBM’s compete with each other for binding to the 
third PDZ domain of Baz in vitro. The cellular context of this competition has not been 
determined, yet, but the stronger affinity of the DE-Cad PBM towards Baz might contribute to 
the observation of an apical exclusion of Baz (Nam and Choi, 2003; Vogelmann and Nelson, 
2004; Harris and Peifer, 2005; Martin-Belmonte et al., 2007; Morais-de-Sá et al., 2010; 
Doerflinger et al., 2010). To date two mechanisms have been described, which promote the 
segregation of Baz from the SAR towards the AJ. First, the phosphorylation of Baz by aPKC 
induces the dissociation of the Par complex and the translocation of Baz to the AJ (Morais-de-
Sá et al., 2010). Second, the phosphorylation of Arm by Pak4 is essential for the retention of 
Baz at the AJ in Drosophila photoreceptor cells (Walther et al., 2016). The direct association 
of DE-Cad with Baz might contribute to the accumulation of Baz at the AJ by sequestering it. 
The role of Baz’s accumulation at the AJ in vivo still remains to be investigated, but it might 
be necessary for Baz as an exocyst receptor to regulate the delivery of cell adhesion proteins 
to the AJ.  
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